Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",A1BG,Alpha-1B-glycoprotein,19834,169,1.19 [0.51-2.79],0.6812818019288258
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AAMDC,Mth938 domain-containing protein,19304,165,0.98 [0.74-1.30],0.8987933582562496
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AARSD1,Alanyl-tRNA editing protein Aarsd1,22638,187,1.10 [0.88-1.38],0.4029417300737385
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ABCA2,ATP-binding cassette sub-family A member 2,19204,165,1.27 [0.87-1.86],0.2143366311570505
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ABHD14B,Protein ABHD14B,22516,190,0.90 [0.72-1.13],0.3646451615930131
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ABL1,Tyrosine-protein kinase ABL1,22638,187,0.94 [0.77-1.14],0.5258757958020361
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ABO,Histo-blood group ABO system transferase,19809,169,1.12 [1.02-1.24],0.0230883321135677
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ABRAXAS2,BRISC complex subunit Abraxas 2,19204,165,0.93 [0.74-1.17],0.5370294367123554
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",22228,185,0.95 [0.81-1.11],0.485940810879042
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",19422,163,0.80 [0.61-1.04],0.0884762408567567
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",19806,170,0.90 [0.76-1.07],0.2208795521028395
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACAN,Aggrecan core protein,22535,185,0.72 [0.46-1.15],0.1694745253481453
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACE,Angiotensin-converting enzyme,19809,169,1.40 [0.80-2.44],0.2385214889378343
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACE2,Angiotensin-converting enzyme 2,22335,183,1.08 [0.85-1.37],0.5379782156583104
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACHE,Acetylcholinesterase,19390,164,1.16 [0.74-1.81],0.512988533111414
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACOT13,Acyl-coenzyme A thioesterase 13,19705,168,0.89 [0.78-1.01],0.0818395726884888
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,22739,185,0.84 [0.64-1.10],0.2089012168956564
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACP1,Low molecular weight phosphotyrosine protein phosphatase,19252,163,0.97 [0.69-1.36],0.8616509262955272
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACP5,Tartrate-resistant acid phosphatase type 5,22851,189,0.92 [0.61-1.39],0.6924192706971217
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACP6,Lysophosphatidic acid phosphatase type 6,22903,188,0.91 [0.77-1.09],0.3141448060944298
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACRBP,Acrosin-binding protein,19698,167,0.74 [0.49-1.12],0.148973211957708
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACRV1,Acrosomal protein SP-10,19252,163,0.84 [0.54-1.30],0.4359155908537435
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACSL1,Long-chain-fatty-acid--CoA ligase 1,19204,165,0.71 [0.44-1.15],0.1685018720485022
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACTA2,"Actin, aortic smooth muscle",22335,183,1.36 [1.06-1.75],0.014144188657054
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACTN2,Alpha-actinin-2,19204,165,0.87 [0.65-1.16],0.3376563004802754
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACTN4,Alpha-actinin-4,22309,181,1.16 [0.80-1.70],0.4312644712521734
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACVRL1,Serine/threonine-protein kinase receptor R3,22559,189,1.79 [1.08-2.95],0.0235782969289155
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACY1,Aminoacylase-1,22739,185,1.15 [0.94-1.40],0.1741392592864889
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,19204,165,0.86 [0.66-1.14],0.3006215525291347
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACYP1,Acylphosphatase-1,19306,163,0.89 [0.71-1.12],0.332069261004578
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADA,Adenosine deaminase,22992,190,1.03 [0.71-1.49],0.89333549225929
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADA2,Adenosine deaminase 2,22587,190,0.92 [0.67-1.25],0.5763288503104853
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,19252,163,1.65 [1.22-2.22],0.0010478149042658
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,22335,183,1.07 [0.70-1.65],0.74360200245905
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,22595,190,1.21 [0.84-1.74],0.3110055172733555
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,22992,190,1.30 [0.89-1.89],0.1815897736034362
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,22903,190,0.96 [0.61-1.52],0.8623378113147571
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,19705,168,1.25 [0.78-2.01],0.3492632382330832
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,19252,163,0.90 [0.55-1.49],0.6908225307159039
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,23014,190,1.08 [0.62-1.88],0.7767186239633483
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,22638,187,1.47 [1.08-2.00],0.0151270081397264
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,22335,183,0.96 [0.62-1.46],0.8324722766535998
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,19252,163,1.43 [0.98-2.08],0.0634290732959477
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,22813,190,1.25 [0.94-1.67],0.1249985724093767
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAMTSL2,ADAMTS-like protein 2,19801,169,1.65 [1.09-2.48],0.0170831935725925
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAMTSL4,ADAMTS-like protein 4,19304,165,1.06 [0.56-2.01],0.8644070205848885
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAMTSL5,ADAMTS-like protein 5,19806,170,1.16 [0.80-1.69],0.4389583733993013
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,22228,185,1.05 [0.77-1.45],0.7509318458704453
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADD1,Alpha-adducin,19390,164,0.89 [0.72-1.10],0.263082734386965
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADGRB3,Adhesion G protein-coupled receptor B3,22559,189,1.66 [1.14-2.40],0.0078634543890055
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADGRD1,Adhesion G-protein coupled receptor D1,19390,164,1.47 [1.00-2.17],0.0510101587076981
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADGRE1,Adhesion G protein-coupled receptor E1,19705,168,1.06 [0.81-1.37],0.6818471046693974
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADGRE2,Adhesion G protein-coupled receptor E2,22848,191,1.14 [0.73-1.80],0.5638165305873355
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,22905,188,0.99 [0.64-1.52],0.9584646654616704
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADGRF5,Adhesion G protein-coupled receptor F5,19806,170,0.75 [0.46-1.22],0.2456854555606137
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADGRG1,Adhesion G-protein coupled receptor G1,22638,187,1.02 [0.85-1.24],0.8239134753436742
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADGRG2,Adhesion G-protein coupled receptor G2,22739,185,0.90 [0.55-1.46],0.6595445542192052
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADGRV1,Adhesion G-protein coupled receptor V1,19195,164,0.93 [0.74-1.16],0.5281928890558223
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADH1B,All-trans-retinol dehydrogenase,19390,164,0.99 [0.82-1.21],0.9576756685494237
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,22335,183,1.12 [0.97-1.30],0.1325642124393884
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADIPOQ,Adiponectin,19834,169,0.72 [0.58-0.89],0.0022303454302657
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADM,Pro-adrenomedullin,22943,189,1.55 [0.93-2.57],0.0914776086238758
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADRA2A,Alpha-2A adrenergic receptor,19204,165,1.00 [0.81-1.23],0.9901196690808376
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AFAP1,Actin filament-associated protein 1,19390,164,0.77 [0.64-0.94],0.0096032033086694
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AFM,Afamin,19834,169,2.21 [1.03-4.73],0.0413220919367702
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AFP,Alpha-fetoprotein,22531,188,1.01 [0.83-1.22],0.9423188818691974
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AGBL2,Cytosolic carboxypeptidase 2,19195,164,1.19 [1.00-1.41],0.0507415925290389
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AGER,Advanced glycosylation end product-specific receptor,22694,189,1.17 [0.85-1.60],0.3411155705275283
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AGR2,Anterior gradient protein 2 homolog,21978,181,0.98 [0.86-1.11],0.7261854420700615
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AGR3,Anterior gradient protein 3,22187,184,1.10 [0.89-1.36],0.3720721109151738
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AGRN,Agrin,22848,191,1.39 [0.96-2.01],0.0801430763702453
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AGRP,Agouti-related protein,22992,190,1.49 [1.17-1.91],0.0014877280876829
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AGT,Angiotensinogen,19809,169,1.21 [0.65-2.26],0.5456572449893222
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AGXT,Serine--pyruvate aminotransferase,22739,185,0.98 [0.83-1.16],0.7947242837678554
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AHCY,Adenosylhomocysteinase,22739,185,0.85 [0.70-1.03],0.0916092085557025
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AHNAK,Neuroblast differentiation-associated protein AHNAK,19304,165,1.08 [0.68-1.72],0.7500752422872643
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AHNAK2,Protein AHNAK2,19304,165,1.63 [1.03-2.59],0.038210036453291
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,19698,167,0.82 [0.64-1.05],0.1100698708862231
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AHSG,Alpha-2-HS-glycoprotein,19809,169,1.13 [0.65-1.95],0.6626423343174177
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AHSP,Alpha-hemoglobin-stabilizing protein,22716,189,1.10 [0.95-1.26],0.2141387063478301
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AIDA,"Axin interactor, dorsalization-associated protein",19251,160,1.09 [0.93-1.29],0.2732087756983306
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AIF1,Allograft inflammatory factor 1,22228,185,0.91 [0.71-1.18],0.4823577582548694
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AIF1L,Allograft inflammatory factor 1-like,19304,165,1.01 [0.78-1.31],0.9098257183012904
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",22593,187,0.92 [0.81-1.04],0.1916017160293425
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AK1,Adenylate kinase isoenzyme 1,22739,185,1.04 [0.86-1.27],0.6850961679622158
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AK2,"Adenylate kinase 2, mitochondrial",19765,168,0.97 [0.84-1.11],0.6244721386106282
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AKAP12,A-kinase anchor protein 12,19390,164,0.99 [0.49-2.00],0.987871398780384
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AKR1B1,Aldo-keto reductase family 1 member B1,22228,185,0.88 [0.74-1.05],0.1482223574523703
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AKR1B10,Aldo-keto reductase family 1 member B10,19251,160,0.84 [0.65-1.09],0.1928547822024101
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AKR1C4,Aldo-keto reductase family 1 member C4,22335,183,0.86 [0.66-1.13],0.2766270678830785
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AKR7L,Aflatoxin B1 aldehyde reductase member 4,19252,163,1.10 [0.91-1.34],0.3213462857203518
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AKT1S1,Proline-rich AKT1 substrate 1,22176,182,1.00 [0.82-1.22],0.9975380642443868
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AKT2,RAC-beta serine/threonine-protein kinase,19775,169,0.92 [0.82-1.03],0.162228040331479
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AKT3,RAC-gamma serine/threonine-protein kinase,22119,184,0.79 [0.62-1.00],0.0494140993486617
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,23014,190,0.95 [0.50-1.82],0.8803896975204102
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ALDH1A1,Retinal dehydrogenase 1,22752,190,0.98 [0.78-1.23],0.8606895650553867
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ALDH2,"Aldehyde dehydrogenase, mitochondrial",19698,167,1.03 [0.78-1.35],0.8451120138031438
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",22669,187,1.04 [0.87-1.24],0.661044113800358
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",19775,169,0.93 [0.68-1.28],0.6671825672842566
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ALMS1,Alstrom syndrome protein 1,19422,163,0.81 [0.56-1.18],0.2675339888066386
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ALPI,Intestinal-type alkaline phosphatase,19252,163,0.96 [0.85-1.09],0.5316611707937018
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ALPP,"Alkaline phosphatase, placental type",22638,187,1.23 [1.09-1.40],0.0012804172439152
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AMBN,Ameloblastin,22309,181,0.96 [0.59-1.56],0.8552520868265718
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AMBP,Protein AMBP,22910,189,1.05 [0.55-1.99],0.8922085433950955
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,19801,169,1.06 [0.59-1.88],0.8528301025369167
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AMFR,E3 ubiquitin-protein ligase AMFR,22176,182,0.84 [0.67-1.05],0.1233721471701179
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AMIGO1,Amphoterin-induced protein 1,19251,160,1.16 [0.89-1.52],0.2687151821104713
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AMIGO2,Amphoterin-induced protein 2,22638,187,0.90 [0.51-1.60],0.7280941971130971
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AMN,Protein amnionless,22309,181,1.06 [0.81-1.39],0.6770984992541889
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AMOT,Angiomotin,19390,164,1.02 [0.70-1.47],0.9329046577827032
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AMOTL2,Angiomotin-like protein 2,19638,165,1.19 [0.90-1.57],0.2284984742088257
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AMPD3,AMP deaminase 3,19765,168,1.19 [0.98-1.45],0.0792916860775434
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,18535,161,1.01 [0.74-1.37],0.948540440952178
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AMY2A,Pancreatic alpha-amylase,21837,179,1.00 [0.75-1.32],0.9788892964691231
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AMY2B,Alpha-amylase 2B,21177,172,1.01 [0.76-1.34],0.9514941592148476
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANG,Angiogenin,22662,191,0.98 [0.68-1.43],0.9262229668644524
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANGPT1,Angiopoietin-1,22665,190,1.05 [0.91-1.23],0.4891881969153557
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANGPT2,Angiopoietin-2,22943,189,1.29 [0.92-1.80],0.1383187544861852
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANGPTL1,Angiopoietin-related protein 1,22432,182,0.95 [0.61-1.50],0.839878925987116
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANGPTL2,Angiopoietin-related protein 2,22780,190,1.01 [0.74-1.39],0.9363350121776592
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANGPTL3,Angiopoietin-related protein 3,22731,192,0.87 [0.61-1.23],0.435594311409639
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANGPTL4,Angiopoietin-related protein 4,22809,191,0.99 [0.74-1.32],0.929414369017968
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANGPTL7,Angiopoietin-related protein 7,22943,189,1.22 [0.87-1.71],0.2469765715945909
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANK2,Ankyrin-2,19204,165,1.15 [0.96-1.37],0.1184689293904151
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,19252,163,0.89 [0.74-1.08],0.2495506967070814
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANKRA2,Ankyrin repeat family A protein 2,19107,162,0.95 [0.73-1.25],0.72222180768299
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANKRD54,Ankyrin repeat domain-containing protein 54,22228,185,1.10 [0.89-1.36],0.3634278283573469
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,19304,165,0.88 [0.59-1.30],0.5160983955714638
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANPEP,Aminopeptidase N,22766,191,1.00 [0.64-1.57],0.996084629368006
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANXA1,Annexin A1,19264,163,0.77 [0.52-1.12],0.1668512984947566
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANXA10,Annexin A10,22176,182,0.95 [0.80-1.11],0.5030564660460475
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANXA11,Annexin A11,22671,186,0.86 [0.72-1.04],0.1185336802018576
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANXA2,Annexin A2,19012,164,0.95 [0.77-1.18],0.6531111984564748
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANXA3,Annexin A3,22903,190,0.87 [0.72-1.04],0.1316678422439661
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANXA4,Annexin A4,22623,185,0.85 [0.70-1.02],0.0803158090210357
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANXA5,Annexin A5,22115,181,0.90 [0.58-1.40],0.6329168289802317
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AOC1,Amiloride-sensitive amine oxidase [copper-containing],22309,181,1.07 [0.87-1.32],0.5184750795423171
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AOC3,Membrane primary amine oxidase,22808,192,0.97 [0.64-1.48],0.900149676468675
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AP1G2,AP-1 complex subunit gamma-like 2,19698,167,0.91 [0.75-1.10],0.3240434327035938
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AP2B1,AP-2 complex subunit beta,19251,160,0.91 [0.66-1.26],0.5799560793710075
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AP3B1,AP-3 complex subunit beta-1,19705,168,0.93 [0.76-1.12],0.4398521029892148
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AP3S2,AP-3 complex subunit sigma-2,19765,168,1.04 [0.76-1.42],0.7996810173248023
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,22638,187,1.07 [0.81-1.42],0.634216485238371
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APCS,Serum amyloid P-component,19652,168,1.07 [0.70-1.64],0.7495432534004713
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,22868,187,0.96 [0.77-1.20],0.7305847742184136
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APLP1,Amyloid-like protein 1,22739,185,0.98 [0.76-1.26],0.8887038183384115
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APOA1,Apolipoprotein A-I,19834,169,0.98 [0.57-1.68],0.9448235787804
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APOA2,Apolipoprotein A-II,19809,169,0.80 [0.59-1.08],0.138937601908465
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APOA4,Apolipoprotein A-IV,19834,169,0.87 [0.57-1.32],0.5089579061258658
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APOB,Apolipoprotein B-100,19809,169,1.41 [0.73-2.73],0.3120192157021075
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APOBR,Apolipoprotein B receptor,19304,165,0.85 [0.60-1.19],0.3389407105659214
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APOC1,Apolipoprotein C-I,19790,169,0.94 [0.62-1.43],0.7725613315716389
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APOD,Apolipoprotein D,18920,165,1.25 [0.94-1.66],0.1172723401910418
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APOE,Apolipoprotein E,19834,169,1.10 [0.93-1.32],0.2699358165839129
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APOF,Apolipoprotein F,19809,169,0.77 [0.48-1.23],0.2684612496149221
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APOH,Beta-2-glycoprotein 1,22752,190,0.91 [0.63-1.31],0.6223239221027963
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APOL1,Apolipoprotein L1,19809,169,0.96 [0.77-1.21],0.7567697414293114
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APOM,Apolipoprotein M,22771,192,0.84 [0.53-1.34],0.4654122991481214
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APP,Amyloid-beta precursor protein,22718,190,0.98 [0.81-1.18],0.8284437988139763
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APPL2,DCC-interacting protein 13-beta,19390,164,0.90 [0.79-1.03],0.1283945429696623
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APRT,Adenine phosphoribosyltransferase,22565,190,0.87 [0.67-1.13],0.2838735921300028
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARAF,Serine/threonine-protein kinase A-Raf,19422,163,0.98 [0.79-1.23],0.876295130364486
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AREG,Amphiregulin,22638,187,1.07 [0.81-1.40],0.6444987126330477
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARF6,ADP-ribosylation factor 6,19705,168,0.93 [0.81-1.07],0.3024612619955352
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARFIP1,Arfaptin-1,19775,169,0.96 [0.77-1.19],0.6986777183392272
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARG1,Arginase-1,22643,184,1.16 [0.91-1.47],0.2375086633981914
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARG2,"Arginase-2, mitochondrial",19698,167,0.79 [0.55-1.14],0.2100565435031931
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARHGAP1,Rho GTPase-activating protein 1,22228,185,0.93 [0.70-1.24],0.627666462791563
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARHGAP25,Rho GTPase-activating protein 25,22228,185,1.03 [0.82-1.28],0.8132469354608621
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARHGAP30,Rho GTPase-activating protein 30,19422,163,1.22 [0.86-1.72],0.2602462691713971
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARHGAP45,Rho GTPase-activating protein 45,19390,164,0.85 [0.71-1.03],0.0935441950638995
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARHGAP5,Rho GTPase-activating protein 5,19107,162,1.01 [0.83-1.22],0.937086264027028
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARHGEF1,Rho guanine nucleotide exchange factor 1,19765,168,0.93 [0.79-1.10],0.3868888896130235
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARHGEF10,Rho guanine nucleotide exchange factor 10,19775,169,1.02 [0.87-1.20],0.7659492629900533
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARHGEF12,Rho guanine nucleotide exchange factor 12,22702,187,0.97 [0.86-1.10],0.6219489334644418
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARHGEF5,Rho guanine nucleotide exchange factor 5,19195,164,0.86 [0.69-1.07],0.1741235080858213
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARID3A,AT-rich interactive domain-containing protein 3A,19195,164,0.82 [0.55-1.21],0.3158276759179327
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARID4B,AT-rich interactive domain-containing protein 4B,22176,182,0.97 [0.71-1.33],0.85075662489498
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARL13B,ADP-ribosylation factor-like protein 13B,19204,165,0.78 [0.61-0.98],0.0349359500783273
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,19204,165,0.74 [0.51-1.08],0.1217708481475018
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARMCX2,Armadillo repeat-containing X-linked protein 2,19195,164,0.94 [0.73-1.20],0.6083211257952517
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARNT,Aryl hydrocarbon receptor nuclear translocator,22309,181,1.08 [0.77-1.53],0.6600423827061558
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,19204,165,1.27 [1.01-1.58],0.0382896861923569
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARSA,Arylsulfatase A,22752,190,0.94 [0.70-1.25],0.6519423940144973
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARSB,Arylsulfatase B,22638,187,0.88 [0.70-1.12],0.3098235492781342
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ART3,Ecto-ADP-ribosyltransferase 3,22808,192,0.96 [0.65-1.40],0.8249296769448755
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ART5,Ecto-ADP-ribosyltransferase 5,19195,164,0.75 [0.55-1.01],0.0612796374002718
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARTN,Artemin,22309,181,0.93 [0.68-1.27],0.646846425894529
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ASAH1,Acid ceramidase,19616,167,0.82 [0.58-1.15],0.2469960058560789
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ASAH2,Neutral ceramidase,22595,190,1.24 [0.95-1.63],0.1078428327495905
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ASGR1,Asialoglycoprotein receptor 1,22595,190,1.61 [1.05-2.46],0.0279065343540768
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ASGR2,Asialoglycoprotein receptor 2,19809,169,1.05 [0.60-1.82],0.8749084342560214
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ASPN,Asporin,19806,170,1.00 [0.59-1.70],0.993658990080766
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ASPSCR1,Tether containing UBX domain for GLUT4,19775,169,1.05 [0.84-1.30],0.6753707154433883
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ASRGL1,Isoaspartyl peptidase/L-asparaginase,19304,165,0.98 [0.85-1.14],0.8060006277105987
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ASS1,Argininosuccinate synthase,19204,165,0.91 [0.75-1.10],0.3239456989949832
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATF2,Cyclic AMP-dependent transcription factor ATF-2,22176,182,0.86 [0.68-1.09],0.2063199546345281
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATF4,Cyclic AMP-dependent transcription factor ATF-4,19107,162,0.92 [0.59-1.44],0.7230040612278621
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATG16L1,Autophagy-related protein 16-1,19705,168,0.97 [0.81-1.15],0.718417858350382
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATG4A,Cysteine protease ATG4A,22228,185,1.04 [0.84-1.29],0.7136178567984868
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATOX1,Copper transport protein ATOX1,22813,190,0.95 [0.79-1.14],0.5717946654535275
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,19204,165,0.85 [0.60-1.20],0.3499389471743098
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,19204,165,0.90 [0.57-1.42],0.6486335447058416
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,19204,165,0.92 [0.63-1.35],0.6814941519041426
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATP1B4,Protein ATP1B4,19107,162,1.26 [0.91-1.74],0.1574720339404047
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATP2B4,Plasma membrane calcium-transporting ATPase 4,19204,165,1.15 [0.94-1.42],0.1780019653758514
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATP5F1D,"ATP synthase subunit delta, mitochondrial",19204,165,1.09 [0.84-1.41],0.5305050189068641
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATP5IF1,"ATPase inhibitor, mitochondrial",22848,191,0.86 [0.77-0.96],0.0096536484804132
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATP5PO,"ATP synthase subunit O, mitochondrial",22176,182,0.90 [0.65-1.25],0.5274300040858931
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATP6AP2,Renin receptor,22228,185,1.28 [0.99-1.66],0.0607726022166317
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATP6V1D,V-type proton ATPase subunit D,22638,187,1.19 [0.77-1.85],0.4249643679844226
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATP6V1F,V-type proton ATPase subunit F,22128,182,1.01 [0.82-1.23],0.9564685476479128
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATP6V1G1,V-type proton ATPase subunit G 1,19304,165,0.96 [0.77-1.18],0.6694855247173872
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATP6V1G2,V-type proton ATPase subunit G 2,19204,165,0.92 [0.78-1.07],0.2837553371117307
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATRAID,All-trans retinoic acid-induced differentiation factor,19705,168,0.87 [0.51-1.48],0.6004452980193113
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATRN,"Attractin, Isoform 2",19834,169,1.14 [0.47-2.74],0.7703630226260483
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATXN10,Ataxin-10,22176,182,0.90 [0.75-1.08],0.2605999276272062
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATXN2,Ataxin-2,19195,164,0.97 [0.85-1.11],0.6540983952425038
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATXN2L,Ataxin-2-like protein,19775,169,1.24 [0.94-1.64],0.1223168573385539
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATXN3,Ataxin-3,19765,168,1.05 [0.83-1.32],0.7016631171658321
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AXIN1,Axin-1,22702,187,0.95 [0.82-1.08],0.423490083823514
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AXL,Tyrosine-protein kinase receptor UFO,22808,192,1.36 [0.86-2.14],0.1844655908789306
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AZI2,5-azacytidine-induced protein 2,19775,169,1.01 [0.77-1.31],0.955016718433796
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AZU1,Azurocidin,22016,180,0.89 [0.74-1.07],0.2144912943567258
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",B2M,Beta-2-microglobulin,19834,169,1.38 [1.03-1.85],0.0326183469077769
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,19204,165,0.58 [0.26-1.25],0.1641388753072807
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",19304,165,1.11 [0.74-1.68],0.6099386102704087
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",22848,191,1.09 [0.69-1.74],0.7083643157631672
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",B4GAT1,"Beta-1,4-glucuronyltransferase 1",22752,190,0.77 [0.45-1.32],0.3384822098911505
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BABAM1,BRISC and BRCA1-A complex member 1,19252,163,0.79 [0.46-1.37],0.4109552650328113
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BACH1,Transcription regulator protein BACH1,22702,187,0.97 [0.81-1.16],0.7376814689954307
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BAG3,BAG family molecular chaperone regulator 3,22559,189,1.19 [0.86-1.66],0.296274610022327
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BAG4,BAG family molecular chaperone regulator 4,19252,163,0.86 [0.63-1.19],0.3739149590653006
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BAG6,Large proline-rich protein BAG6,22335,183,1.16 [0.80-1.68],0.4269667267403181
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,22228,185,0.97 [0.79-1.19],0.7989865225253678
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BAMBI,BMP and activin membrane-bound inhibitor homolog,22228,185,1.05 [0.68-1.63],0.8211654256678109
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BANK1,B-cell scaffold protein with ankyrin repeats,22702,187,0.92 [0.82-1.04],0.1962704603843539
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BAP18,Chromatin complexes subunit BAP18,19765,168,1.05 [0.85-1.29],0.6491741725187137
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BATF,Basic leucine zipper transcriptional factor ATF-like,19251,160,0.94 [0.78-1.14],0.53580644581062
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BAX,Apoptosis regulator BAX,22146,182,0.88 [0.76-1.03],0.1080004346876103
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BCAM,Basal cell adhesion molecule,22752,190,1.56 [0.93-2.64],0.0934143412422025
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BCAN,Brevican core protein,22595,190,0.92 [0.63-1.35],0.6850344251449085
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",19806,170,1.13 [0.70-1.81],0.6261022390859343
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",19195,164,1.14 [0.90-1.46],0.2751808857896837
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BCHE,Cholinesterase,19434,166,1.19 [0.69-2.06],0.5390949051866615
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BCL2,Apoptosis regulator Bcl-2,19705,168,1.01 [0.77-1.33],0.927215822932646
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BCL2L1,Bcl-2-like protein 1,19765,168,0.92 [0.80-1.07],0.2885128947572375
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",22702,187,0.81 [0.62-1.06],0.1329073691115258
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BCL2L15,Bcl-2-like protein 15,19252,163,1.01 [0.78-1.31],0.9113211123215345
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BCL7A,B-cell CLL/lymphoma 7 protein family member A,19107,162,1.00 [0.79-1.27],0.9792881535651584
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BCL7B,B-cell CLL/lymphoma 7 protein family member B,19698,167,1.11 [0.81-1.51],0.5196491785778479
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BCR,Breakpoint cluster region protein,22702,187,0.93 [0.81-1.07],0.3097919536441996
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BDNF,Brain-derived neurotrophic factor,19801,169,1.00 [0.84-1.19],0.9930787213332318
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BECN1,Beclin-1,19304,165,0.98 [0.77-1.25],0.8704987826369972
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BEX3,Protein BEX3,19107,162,1.32 [1.05-1.66],0.0166946976312962
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BGLAP,Osteocalcin,19801,169,0.92 [0.78-1.08],0.3224736045354848
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BGN,Biglycan,22189,185,1.02 [0.92-1.14],0.6675556466944612
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BHLHE40,Class E basic helix-loop-helix protein 40,19195,164,1.07 [0.87-1.30],0.527174805754983
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,19204,165,1.01 [0.56-1.82],0.9649648978363587
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BID,BH3-interacting domain death agonist,22702,187,0.91 [0.75-1.11],0.3484973101925852
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BIN2,Bridging integrator 2,22752,190,0.92 [0.79-1.06],0.2256511300916514
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BIRC2,Baculoviral IAP repeat-containing protein 2,22228,185,0.85 [0.69-1.05],0.1265080842343442
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BLMH,Bleomycin hydrolase,23014,190,0.74 [0.49-1.10],0.1328672932277265
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BLNK,B-cell linker protein,19252,163,0.91 [0.60-1.39],0.6780936772224642
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,19195,164,0.94 [0.76-1.16],0.5610523639167319
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,19765,168,0.87 [0.59-1.28],0.4772189309244379
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BLVRB,Flavin reductase,22752,190,1.13 [0.95-1.35],0.1726238462047976
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BMP10,Bone morphogenetic protein 10,19390,164,0.68 [0.41-1.14],0.1449730010826315
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BMP4,Bone morphogenetic protein 4,22559,189,1.01 [0.76-1.35],0.9385029998312364
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BMP6,Bone morphogenetic protein 6,22298,182,1.18 [0.85-1.62],0.320072259342918
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BMPER,BMP-binding endothelial regulator protein,19390,164,1.09 [0.57-2.10],0.7952029673290774
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,19806,170,0.92 [0.59-1.43],0.6971545171368686
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,19252,163,1.03 [0.73-1.45],0.8564860752186991
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BOC,Brother of CDO,22335,183,1.69 [0.97-2.96],0.0653323878513555
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BOLA1,BolA-like protein 1,19195,164,0.83 [0.62-1.11],0.2119567483545628
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BOLA2_BOLA2B,BolA-like protein 2,19304,165,1.07 [0.82-1.40],0.6097568927093848
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BPIFA2,BPI fold-containing family A member 2,18614,155,0.98 [0.85-1.13],0.7710892151636692
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BPIFB1,BPI fold-containing family B member 1,22683,187,1.03 [0.84-1.27],0.7559570157163923
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BPIFB2,BPI fold-containing family B member 2,19771,169,1.03 [0.85-1.26],0.7550742512666209
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BRAP,BRCA1-associated protein,19534,167,0.93 [0.81-1.06],0.2652704713621568
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BRD1,Bromodomain-containing protein 1,19422,163,1.00 [0.62-1.63],0.9850853682678238
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BRD2,Bromodomain-containing protein 2,19195,164,1.01 [0.65-1.56],0.9756166831193248
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BRD3,Bromodomain-containing protein 3,19204,165,1.16 [0.90-1.51],0.251711348336568
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BRDT,Bromodomain testis-specific protein,19204,165,0.83 [0.55-1.26],0.381354098306141
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BRK1,Protein BRICK1,22176,182,1.01 [0.75-1.36],0.9325975675846762
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BRME1,Break repair meiotic recombinase recruitment factor 1,19195,164,0.93 [0.65-1.32],0.6755429413859757
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BRSK2,Serine/threonine-protein kinase BRSK2,19775,169,0.98 [0.68-1.41],0.917437027025672
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BSG,Basigin,22951,189,0.91 [0.49-1.68],0.7558485690033865
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BSND,Barttin,19107,162,1.16 [0.78-1.73],0.4619879798270281
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,22944,191,1.12 [0.83-1.52],0.4488196387033034
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BST2,Bone marrow stromal antigen 2,22944,191,0.95 [0.75-1.21],0.6966094785814991
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BTC,Probetacellulin,22228,185,0.88 [0.73-1.06],0.1899875076574856
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BTD,Biotinidase,19834,169,1.14 [0.56-2.31],0.7133587335592801
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BTLA,B- and T-lymphocyte attenuator,19107,162,0.88 [0.71-1.08],0.216578852234011
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BTN1A1,Butyrophilin subfamily 1 member A1,19662,166,1.03 [0.73-1.46],0.8624156418044245
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BTN2A1,Butyrophilin subfamily 2 member A1,22848,191,0.99 [0.60-1.63],0.9647464295317076
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BTN3A2,Butyrophilin subfamily 3 member A2,22702,187,1.01 [0.72-1.43],0.9355305967402612
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BTNL10,Butyrophilin-like protein 10,19107,162,1.11 [0.80-1.54],0.5150719507400376
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C19orf12,Protein C19orf12,22176,182,1.08 [0.89-1.29],0.4420600763390223
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C1GALT1C1,C1GALT1-specific chaperone 1,19204,165,0.66 [0.40-1.10],0.1083546454410256
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C1QA,Complement C1q subcomponent subunit A,22873,188,0.93 [0.53-1.65],0.8068697947674313
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",19775,169,0.80 [0.61-1.05],0.1080668229052772
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C1QL2,Complement C1q-like protein 2,19252,163,0.94 [0.66-1.32],0.7094345840738928
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,22808,192,0.98 [0.73-1.31],0.9000484718308474
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,19390,164,1.31 [0.87-1.95],0.1945584863725742
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,19775,169,1.34 [0.91-1.97],0.135619526307688
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,19348,164,0.92 [0.68-1.23],0.5673596825732933
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C1R,Complement C1r subcomponent,19834,169,1.08 [0.50-2.32],0.8503778329814942
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C1RL,Complement C1r subcomponent-like protein,19801,168,1.13 [0.53-2.41],0.7467986138063801
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C1S,Complement C1s subcomponent,19834,169,0.90 [0.45-1.81],0.7749205517183781
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C2,Complement C2,22771,192,0.84 [0.52-1.36],0.4864921964752065
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C2CD2L,Phospholipid transfer protein C2CD2L,22128,182,0.89 [0.65-1.23],0.484311195606686
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C2orf69,UPF0565 protein C2orf69,19251,160,1.04 [0.81-1.34],0.7424149482816406
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C3,Complement C3,18823,161,1.02 [0.72-1.43],0.92455559881804
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C4BPB,C4b-binding protein beta chain,22813,190,0.77 [0.56-1.05],0.097219868253237
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C5,Complement C5,19834,169,0.87 [0.32-2.35],0.7807920487784601
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C7,Complement component C7,19354,164,0.93 [0.58-1.48],0.7498968229312236
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C7orf50,Uncharacterized protein C7orf50,19765,168,0.80 [0.39-1.63],0.5387664897013688
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C8B,Complement component C8 beta chain,19834,169,1.49 [0.92-2.42],0.1029005573615948
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C9,Complement component C9,19809,169,0.83 [0.63-1.11],0.2088038056838317
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C9orf40,Uncharacterized protein C9orf40,19705,168,1.13 [0.95-1.33],0.1715451277740097
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CA1,Carbonic anhydrase 1,22209,187,1.16 [0.95-1.41],0.1575773218671926
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CA11,Carbonic anhydrase-related protein 11,22228,185,0.97 [0.65-1.45],0.8841498440335458
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CA12,Carbonic anhydrase 12,22638,187,1.29 [0.88-1.89],0.2001818056944375
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CA13,Carbonic anhydrase 13,22500,184,0.89 [0.79-1.00],0.0527413710370188
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CA14,Carbonic anhydrase 14,22943,189,1.18 [0.82-1.71],0.3775452759649406
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CA2,Carbonic anhydrase 2,22674,188,1.09 [0.91-1.30],0.346083122093295
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CA3,Carbonic anhydrase 3,22975,190,0.96 [0.78-1.18],0.6964110996188606
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CA4,Carbonic anhydrase 4,23014,190,0.62 [0.36-1.07],0.0832479823117534
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CA5A,"Carbonic anhydrase 5A, mitochondrial",22335,183,0.95 [0.82-1.09],0.4596612063878165
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CA6,Carbonic anhydrase 6,22679,189,1.10 [0.90-1.36],0.3415706596030576
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CA7,Carbonic anhydrase 7,19422,163,0.83 [0.53-1.30],0.417412985478699
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CA8,Carbonic anhydrase-related protein,19252,163,1.17 [0.72-1.91],0.5245674221346812
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CA9,Carbonic anhydrase 9,22943,189,0.94 [0.71-1.23],0.644043155514517
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CABP2,Calcium-binding protein 2,19251,160,1.12 [0.91-1.39],0.2881772113271504
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,19195,164,0.94 [0.59-1.48],0.7788099888325405
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,19204,165,0.99 [0.78-1.26],0.9315184884880509
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,19195,164,1.01 [0.79-1.29],0.9514828755285104
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,19775,169,0.92 [0.77-1.09],0.3207953242094816
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CACYBP,Calcyclin-binding protein,19347,164,0.90 [0.78-1.05],0.1731832889802998
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CADPS,Calcium-dependent secretion activator 1,19251,160,0.91 [0.64-1.31],0.6240346434832492
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CALB1,Calbindin,22638,187,0.95 [0.70-1.29],0.7551468595070536
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CALB2,Calretinin,22176,182,1.07 [0.72-1.58],0.7364942012897486
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CALCA,Calcitonin,22547,190,1.12 [0.90-1.39],0.3196472744701272
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CALCB,Calcitonin gene-related peptide 2,19765,168,0.99 [0.68-1.43],0.9463346470108678
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,22868,187,1.00 [0.88-1.13],0.98790550193331
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,19304,165,0.90 [0.74-1.09],0.2858671172453668
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CALY,Neuron-specific vesicular protein calcyon,19204,165,0.87 [0.57-1.34],0.5233709345284032
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,22228,185,1.12 [0.83-1.50],0.4555347572003614
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,19251,160,1.10 [0.84-1.42],0.4915244973884903
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,19775,169,0.99 [0.86-1.14],0.8791178347693355
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CANT1,Soluble calcium-activated nucleotidase 1,22673,185,0.99 [0.52-1.88],0.976311634050826
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CAPG,Macrophage-capping protein,22586,185,0.89 [0.71-1.12],0.3113159845807862
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CAPN3,Calpain-3,19698,167,1.20 [0.85-1.71],0.2970127842385656
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CAPS,Calcyphosin,19765,168,0.90 [0.76-1.08],0.2680899901393353
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CARHSP1,Calcium-regulated heat-stable protein 1,22176,182,1.16 [0.91-1.47],0.2270978822524522
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CASC3,Protein CASC3,19251,160,0.82 [0.56-1.19],0.2895481111183384
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CASP1,Caspase-1,22176,182,0.95 [0.78-1.16],0.6395037173069904
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CASP10,Caspase-10,22176,182,0.88 [0.73-1.06],0.1662495032522083
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CASP2,Caspase-2,22702,187,0.89 [0.74-1.08],0.2465506605714801
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CASP3,Caspase-3,23014,190,0.90 [0.78-1.03],0.1341701782502852
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CASP4,Caspase-4,19422,163,1.01 [0.93-1.10],0.7754949268302735
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CASP7,Caspase-7,19765,168,0.91 [0.77-1.09],0.3183963211806377
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CASP8,Caspase-8,22870,188,0.90 [0.73-1.11],0.3265111877002453
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CASP9,Caspase-9,19252,163,0.96 [0.75-1.22],0.7227945267705167
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CASQ2,Calsequestrin-2,19204,165,1.20 [0.93-1.54],0.1673928433144527
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CAT,Catalase,19505,167,1.11 [0.86-1.44],0.4187812681435673
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CBLIF,Cobalamin binding intrinsic factor,22705,185,1.02 [0.86-1.21],0.7975492706343004
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CBLN1,Cerebellin-1,19195,164,0.89 [0.74-1.06],0.1922961897575748
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CBLN4,Cerebellin-4,22943,189,1.35 [0.93-1.95],0.1133084857620034
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CBS,Cystathionine beta-synthase,19304,165,0.93 [0.69-1.25],0.6210039796504787
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CBX2,Chromobox protein homolog 2,19204,165,0.96 [0.67-1.38],0.8387634552804761
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,22595,190,0.97 [0.81-1.16],0.740775523816442
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCAR2,Cell cycle and apoptosis regulator protein 2,19765,168,0.78 [0.55-1.09],0.1393743963512351
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCDC134,Coiled-coil domain-containing protein 134,19698,167,1.02 [0.76-1.37],0.89878951427026
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCDC28A,Coiled-coil domain-containing protein 28A,19251,160,0.86 [0.51-1.44],0.5704597440078301
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCDC50,Coiled-coil domain-containing protein 50,19775,169,0.89 [0.73-1.10],0.2793913331508472
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCDC80,Coiled-coil domain-containing protein 80,22739,185,1.40 [0.98-2.01],0.0672106124950514
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,19304,165,1.06 [0.84-1.35],0.6062660373389346
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL11,Eotaxin,22992,190,1.47 [1.05-2.07],0.0264818476312093
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL13,C-C motif chemokine 13,22952,190,1.07 [0.89-1.28],0.476886130459376
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL14,C-C motif chemokine 14,22662,191,1.13 [0.82-1.55],0.454052977262531
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL15,C-C motif chemokine 15,23014,190,1.08 [0.81-1.44],0.6067616187475039
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL16,C-C motif chemokine 16,23014,190,1.12 [0.87-1.43],0.3884299499743521
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL17,C-C motif chemokine 17,22711,189,1.09 [0.95-1.25],0.2362269762415088
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL18,C-C motif chemokine 18,22397,190,0.98 [0.81-1.18],0.8293952758148417
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL19,C-C motif chemokine 19,22944,191,1.04 [0.95-1.14],0.3541618930340581
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL2,C-C motif chemokine 2,22559,189,1.26 [1.00-1.58],0.0512882157948008
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL20,C-C motif chemokine 20,22992,190,0.91 [0.78-1.06],0.2137484312736879
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL21,C-C motif chemokine 21,22848,191,1.33 [1.06-1.68],0.0142002996537392
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL22,C-C motif chemokine 22,22520,189,1.03 [0.80-1.32],0.8335718084522726
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL23,C-C motif chemokine 23,22848,191,1.03 [0.75-1.39],0.8746682134540029
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL24,C-C motif chemokine 24,22809,191,1.20 [1.03-1.39],0.0192376651867554
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL25,C-C motif chemokine 25,22992,190,0.83 [0.63-1.08],0.1613782730551156
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL26,C-C motif chemokine 26,22702,187,1.10 [0.97-1.25],0.1205285335679298
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL27,C-C motif chemokine 27,22739,185,1.17 [0.94-1.46],0.1547417180158617
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL28,C-C motif chemokine 28,22627,187,1.07 [0.86-1.34],0.5265169017042748
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL3,C-C motif chemokine 3,22702,187,1.10 [0.91-1.32],0.3206910071282053
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL4,C-C motif chemokine 4,22779,190,1.12 [0.96-1.32],0.1463426934603298
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL5,C-C motif chemokine 5,22808,192,0.94 [0.83-1.07],0.3480732227540799
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL7,C-C motif chemokine 7,22702,187,1.03 [0.83-1.28],0.7732142800810113
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL8,C-C motif chemokine 8,22910,189,1.01 [0.82-1.25],0.9334185000687896
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCN1,CCN family member 1,22598,187,1.20 [1.01-1.43],0.0397703477058417
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCN2,CCN family member 2,22735,190,1.02 [0.81-1.27],0.8863328977251826
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCN3,CCN family member 3,22981,190,1.08 [0.74-1.57],0.6799631974143344
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCN4,CCN family member 4,22943,189,1.20 [0.89-1.62],0.2363280803814073
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCN5,CCN family member 5,22752,190,1.21 [0.88-1.66],0.2508779216754423
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCND2,G1/S-specific cyclin-D2,19422,163,1.20 [0.79-1.82],0.3860818643857076
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCNE1,G1/S-specific cyclin-E1,19252,163,0.99 [0.83-1.17],0.8911856006369934
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCS,Copper chaperone for superoxide dismutase,22595,190,1.08 [0.83-1.41],0.5494673857691966
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCT5,T-complex protein 1 subunit epsilon,22228,185,1.21 [0.93-1.58],0.1524678879622594
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD101,Immunoglobulin superfamily member 2,19705,168,1.27 [0.90-1.81],0.1757575501849155
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD109,CD109 antigen,22752,190,1.17 [0.79-1.72],0.4333805889728405
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD14,Monocyte differentiation antigen CD14,22240,186,0.78 [0.57-1.08],0.1341944096806727
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD160,CD160 antigen,22992,190,1.04 [0.79-1.37],0.7808724560331513
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD163,Scavenger receptor cysteine-rich type 1 protein M130,22808,192,1.13 [0.85-1.52],0.4037038891055847
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD164,Sialomucin core protein 24,22752,190,0.93 [0.55-1.55],0.7732778703500349
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD164L2,CD164 sialomucin-like 2 protein,19251,160,1.24 [0.86-1.79],0.2423900742586938
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD177,CD177 antigen,22721,188,0.92 [0.84-1.01],0.0807194850719235
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD1C,T-cell surface glycoprotein CD1c,22813,190,1.02 [0.59-1.76],0.9486689188637538
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD2,T-cell surface antigen CD2,19204,165,0.98 [0.67-1.44],0.9212851350013904
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD200,OX-2 membrane glycoprotein,22702,187,0.77 [0.47-1.27],0.3065656620910674
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD200R1,Cell surface glycoprotein CD200 receptor 1,22633,186,0.87 [0.59-1.28],0.4780343413826965
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD207,C-type lectin domain family 4 member K,22244,185,1.15 [0.82-1.62],0.4157378927000987
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD209,CD209 antigen,22789,188,1.14 [0.82-1.58],0.4510193884501664
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,22992,190,1.20 [0.88-1.65],0.2540023432463855
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD226,CD226 antigen,19252,163,1.08 [0.75-1.55],0.6798201383024478
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD244,Natural killer cell receptor 2B4,22992,190,1.11 [0.69-1.79],0.6618856151677164
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD248,Endosialin,19801,169,0.99 [0.69-1.42],0.9561668387930042
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,22813,190,0.70 [0.50-0.98],0.0349171446255266
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD274,Programmed cell death 1 ligand 1,22595,190,0.92 [0.63-1.35],0.6716452311156228
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD276,CD276 antigen,22738,190,1.10 [0.77-1.57],0.6132975130655547
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,22228,185,1.29 [0.92-1.82],0.1372246343533473
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD2AP,CD2-associated protein,22739,185,1.09 [0.89-1.33],0.4131838665465362
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD300A,CMRF35-like molecule 8,19390,164,1.02 [0.62-1.68],0.941419567437256
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD300C,CMRF35-like molecule 6,22944,191,1.07 [0.74-1.54],0.7252792375737476
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD300E,CMRF35-like molecule 2,22863,188,1.14 [0.83-1.58],0.4078525549246629
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD300LF,CMRF35-like molecule 1,22943,189,1.16 [0.93-1.44],0.1944764057000389
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD300LG,CMRF35-like molecule 9,22752,190,0.74 [0.52-1.04],0.0815731132437584
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD302,CD302 antigen,22638,187,1.44 [0.95-2.18],0.0819670532587227
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD33,Myeloid cell surface antigen CD33,22813,190,0.99 [0.84-1.16],0.8773745688264124
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD34,Hematopoietic progenitor cell antigen CD34,22862,191,0.71 [0.42-1.21],0.2058240591316751
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD36,Platelet glycoprotein 4,19252,163,1.17 [0.83-1.64],0.3657362918318677
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,22638,187,1.56 [1.04-2.35],0.0318877467097288
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD3D,T-cell surface glycoprotein CD3 delta chain,19195,164,1.30 [0.92-1.84],0.1380164939720009
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD3E,T-cell surface glycoprotein CD3 epsilon chain,19422,163,1.08 [0.76-1.56],0.6585692406401823
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD3G,T-cell surface glycoprotein CD3 gamma chain,19252,163,1.12 [0.97-1.28],0.1186070703297012
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD4,T-cell surface glycoprotein CD4,22660,187,1.57 [1.16-2.14],0.0037540237118108
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD40,Tumor necrosis factor receptor superfamily member 5,22740,190,0.76 [0.58-0.99],0.0435111931122295
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD40LG,CD40 ligand,22992,190,1.01 [0.85-1.19],0.9408596602582636
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD46,Membrane cofactor protein,22580,190,0.78 [0.48-1.25],0.2938503389145578
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,22809,191,0.76 [0.49-1.17],0.2087393334708713
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD5,T-cell surface glycoprotein CD5,22910,189,0.91 [0.61-1.35],0.6322932552246179
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD55,Complement decay-accelerating factor,21929,184,1.03 [0.62-1.71],0.9190301680736336
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD58,Lymphocyte function-associated antigen 3,22704,190,1.22 [0.59-2.53],0.5886581167172513
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD59,CD59 glycoprotein,21902,183,1.12 [0.62-2.02],0.7100316569300245
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD5L,CD5 antigen-like,19716,168,1.42 [1.04-1.93],0.0265325339819448
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD6,T-cell differentiation antigen CD6,22951,189,0.98 [0.77-1.25],0.8928555803583474
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD63,CD63 antigen,22559,189,0.96 [0.75-1.23],0.7404710709999316
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD69,Early activation antigen CD69,22641,184,0.89 [0.77-1.03],0.1141711241468492
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD7,T-cell antigen CD7,19213,163,1.06 [0.74-1.51],0.7453777530825825
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD70,CD70 antigen,22702,187,0.83 [0.61-1.13],0.2290538104543688
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,19390,164,0.97 [0.67-1.39],0.851659666642709
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,22944,191,1.06 [0.73-1.54],0.7574130904715279
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,22992,190,0.79 [0.58-1.07],0.1269987422532474
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,19806,170,1.14 [0.75-1.74],0.5345946773262215
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD82,CD82 antigen,19422,163,0.82 [0.55-1.22],0.3295789003001309
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,22702,187,1.14 [0.77-1.67],0.5111842682324319
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD84,SLAM family member 5,22702,187,0.77 [0.51-1.17],0.2168036832564585
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD86,T-lymphocyte activation antigen CD86,19705,168,1.18 [0.71-1.96],0.5234410140496599
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD8A,T-cell surface glycoprotein CD8 alpha chain,22944,191,0.91 [0.70-1.19],0.5006940695381937
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD93,Complement component C1q receptor,21858,188,1.09 [0.72-1.65],0.6905593572757451
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD99,CD99 antigen,22752,190,0.88 [0.45-1.70],0.695984951573447
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD99L2,CD99 antigen-like protein 2,22752,190,0.88 [0.51-1.52],0.6459515433486387
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDA,Cytidine deaminase,19764,169,1.06 [0.78-1.43],0.7223182798330614
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDAN1,Codanin-1,19765,168,1.15 [0.65-2.05],0.6298063336773538
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDC123,Cell division cycle protein 123 homolog,19107,162,1.00 [0.79-1.27],0.9778115787806734
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDC25A,M-phase inducer phosphatase 1,19107,162,1.05 [0.73-1.51],0.7913613541499429
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDC26,Anaphase-promoting complex subunit CDC26,19677,168,0.83 [0.67-1.03],0.0961734433709878
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDC27,Cell division cycle protein 27 homolog,22228,185,0.98 [0.79-1.22],0.8885822553920965
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDC37,Hsp90 co-chaperone Cdc37,22813,190,0.89 [0.76-1.03],0.1237435966736285
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDC42BPB,Serine/threonine-protein kinase MRCK beta,19705,168,0.98 [0.85-1.13],0.8015996933886019
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,22595,190,0.93 [0.71-1.20],0.5586045281677998
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDH1,Cadherin-1,21953,183,0.86 [0.60-1.23],0.4171719844184228
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDH15,Cadherin-15,22896,191,1.24 [0.98-1.57],0.077854281895322
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDH17,Cadherin-17,22739,185,1.06 [0.87-1.28],0.5618258428793881
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDH2,Cadherin-2,22739,185,1.26 [0.87-1.82],0.2167617169412505
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDH22,Cadherin-22,19422,163,1.31 [0.83-2.06],0.2439460747049998
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDH23,Cadherin-23,19765,168,1.45 [0.86-2.44],0.160786998747901
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDH3,Cadherin-3,22944,191,2.08 [1.53-2.84],3.7683510215934303e-06
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDH4,Cadherin-4,19195,164,0.83 [0.59-1.16],0.2668958236820989
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDH5,Cadherin-5,23014,190,0.76 [0.50-1.17],0.2197524198167878
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDH6,Cadherin-6,22739,185,1.03 [0.74-1.45],0.8544195551406604
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDHR1,Cadherin-related family member 1,22176,182,1.00 [0.73-1.37],0.9995239570933926
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDHR2,Cadherin-related family member 2,22638,187,1.04 [0.88-1.23],0.6229669056385014
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDHR5,Cadherin-related family member 5,22739,185,1.39 [0.98-1.99],0.0674613766720747
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDK1,Cyclin-dependent kinase 1,19107,162,1.24 [0.83-1.85],0.3026474999776657
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,19775,169,0.90 [0.69-1.18],0.4488410500399679
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDKL5,Cyclin-dependent kinase-like 5,19195,164,1.07 [0.82-1.38],0.6200697840641443
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDKN1A,Cyclin-dependent kinase inhibitor 1,22638,187,1.01 [0.89-1.14],0.9311073514817998
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,22638,187,0.89 [0.78-1.01],0.0804731393183516
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDNF,Cerebral dopamine neurotrophic factor,22638,187,0.90 [0.60-1.36],0.6268889093254564
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,22780,190,1.49 [0.91-2.43],0.1131984054253159
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDSN,Corneodesmosin,22912,190,1.12 [0.84-1.50],0.4438039352479842
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,22774,189,0.76 [0.45-1.28],0.3028145092913588
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,19705,168,1.02 [0.84-1.24],0.8468315396853464
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,19422,163,1.14 [0.95-1.37],0.14711887985876
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,19705,168,1.39 [0.97-1.98],0.0687764718748091
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,19422,163,1.06 [0.77-1.46],0.7271416905466858
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,22702,187,0.86 [0.73-1.00],0.0530847506520643
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,22228,185,0.87 [0.66-1.15],0.3223833331798653
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,21925,184,1.00 [0.82-1.23],0.9746790409691116
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,19801,169,0.93 [0.62-1.37],0.7028720653558804
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,22335,183,1.04 [0.80-1.36],0.7754185301546426
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEBPA,CCAAT/enhancer-binding protein alpha,19252,163,1.07 [0.73-1.56],0.7396200651119245
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEBPB,CCAAT/enhancer-binding protein beta,22335,183,1.07 [0.77-1.51],0.6770280011573759
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CELA2A,Chymotrypsin-like elastase family member 2A,19801,169,1.10 [0.86-1.41],0.4453924360815441
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CELA3A,Chymotrypsin-like elastase family member 3A,22976,190,1.07 [0.86-1.34],0.5422494830854723
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,19390,164,2.31 [1.41-3.77],0.0008387923746228
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEMIP2,Cell surface hyaluronidase,19252,163,0.80 [0.48-1.34],0.4020373473965993
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEND1,Cell cycle exit and neuronal differentiation protein 1,19195,164,1.10 [0.88-1.37],0.4204144049502835
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CENPF,Centromere protein F,19422,163,1.10 [0.85-1.44],0.4569475593685214
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CENPJ,Centromere protein J,19422,163,1.10 [0.90-1.33],0.3522347221794952
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEP112,Centrosomal protein of 112 kDa,19204,165,0.76 [0.50-1.14],0.1799667653688882
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEP152,Centrosomal protein of 152 kDa,19107,162,1.19 [0.86-1.64],0.2872669207206688
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEP164,Centrosomal protein of 164 kDa,22309,181,0.98 [0.79-1.20],0.8351382889027711
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEP170,Centrosomal protein of 170 kDa,19304,165,0.94 [0.77-1.16],0.5831949291914029
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEP20,Centrosomal protein 20,22228,185,0.88 [0.73-1.05],0.1614916516675057
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEP290,Centrosomal protein of 290 kDa,19422,163,0.96 [0.72-1.28],0.7859593200863682
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEP350,Centrosome-associated protein 350,19107,162,1.04 [0.71-1.52],0.8413338209592968
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEP43,Centrosomal protein 43,22159,183,1.05 [0.87-1.27],0.6064221935390435
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEP85,Centrosomal protein of 85 kDa,22228,185,0.95 [0.77-1.17],0.614766436349053
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CERT,Ceramide transfer protein,22176,182,0.82 [0.66-1.02],0.0723496276724887
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CES1,Liver carboxylesterase 1,22787,188,1.10 [0.95-1.27],0.2238148562248145
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CES2,Cocaine esterase,22638,187,1.03 [0.82-1.31],0.7821690290491035
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CES3,Carboxylesterase 3,22638,187,1.14 [0.96-1.36],0.1330911919636692
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CETN2,Centrin-2,22176,182,0.80 [0.65-0.98],0.0325054529522998
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CETN3,Centrin-3,19705,168,0.81 [0.67-0.99],0.0371704000677207
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CFB,Complement factor B,19455,165,1.06 [0.67-1.69],0.7986429991859838
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CFC1,Cryptic protein,22228,185,0.98 [0.73-1.32],0.9139479771440264
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CFD,Complement factor D,19834,169,1.50 [0.74-3.01],0.2590844415430607
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CFH,Complement factor H,18659,157,1.85 [0.95-3.60],0.0705556844581355
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CFHR2,Complement factor H-related protein 2,19690,167,1.20 [0.92-1.58],0.1823881230578574
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CFHR4,Complement factor H-related protein 4,19803,169,0.97 [0.79-1.18],0.7325043969774864
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CFHR5,Complement factor H-related protein 5,19542,168,0.98 [0.69-1.39],0.8910797742038444
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CFI,Complement factor I,19834,169,1.24 [0.60-2.60],0.5594438660711345
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CFP,Properdin,19834,169,0.96 [0.49-1.88],0.9064459522642122
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CGA,Glycoprotein hormones alpha chain,22752,190,1.01 [0.86-1.19],0.9110465051987264
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,19809,169,1.02 [0.72-1.45],0.9132097732165564
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CGN,Cingulin,19251,160,1.27 [0.95-1.70],0.1026289818660468
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CGREF1,Cell growth regulator with EF hand domain protein 1,22739,185,1.16 [0.85-1.58],0.3348854964079628
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,22228,185,1.06 [0.86-1.30],0.602998019986906
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHAD,Chondroadherin,19390,164,0.75 [0.57-0.99],0.0394612056421494
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",19765,168,1.02 [0.70-1.49],0.9248744004483256
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHCHD6,MICOS complex subunit MIC25,19698,167,0.87 [0.50-1.51],0.6188058711427478
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHEK2,Serine/threonine-protein kinase Chk2,22335,183,0.96 [0.65-1.42],0.8294434899911619
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHGA,Chromogranin-A,19801,169,0.87 [0.74-1.03],0.1010560882663743
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHGB,Secretogranin-1,22853,191,1.15 [0.84-1.57],0.397295693165748
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHI3L1,Chitinase-3-like protein 1,22216,188,0.97 [0.81-1.15],0.7038079308803961
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHIT1,Chitotriosidase-1,22833,188,0.96 [0.89-1.04],0.2879936013816035
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHL1,Neural cell adhesion molecule L1-like protein,22771,192,0.97 [0.65-1.46],0.9016032198305644
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHM,Rab proteins geranylgeranyltransferase component A 1,19251,160,0.91 [0.71-1.18],0.481334172278513
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHMP1A,Charged multivesicular body protein 1a,22595,190,0.89 [0.76-1.05],0.1777057212030625
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHMP6,Charged multivesicular body protein 6,19806,170,0.83 [0.64-1.08],0.1685284758132873
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHP1,Calcineurin B homologous protein 1,19195,164,1.04 [0.86-1.27],0.6738320504264022
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHRDL1,Chordin-like protein 1,22809,191,1.32 [0.87-2.00],0.1976030892486465
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHRDL2,Chordin-like protein 2,22739,185,2.05 [1.66-2.53],2.3713637476165868e-11
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHRM1,Muscarinic acetylcholine receptor M1,19251,160,1.01 [0.67-1.52],0.9518704449355734
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CIAPIN1,Anamorsin,22813,190,0.88 [0.72-1.08],0.2134275802006629
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CILP,Cartilage intermediate layer protein 1,19801,169,1.29 [0.97-1.70],0.076432008998473
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CINP,Cyclin-dependent kinase 2-interacting protein,19422,163,1.30 [0.99-1.70],0.0555187313256363
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CIRBP,Cold-inducible RNA-binding protein,19705,168,0.89 [0.76-1.03],0.123569439036343
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CIT,Citron Rho-interacting kinase,19251,160,1.11 [0.81-1.53],0.5216984689371362
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,22882,188,0.92 [0.56-1.52],0.754169985974833
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CKB,Creatine kinase B-type,19801,169,0.79 [0.62-1.01],0.0566453077615649
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",22664,190,0.91 [0.78-1.08],0.2803853539259761
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLASP1,CLIP-associating protein 1,19107,162,1.11 [0.92-1.35],0.2749987765645532
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLC,Galectin-10,22704,185,1.00 [0.82-1.22],0.9944536346493628
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC10A,C-type lectin domain family 10 member A,22595,190,0.85 [0.59-1.22],0.376655746735116
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC11A,C-type lectin domain family 11 member A,22704,190,0.90 [0.69-1.17],0.4162304587707865
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC12A,C-type lectin domain family 12 member A,19252,163,1.16 [0.56-2.43],0.6842186637880796
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC14A,C-type lectin domain family 14 member A,22752,190,1.00 [0.67-1.50],0.9944757329345232
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC1A,C-type lectin domain family 1 member A,22335,183,1.03 [0.69-1.54],0.8907459126413567
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC1B,C-type lectin domain family 1 member B,22944,191,0.93 [0.81-1.06],0.2775089479767509
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC2L,C-type lectin domain family 2 member L,19251,160,1.23 [0.96-1.58],0.1017863273769135
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC3B,Tetranectin,19357,165,1.25 [0.62-2.51],0.5349791468775171
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC4A,C-type lectin domain family 4 member A,22702,187,0.72 [0.50-1.04],0.0821808874763188
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC4C,C-type lectin domain family 4 member C,22702,187,1.12 [0.85-1.47],0.4279747240970302
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC4D,C-type lectin domain family 4 member D,22702,187,1.12 [0.91-1.38],0.2719994892881192
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC4G,C-type lectin domain family 4 member G,22702,187,1.01 [0.68-1.50],0.9484339530032596
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC4M,C-type lectin domain family 4 member M,19762,169,1.11 [0.82-1.51],0.4873819625278144
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC5A,C-type lectin domain family 5 member A,22671,184,0.89 [0.56-1.41],0.6137750656464203
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC6A,C-type lectin domain family 6 member A,22228,185,0.88 [0.66-1.17],0.3753736871044506
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC7A,C-type lectin domain family 7 member A,22992,190,1.17 [0.91-1.50],0.2167291885417304
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLGN,Calmegin,19251,160,0.95 [0.67-1.34],0.7773754591152946
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLIC5,Chloride intracellular channel protein 5,19251,160,0.86 [0.52-1.42],0.5603155586519422
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLINT1,Clathrin interactor 1,19107,162,1.11 [0.82-1.51],0.5102860494747771
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLIP2,CAP-Gly domain-containing linker protein 2,22702,187,0.94 [0.84-1.06],0.3208326368235619
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLMP,CXADR-like membrane protein,22943,189,1.51 [0.80-2.83],0.2034983126774227
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLNS1A,Methylosome subunit pICln,19251,160,0.85 [0.53-1.36],0.5028293840174549
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",22547,190,0.95 [0.83-1.09],0.4438510647972731
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLPS,Colipase,22716,189,0.91 [0.76-1.09],0.3126069320149149
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLSPN,Claspin,22128,182,0.85 [0.55-1.31],0.4624683695117091
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLSTN1,Calsyntenin-1,22176,182,1.06 [0.83-1.34],0.6571139087913941
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLSTN2,Calsyntenin-2,22992,190,1.36 [1.01-1.83],0.0439260371823356
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLSTN3,Calsyntenin-3,19765,168,1.81 [1.19-2.74],0.0055482262674635
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLTA,Clathrin light chain A,22335,183,1.02 [0.78-1.35],0.8615104485093626
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLU,Clusterin,19834,169,1.26 [0.88-1.79],0.2075139750722425
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLUL1,Clusterin-like protein 1,22708,185,0.95 [0.72-1.27],0.7461943863098444
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CMC1,COX assembly mitochondrial protein homolog,19806,170,0.89 [0.76-1.05],0.1787195364349196
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CMIP,C-Maf-inducing protein,19698,167,0.89 [0.75-1.07],0.2266497258280111
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CNDP1,Beta-Ala-His dipeptidase,22808,192,0.95 [0.72-1.25],0.7162820695479737
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CNGB3,Cyclic nucleotide-gated cation channel beta-3,19195,164,0.89 [0.66-1.20],0.4568856263683971
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",19267,165,0.89 [0.74-1.08],0.2339310593357851
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CNPY2,Protein canopy homolog 2,22335,183,1.05 [0.85-1.29],0.6335260458304208
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CNPY4,Protein canopy homolog 4,22638,187,0.86 [0.72-1.02],0.0899767124395142
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CNST,Consortin,22739,185,0.92 [0.82-1.03],0.160586940352977
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CNTF,Ciliary neurotrophic factor,19195,164,1.18 [0.77-1.80],0.4571888811481742
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CNTN1,Contactin-1,23014,190,1.15 [0.72-1.82],0.566588436092581
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CNTN2,Contactin-2,22943,189,0.88 [0.66-1.17],0.366822866644338
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CNTN3,Contactin-3,22752,190,0.99 [0.68-1.43],0.9420274754711612
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CNTN4,Contactin-4,22752,190,0.82 [0.49-1.40],0.4759166808756109
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CNTN5,Contactin-5,22796,191,1.13 [0.80-1.59],0.4950005648326302
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CNTNAP2,Contactin-associated protein-like 2,22702,187,1.09 [0.79-1.50],0.5863730794285167
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CNTNAP4,Contactin-associated protein-like 4,19251,160,1.11 [0.98-1.26],0.1053217008408557
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COCH,Cochlin,19806,170,0.92 [0.67-1.26],0.5921890841414594
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COL15A1,Collagen alpha-1(XV) chain,19801,169,1.25 [0.72-2.15],0.4296893893447395
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COL18A1,Collagen alpha-1(XVIII) chain,22836,188,0.98 [0.57-1.71],0.9496531200564226
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COL1A1,Collagen alpha-1(I) chain,23014,190,0.61 [0.37-1.02],0.0589710939916127
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COL24A1,Collagen alpha-1(XXIV) chain,19705,168,1.02 [0.79-1.34],0.8558693520051572
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COL28A1,Collagen alpha-1(XXVIII) chain,19251,160,0.91 [0.74-1.12],0.378880471293187
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COL2A1,Collagen alpha-1(II) chain,19304,165,0.79 [0.65-0.95],0.0135876832942906
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COL3A1,Collagen alpha-1(III) chain,19801,169,0.91 [0.48-1.72],0.7741382954782707
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COL4A1,Collagen alpha-1(IV) chain,22739,185,0.82 [0.59-1.13],0.2230702117965352
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COL4A4,Collagen alpha-4(IV) chain,19391,163,1.02 [0.76-1.36],0.8929550407942844
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COL5A1,Collagen alpha-1(V) chain,19390,164,0.90 [0.62-1.32],0.6010611790233559
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COL6A3,Collagen alpha-3(VI) chain,23014,190,1.65 [1.16-2.34],0.0048649753757803
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COL9A1,Collagen alpha-1(IX) chain,22702,187,0.77 [0.58-1.01],0.0605177080450475
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COL9A2,Collagen alpha-2(IX) chain,19422,163,0.98 [0.71-1.36],0.914116258877855
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COLEC12,Collectin-12,22738,190,1.22 [0.74-2.01],0.4462981047045256
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COMMD1,COMM domain-containing protein 1,19304,165,0.88 [0.69-1.13],0.3233932393393803
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COMMD9,COMM domain-containing protein 9,19698,167,1.00 [0.69-1.45],0.992259140351809
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COMP,Cartilage oligomeric matrix protein,22480,191,0.92 [0.63-1.34],0.6585172565680797
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COMT,Catechol O-methyltransferase,22099,182,0.92 [0.78-1.07],0.2836622295013312
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COPB2,Coatomer subunit beta',19204,165,0.89 [0.62-1.27],0.5217337524337571
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COPE,Coatomer subunit epsilon,22176,182,1.04 [0.80-1.36],0.7572011818378094
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",19304,165,0.86 [0.60-1.23],0.4211740028680037
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CORO1A,Coronin-1A,22253,183,0.88 [0.76-1.03],0.1207746379060458
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CORO6,Coronin-6,19195,164,1.03 [0.69-1.55],0.8723024425939839
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",22638,187,0.94 [0.78-1.13],0.4938757687355685
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COX6B1,Cytochrome c oxidase subunit 6B1,19806,170,0.83 [0.52-1.31],0.4195889209139283
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CPA1,Carboxypeptidase A1,23014,190,1.00 [0.80-1.24],0.9956950074713236
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CPA2,Carboxypeptidase A2,22858,191,0.95 [0.78-1.15],0.6030337076103511
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CPA4,Carboxypeptidase A4,18997,161,0.84 [0.59-1.18],0.3059821312456526
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CPB1,Carboxypeptidase B,23014,190,1.17 [0.94-1.46],0.1514072182589598
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CPB2,Carboxypeptidase B2,19790,169,0.64 [0.33-1.23],0.1823454219518044
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CPE,Carboxypeptidase E,22777,185,0.68 [0.51-0.92],0.0114215944971773
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CPLX2,Complexin-2,19107,162,0.83 [0.49-1.40],0.4842865843319968
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CPM,Carboxypeptidase M,22836,190,1.62 [1.14-2.30],0.0073400707096006
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",19252,163,0.83 [0.48-1.45],0.5146354561184239
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CPPED1,Serine/threonine-protein phosphatase CPPED1,22944,191,0.94 [0.78-1.14],0.5331459367305955
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CPQ,Carboxypeptidase Q,19758,168,1.04 [0.69-1.56],0.8498226058141488
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CPTP,Ceramide-1-phosphate transfer protein,19204,165,0.82 [0.54-1.23],0.3297389711667451
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CPVL,Probable serine carboxypeptidase CPVL,22915,189,1.03 [0.75-1.42],0.8366857177574838
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CPXM1,Probable carboxypeptidase X1,22813,190,1.07 [0.90-1.29],0.4415590893543472
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CPXM2,Inactive carboxypeptidase-like protein X2,19806,170,1.21 [0.71-2.06],0.4759656289096086
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CR1,Complement receptor type 1,19727,168,1.45 [0.96-2.18],0.0784086460329591
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CR2,Complement receptor type 2,22808,192,1.21 [0.92-1.59],0.1810307988811639
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,22228,185,0.98 [0.84-1.14],0.7619669807915356
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRADD,Death domain-containing protein CRADD,22547,190,0.89 [0.75-1.05],0.1570455884063216
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CREB3,Cyclic AMP-responsive element-binding protein 3,19107,162,1.10 [0.86-1.41],0.4537882830581659
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CREBZF,CREB/ATF bZIP transcription factor,19107,162,1.21 [0.69-2.14],0.5112030046197915
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CREG1,Protein CREG1,22443,187,1.24 [0.87-1.75],0.22811445289756
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRELD1,Protein disulfide isomerase CRELD1,19390,164,1.02 [0.69-1.51],0.9293449041982872
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRELD2,Protein disulfide isomerase CRELD2,22809,191,0.93 [0.72-1.18],0.5359703227902577
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRH,Corticoliberin,22187,185,0.96 [0.82-1.12],0.5881226620526357
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRHBP,Corticotropin-releasing factor-binding protein,22738,190,0.82 [0.52-1.30],0.3973055227263214
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRHR1,Corticotropin-releasing factor receptor 1,22335,183,1.09 [0.90-1.32],0.3827694472500034
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRIM1,Cysteine-rich motor neuron 1 protein,22848,191,1.23 [0.66-2.32],0.5145694802256203
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRIP2,Cysteine-rich protein 2,22595,190,1.47 [1.09-1.99],0.0126777141400323
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRISP2,Cysteine-rich secretory protein 2,22943,189,1.01 [0.82-1.24],0.9161292384243076
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRISP3,Cysteine-rich secretory protein 3,19626,166,0.94 [0.55-1.61],0.8181964339439575
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRKL,Crk-like protein,22775,191,0.92 [0.82-1.04],0.1938608630817974
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRLF1,Cytokine receptor-like factor 1,22848,191,2.04 [1.22-3.39],0.0062816456284979
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRNN,Cornulin,22096,183,1.09 [0.90-1.32],0.3882706283978097
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRTAC1,Cartilage acidic protein 1,23014,190,0.74 [0.48-1.13],0.1586377003882269
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,22595,190,1.04 [0.80-1.34],0.7683248726956103
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRTAP,Cartilage-associated protein,19251,160,1.10 [0.82-1.46],0.5328584211801646
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRX,Cone-rod homeobox protein,22335,183,0.96 [0.84-1.09],0.521867085016529
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRYBB1,Beta-crystallin B1,19806,170,0.81 [0.64-1.03],0.0799660844738615
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRYBB2,Beta-crystallin B2,19765,168,1.14 [0.96-1.34],0.126142717298487
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRYGD,Gamma-crystallin D,19765,168,0.89 [0.77-1.03],0.1296718337301353
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRYM,Ketimine reductase mu-crystallin,19195,164,0.99 [0.81-1.21],0.9053508632434112
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRYZL1,Quinone oxidoreductase-like protein 1,19304,165,0.90 [0.77-1.06],0.2149245055736603
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CSDE1,Cold shock domain-containing protein E1,19204,165,1.02 [0.90-1.16],0.7395863073412525
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,22848,191,1.05 [0.65-1.68],0.8446644028002486
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CSF1R,Macrophage colony-stimulating factor 1 receptor,19809,169,1.31 [0.91-1.87],0.1425875346972203
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CSF2,Granulocyte-macrophage colony-stimulating factor,19204,165,1.05 [0.69-1.58],0.8332770792173442
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,22595,190,0.99 [0.80-1.22],0.888928999048899
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CSF2RB,Cytokine receptor common subunit beta,19252,163,1.00 [0.71-1.41],0.9928583964307274
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CSF3,Granulocyte colony-stimulating factor,22309,181,0.84 [0.63-1.11],0.2157352442789403
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CSF3R,Granulocyte colony-stimulating factor receptor,19252,163,1.10 [0.68-1.78],0.6967035881338486
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CSH1,Chorionic somatomammotropin hormone 1,19809,169,0.91 [0.55-1.51],0.7228953573148378
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CSNK1D,Casein kinase I isoform delta,19252,163,0.94 [0.73-1.20],0.6131049461495133
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CSNK2A1,Casein kinase II subunit alpha,19775,169,0.79 [0.56-1.10],0.1557569972112225
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CSPG4,Chondroitin sulfate proteoglycan 4,19801,169,1.00 [0.64-1.56],0.9933787037873198
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CSPG5,Chondroitin sulfate proteoglycan 5,19195,164,1.04 [0.78-1.39],0.774279296643321
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CSRP3,Cysteine and glycine-rich protein 3,19204,165,0.99 [0.85-1.17],0.9503431041235494
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CST1,Cystatin-SN,17181,144,1.04 [0.89-1.22],0.6012903917649075
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CST3,Cystatin-C,22774,191,1.42 [0.91-2.23],0.1211412222017165
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CST5,Cystatin-D,22363,189,1.09 [0.86-1.37],0.4825578414691429
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CST6,Cystatin-M,22162,182,1.72 [1.31-2.26],9.65713675457074e-05
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CST7,Cystatin-F,22779,190,1.01 [0.88-1.16],0.8611279304763353
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CSTB,Cystatin-B,22426,184,1.05 [0.77-1.45],0.7472556409607515
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTAG1A_CTAG1B,Cancer/testis antigen 1,19379,163,0.84 [0.61-1.14],0.2649288545287249
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTBS,Di-N-acetylchitobiase,19513,167,1.69 [0.96-2.97],0.067154733036554
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTF1,Cardiotrophin-1,22335,183,0.87 [0.74-1.02],0.0966584669793782
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTHRC1,Collagen triple helix repeat-containing protein 1,19801,169,1.33 [0.80-2.20],0.2734900743780206
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTLA4,Cytotoxic T-lymphocyte protein 4,19801,169,0.92 [0.56-1.53],0.7527224715590473
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTNNA1,Catenin alpha-1,19195,164,1.21 [0.85-1.71],0.2947744270264297
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTRB1,Chymotrypsinogen B,22752,190,1.15 [0.91-1.45],0.2419690421510983
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTRC,Chymotrypsin-C,22747,190,1.14 [0.93-1.39],0.2023710768293214
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTRL,Chymotrypsin-like protease CTRL-1,19765,168,0.85 [0.69-1.06],0.1420780311331112
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTSB,Cathepsin B,22759,187,0.95 [0.74-1.21],0.6548091284721562
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTSC,Dipeptidyl peptidase 1,22703,190,0.97 [0.72-1.31],0.8480482707758028
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTSD,Cathepsin D,21214,180,0.92 [0.66-1.29],0.6406620961389428
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTSE,Cathepsin E,19390,164,1.16 [0.88-1.55],0.2941939448321299
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTSF,Cathepsin F,22813,190,0.85 [0.62-1.17],0.3261282415935669
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTSH,Pro-cathepsin H,22273,183,0.89 [0.74-1.06],0.1896256748745554
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTSL,Cathepsin L1,22739,185,1.24 [0.72-2.12],0.4383861245764789
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTSO,Cathepsin O,22992,190,1.31 [0.86-1.98],0.2078702153329078
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTSS,Cathepsin S,17862,152,1.26 [0.66-2.41],0.4908728193314503
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTSV,Cathepsin L2,22882,187,1.31 [0.98-1.73],0.0644509005798146
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTSZ,Cathepsin Z,22728,191,1.21 [0.81-1.80],0.3618450381968655
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CUZD1,CUB and zona pellucida-like domain-containing protein 1,19251,160,0.71 [0.44-1.15],0.1631105318170316
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CWC15,Spliceosome-associated protein CWC15 homolog,19586,167,1.05 [0.83-1.32],0.6751361716821508
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CX3CL1,Fractalkine,22595,190,1.09 [0.75-1.58],0.6401174441165396
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CXADR,Coxsackievirus and adenovirus receptor,22702,187,0.89 [0.69-1.16],0.3969500275298531
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CXCL1,Growth-regulated alpha protein,22703,189,0.94 [0.83-1.08],0.4027177794353623
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CXCL10,C-X-C motif chemokine 10,22848,191,1.01 [0.84-1.22],0.8846149696197272
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CXCL11,C-X-C motif chemokine 11,22944,191,0.98 [0.83-1.15],0.8132375325287946
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CXCL12,Stromal cell-derived factor 1,22309,181,1.11 [0.81-1.53],0.5066058966818114
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CXCL13,C-X-C motif chemokine 13,22944,191,1.09 [0.91-1.31],0.3556581720013064
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CXCL14,C-X-C motif chemokine 14,22309,181,0.93 [0.74-1.17],0.5286757506596629
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CXCL16,C-X-C motif chemokine 16,22974,189,0.77 [0.44-1.32],0.3411237487044287
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CXCL17,C-X-C motif chemokine 17,22992,190,1.16 [0.86-1.58],0.3354077873805896
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CXCL3,C-X-C motif chemokine 3,22740,190,0.87 [0.76-0.99],0.0317328837753646
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CXCL5,C-X-C motif chemokine 5,22666,185,0.92 [0.82-1.03],0.1368131032955281
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CXCL6,C-X-C motif chemokine 6,22992,190,0.95 [0.81-1.12],0.568752384364683
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CXCL8,Interleukin-8,22566,187,0.86 [0.71-1.05],0.1429554104395288
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CXCL9,C-X-C motif chemokine 9,22848,191,0.87 [0.71-1.06],0.17055539212149
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CYB5A,Cytochrome b5,19107,162,0.93 [0.75-1.14],0.4698636300451682
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CYB5R2,NADH-cytochrome b5 reductase 2,19462,167,0.91 [0.70-1.20],0.5110477511459801
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",19204,165,0.91 [0.75-1.10],0.3324380085149523
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CYTH3,Cytohesin-3,19107,162,1.03 [0.84-1.25],0.7983181145118412
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CYTL1,Cytokine-like protein 1,19801,169,1.12 [0.60-2.10],0.721389605343429
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DAAM1,Disheveled-associated activator of morphogenesis 1,19390,164,0.95 [0.79-1.14],0.5859062837246537
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DAB2,Disabled homolog 2,22943,189,0.93 [0.83-1.04],0.1988754291136826
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DAG1,Dystroglycan,22848,191,0.84 [0.63-1.10],0.2010732242717546
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DAND5,DAN domain family member 5,19252,163,1.01 [0.78-1.31],0.9472401769297588
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DAPK2,Death-associated protein kinase 2,19252,163,0.96 [0.73-1.28],0.8000785576512316
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,22702,187,0.89 [0.81-0.99],0.0293635070023899
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DARS1,"Aspartate--tRNA ligase, cytoplasmic",22547,190,0.95 [0.80-1.14],0.6039002075491366
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DBH,Dopamine beta-hydroxylase,19767,168,1.04 [0.90-1.21],0.561978378901738
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DBI,Acyl-CoA-binding protein,22650,187,0.91 [0.76-1.07],0.2528411889487382
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DBN1,Drebrin,19252,163,1.04 [0.77-1.40],0.7889577768192501
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DBNL,Drebrin-like protein,22848,191,0.92 [0.80-1.05],0.2135521551821645
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",22813,190,0.66 [0.46-0.95],0.0237244988440032
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DCC,Netrin receptor DCC,19251,160,0.97 [0.50-1.85],0.917495482927809
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DCDC2C,Doublecortin domain-containing protein 2C,19107,162,1.11 [0.89-1.37],0.3504779498251488
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DCLRE1C,Protein artemis,19107,162,1.31 [0.84-2.04],0.2268017147266337
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DCN,Decorin,22335,183,0.90 [0.50-1.60],0.7105177669411032
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DCTD,Deoxycytidylate deaminase,19390,164,0.89 [0.76-1.04],0.1363847473816943
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DCTN1,Dynactin subunit 1,22943,189,1.00 [0.82-1.22],0.9929120487560728
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DCTN2,Dynactin subunit 2,22638,187,0.98 [0.85-1.13],0.7925978553245463
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DCTN6,Dynactin subunit 6,22176,182,0.96 [0.79-1.16],0.653466663206967
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,22739,185,1.01 [0.66-1.54],0.9552835841053446
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DCUN1D1,DCN1-like protein 1,19195,164,1.06 [0.88-1.28],0.5109919759623254
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DCUN1D2,DCN1-like protein 2,19107,162,1.15 [0.98-1.34],0.0931520512878356
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DCXR,L-xylulose reductase,22813,190,0.97 [0.77-1.24],0.8347887926953631
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DDA1,DET1- and DDB1-associated protein 1,19204,165,0.84 [0.56-1.25],0.3919170731934327
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",22638,187,0.78 [0.58-1.06],0.1115246249331679
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DDC,Aromatic-L-amino-acid decarboxylase,22705,185,0.76 [0.58-0.99],0.0456619878035593
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DDHD2,Phospholipase DDHD2,19775,169,0.95 [0.76-1.19],0.6397706868991246
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DDI2,Protein DDI1 homolog 2,19390,164,0.99 [0.82-1.19],0.9063676004898968
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DDR1,Epithelial discoidin domain-containing receptor 1,22944,191,1.47 [0.85-2.54],0.1718617276704621
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DDT,D-dopachrome decarboxylase,19801,169,1.13 [0.80-1.59],0.481647714778586
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DDX1,ATP-dependent RNA helicase DDX1,19705,168,0.89 [0.66-1.22],0.4761927549651926
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DDX25,ATP-dependent RNA helicase DDX25,19251,160,0.89 [0.59-1.35],0.5849444729249285
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DDX39A,ATP-dependent RNA helicase DDX39A,19252,163,1.18 [0.61-2.28],0.6193680751627637
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DDX4,Probable ATP-dependent RNA helicase DDX4,19252,163,0.98 [0.73-1.30],0.86690872984789
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DDX53,Probable ATP-dependent RNA helicase DDX53,19251,160,1.14 [0.75-1.74],0.540088921078437
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DDX58,Antiviral innate immune response receptor RIG-I,22228,185,0.95 [0.75-1.20],0.6777277450412085
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",22702,187,0.87 [0.76-1.00],0.0462015484244718
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DEFA1_DEFA1B,Neutrophil defensin 1,22260,185,0.94 [0.73-1.21],0.629363057979548
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DEFB103A_DEFB103B,Beta-defensin 103,19097,160,1.08 [0.76-1.54],0.6686849574167428
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DEFB104A_DEFB104B,Beta-defensin 104,19195,164,1.06 [0.82-1.38],0.6520318785943968
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DEFB116,Beta-defensin 116,19195,164,1.01 [0.84-1.22],0.9229745127991368
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DEFB118,Beta-defensin 118,19195,164,0.92 [0.69-1.22],0.5637490592864107
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DEFB4A_DEFB4B,Beta-defensin 4A,22429,183,1.08 [0.99-1.18],0.0747846454628489
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DENND2B,DENN domain-containing protein 2B,19204,165,1.12 [0.87-1.44],0.3652885821595696
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DENR,Density-regulated protein,19252,163,0.89 [0.67-1.17],0.4022538211390577
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DFFA,DNA fragmentation factor subunit alpha,22992,190,0.89 [0.74-1.08],0.2520678573244347
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DGCR6,Protein DGCR6,19195,164,1.11 [0.82-1.50],0.4938040230082267
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DGKA,Diacylglycerol kinase alpha,19252,163,0.88 [0.66-1.17],0.3683992768925234
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DGKZ,Diacylglycerol kinase zeta,22309,181,0.81 [0.55-1.18],0.2692774859796657
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DHODH,Dihydroorotate dehydrogenase,19204,165,0.87 [0.63-1.22],0.4245758230398002
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DHPS,Deoxyhypusine synthase,19698,167,0.97 [0.68-1.38],0.8756732834221744
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,19765,168,0.77 [0.55-1.10],0.1537244083939705
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DIABLO,"Diablo homolog, mitochondrial",22671,184,0.88 [0.78-0.99],0.0271357865864313
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DIPK1C,Divergent protein kinase domain 1C,19251,160,1.20 [0.88-1.65],0.2514294986139778
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DIPK2B,Divergent protein kinase domain 2B,19390,164,0.73 [0.41-1.29],0.279933254276794
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DKK1,Dickkopf-related protein 1,22944,191,1.05 [0.85-1.29],0.667594040709496
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DKK3,Dickkopf-related protein 3,23014,190,1.07 [0.70-1.65],0.7459619553106778
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DKK4,Dickkopf-related protein 4,22564,190,1.41 [1.09-1.83],0.009873526530958
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DKKL1,Dickkopf-like protein 1,22638,187,1.00 [0.86-1.15],0.951597331986272
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DLG4,Disks large homolog 4,19765,168,0.99 [0.80-1.21],0.8937948219628816
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DLGAP5,Disks large-associated protein 5,19775,169,0.85 [0.62-1.18],0.3318474889945852
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DLK1,Protein delta homolog 1,23014,190,1.03 [0.81-1.30],0.8145378148413771
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DLL1,Delta-like protein 1,22813,190,1.07 [0.69-1.65],0.765703848118918
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DLL4,Delta-like protein 4,19304,165,0.89 [0.71-1.13],0.3446959024874912
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DMD,Dystrophin,19304,165,0.97 [0.72-1.31],0.8395437551996876
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DMP1,Dentin matrix acidic phosphoprotein 1,19304,165,0.89 [0.71-1.11],0.2897820369941264
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNAJA1,DnaJ homolog subfamily A member 1,19107,162,1.29 [1.00-1.67],0.0509897808058995
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNAJA2,DnaJ homolog subfamily A member 2,22923,189,0.92 [0.79-1.08],0.3102981851523954
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNAJA4,DnaJ homolog subfamily A member 4,19765,168,1.06 [0.87-1.29],0.5884656584570063
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNAJB1,DnaJ homolog subfamily B member 1,22638,187,0.99 [0.85-1.15],0.884798386577487
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNAJB14,DnaJ homolog subfamily B member 14,19705,168,0.79 [0.63-1.01],0.0569834077250644
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNAJB2,DnaJ homolog subfamily B member 2,19390,164,0.96 [0.73-1.26],0.7706386803692159
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNAJB6,DnaJ homolog subfamily B member 6,19196,161,0.88 [0.74-1.06],0.1820330247238872
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNAJB8,DnaJ homolog subfamily B member 8,22335,183,1.16 [0.96-1.41],0.122088749309095
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNAJC21,DnaJ homolog subfamily C member 21,19765,168,1.01 [0.69-1.49],0.9485216915951876
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNAJC6,Putative tyrosine-protein phosphatase auxilin,19304,165,0.98 [0.82-1.17],0.795669397200919
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNAJC9,DnaJ homolog subfamily C member 9,19705,168,0.94 [0.78-1.14],0.5392879236985471
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNER,Delta and Notch-like epidermal growth factor-related receptor,22705,189,0.89 [0.53-1.49],0.6547415725828607
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNLZ,DNL-type zinc finger protein,19195,164,0.94 [0.79-1.12],0.5046947003786487
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNM1,Dynamin-1,19705,168,0.89 [0.78-1.01],0.0606457365663166
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNM3,Dynamin-3,19775,169,1.02 [0.78-1.34],0.8704555737292726
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNMBP,Dynamin-binding protein,22595,190,1.00 [0.81-1.23],0.9708393369154378
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNPEP,Aspartyl aminopeptidase,19765,168,0.93 [0.73-1.20],0.5860447916958555
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,22814,191,1.01 [0.79-1.28],0.9556807428783048
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DOC2B,Double C2-like domain-containing protein beta,19251,160,1.02 [0.68-1.52],0.9340585665418742
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DOCK9,Dedicator of cytokinesis protein 9,19195,164,1.12 [1.00-1.24],0.0453804277632952
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DOK1,Docking protein 1,19765,168,0.93 [0.84-1.04],0.2026401797376026
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DOK2,Docking protein 2,22739,185,0.94 [0.84-1.05],0.2539159138437888
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DPEP1,Dipeptidase 1,22547,190,1.08 [0.84-1.40],0.5351746929221042
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DPEP2,Dipeptidase 2,22638,187,0.55 [0.34-0.87],0.0101312204877954
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DPP10,Inactive dipeptidyl peptidase 10,22702,187,0.90 [0.61-1.31],0.5673400101189776
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DPP4,Dipeptidyl peptidase 4,22298,190,0.82 [0.53-1.28],0.3851839524949336
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DPP6,Dipeptidyl aminopeptidase-like protein 6,22638,187,0.97 [0.66-1.44],0.8979879329651561
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DPP7,Dipeptidyl peptidase 2,22550,184,1.00 [0.80-1.25],0.9742734370653406
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DPT,Dermatopontin,23014,190,0.62 [0.39-0.99],0.0469927930763716
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DPY30,Protein dpy-30 homolog,22868,187,0.94 [0.75-1.17],0.5752941034229293
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DRAXIN,Draxin,22595,190,1.14 [0.85-1.53],0.3937635612334367
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DRG2,Developmentally-regulated GTP-binding protein 2,22638,187,0.89 [0.71-1.13],0.3510952949654291
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DSC2,Desmocollin-2,22506,189,0.99 [0.67-1.46],0.965340226801932
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DSCAM,Down syndrome cell adhesion molecule,19775,169,0.91 [0.60-1.39],0.6737734191367599
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DSG2,Desmoglein-2,22752,190,0.71 [0.45-1.14],0.1557375047430612
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DSG3,Desmoglein-3,22873,187,1.39 [0.94-2.04],0.0963669533838757
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DSG4,Desmoglein-4,22558,187,1.27 [0.98-1.63],0.0662667761704887
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DTD1,D-aminoacyl-tRNA deacylase 1,19390,164,0.87 [0.73-1.03],0.1086790231903987
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DTNB,Dystrobrevin beta,19670,167,1.07 [0.75-1.52],0.7135292068908421
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DTX2,Probable E3 ubiquitin-protein ligase DTX2,19251,160,1.08 [0.87-1.34],0.5041426355047367
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DTX3,Probable E3 ubiquitin-protein ligase DTX3,22638,187,1.04 [0.60-1.79],0.8994889315237179
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DTYMK,Thymidylate kinase,19806,170,0.98 [0.79-1.21],0.8170538918119572
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DUOX2,Dual oxidase 2,22335,183,1.12 [0.95-1.31],0.178294585667683
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DUSP13,Dual specificity protein phosphatase 13 isoform A,19698,167,1.25 [0.91-1.73],0.1736298984070064
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DUSP29,Dual specificity phosphatase 29,19251,160,1.04 [0.84-1.29],0.7342425551067007
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DUSP3,Dual specificity protein phosphatase 3,22176,182,0.92 [0.79-1.09],0.3390872358035434
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",19705,168,0.93 [0.80-1.07],0.316744007103571
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DXO,Decapping and exoribonuclease protein,19765,168,0.86 [0.62-1.19],0.3648143703274724
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,19698,167,1.08 [0.80-1.44],0.6223107736536888
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DYNLT1,Dynein light chain Tctex-type 1,19251,160,1.16 [0.98-1.37],0.0862892446655455
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DYNLT3,Dynein light chain Tctex-type 3,19698,167,1.03 [0.73-1.43],0.8842691700280237
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,22595,190,0.94 [0.82-1.08],0.371668412690984
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EBI3_IL27,Interleukin-27,22903,188,0.99 [0.65-1.52],0.9715053899095768
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ECE1,Endothelin-converting enzyme 1,22176,182,0.90 [0.62-1.32],0.6007088606564934
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",19806,170,0.96 [0.79-1.17],0.7215774426919692
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ECHS1,"Enoyl-CoA hydratase, mitochondrial",19304,165,0.88 [0.75-1.02],0.0967899774587228
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ECI2,Enoyl-CoA delta isomerase 2,19204,165,0.98 [0.76-1.25],0.8547501156316181
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ECM1,Extracellular matrix protein 1,19266,164,1.13 [0.74-1.71],0.5777265990637673
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ECSCR,Endothelial cell-specific chemotaxis regulator,19195,164,1.20 [0.95-1.53],0.1321474670368566
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,22943,189,1.06 [0.74-1.52],0.7571496324356167
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EDAR,Tumor necrosis factor receptor superfamily member EDAR,22702,187,0.86 [0.75-1.00],0.0445883744181957
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EDDM3B,Epididymal secretory protein E3-beta,19698,167,0.92 [0.64-1.31],0.6273627594060522
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,19204,165,1.07 [0.73-1.58],0.7240687595683827
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EDF1,Endothelial differentiation-related factor 1,19775,169,0.87 [0.69-1.09],0.2291248740803576
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,22335,183,0.84 [0.57-1.25],0.4031930275547783
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EDN1,Endothelin-1,19304,165,1.75 [1.05-2.90],0.0318452831313081
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EDNRB,Endothelin receptor type B,19252,163,1.14 [0.84-1.55],0.3885122370863544
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EEF1D,Elongation factor 1-delta,19806,170,0.95 [0.81-1.11],0.5066299202681989
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EFCAB14,EF-hand calcium-binding domain-containing protein 14,19705,168,1.37 [0.84-2.25],0.2081829644060356
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EFCAB2,Dynein regulatory complex protein 8,19422,163,1.07 [0.70-1.62],0.7661972995101254
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,22768,191,0.63 [0.41-0.96],0.0320881044001205
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EFHD1,EF-hand domain-containing protein D1,19775,169,1.46 [1.02-2.10],0.0395459256208605
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EFNA1,Ephrin-A1,22718,190,0.98 [0.61-1.58],0.9428654731370706
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,22559,189,1.44 [0.94-2.20],0.0953399564029503
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EFNB2,Ephrin-B2,19251,160,0.99 [0.76-1.29],0.9447915936044848
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EGF,Pro-epidermal growth factor,22708,190,0.93 [0.82-1.05],0.2429985109138977
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EGFL7,Epidermal growth factor-like protein 7,22228,185,1.49 [1.13-1.95],0.0042697393230155
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EGFLAM,Pikachurin,19705,168,1.13 [0.71-1.81],0.6070762858156068
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EGFR,Epidermal growth factor receptor,23014,190,0.57 [0.26-1.25],0.1598538687535069
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EGLN1,Egl nine homolog 1,22702,187,0.92 [0.72-1.18],0.5337457555301597
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EHBP1,EH domain-binding protein 1,19806,170,0.90 [0.73-1.10],0.2889115711631801
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EHD3,EH domain-containing protein 3,19304,165,0.91 [0.80-1.03],0.136631601324999
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",19765,168,1.14 [0.89-1.46],0.3092735867887406
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",19634,165,0.97 [0.84-1.11],0.6143702360340456
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,19204,165,0.88 [0.69-1.11],0.278604177584056
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,19304,165,1.10 [0.77-1.56],0.596076673297132
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EIF4B,Eukaryotic translation initiation factor 4B,22595,190,0.92 [0.74-1.14],0.4580610133971264
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EIF4E,Eukaryotic translation initiation factor 4E,19252,163,0.94 [0.79-1.11],0.4650230781342988
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,22739,185,1.07 [0.88-1.30],0.4909161803446087
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,22992,190,0.96 [0.84-1.09],0.5022158454509171
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,19775,169,0.91 [0.72-1.14],0.3973396050787616
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EIF5,Eukaryotic translation initiation factor 5,19204,165,0.81 [0.57-1.17],0.2672860947709905
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EIF5A,Eukaryotic translation initiation factor 5A-1,22309,181,1.13 [0.72-1.78],0.5855314252120865
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ELAC1,Zinc phosphodiesterase ELAC protein 1,19775,169,0.94 [0.79-1.11],0.4702282691911132
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ELAVL4,ELAV-like protein 4,19195,164,1.05 [0.89-1.24],0.5707763531412007
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ELN,Elastin,19806,170,1.14 [0.76-1.71],0.5169023222112541
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ELOA,Elongin-A,22638,187,0.90 [0.70-1.17],0.4390499500844135
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ELOB,Elongin-B,19204,165,0.96 [0.65-1.41],0.8309594014301127
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENAH,Protein enabled homolog,22309,181,1.07 [0.81-1.40],0.6472382979820828
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENDOU,Poly(U)-specific endoribonuclease,18291,155,1.27 [0.96-1.70],0.0964903535970493
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENG,Endoglin,23014,190,1.28 [0.61-2.70],0.511990739864131
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENO1,Alpha-enolase,22708,188,0.82 [0.70-0.97],0.0188053551023629
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENO2,Gamma-enolase,22944,191,0.87 [0.71-1.06],0.1605167663563907
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENO3,Beta-enolase,19304,165,1.30 [1.03-1.65],0.0284157854328553
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENOPH1,Enolase-phosphatase E1,19698,167,0.95 [0.71-1.26],0.7061635283152248
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,19204,165,0.79 [0.45-1.39],0.4202662948740856
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENPEP,Glutamyl aminopeptidase,19204,165,0.84 [0.57-1.24],0.3722691352035201
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,23014,190,1.01 [0.66-1.55],0.9584460128168476
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,22848,191,1.28 [0.91-1.80],0.1640102836220964
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,19304,165,0.69 [0.46-1.02],0.0654618090700946
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,22040,182,1.01 [0.87-1.18],0.8638876492325622
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENSA,Alpha-endosulfine,19698,167,0.78 [0.57-1.06],0.1074831230572901
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,22228,185,1.14 [0.87-1.51],0.3454036496871658
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,22335,183,0.83 [0.45-1.55],0.5579440350357843
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,22335,183,1.44 [0.85-2.43],0.1744023040070772
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENTR1,Endosome-associated-trafficking regulator 1,19304,165,1.00 [0.77-1.30],0.9977953607832531
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EP300,Histone acetyltransferase p300,19252,163,0.87 [0.53-1.43],0.5946428280702292
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EPB41L5,Band 4.1-like protein 5,19251,160,0.99 [0.78-1.26],0.9641421039835004
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EPCAM,Epithelial cell adhesion molecule,22742,190,0.86 [0.75-0.98],0.0209447182961969
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EPGN,Epigen,19698,167,1.39 [1.12-1.71],0.0026369041453337
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EPHA1,Ephrin type-A receptor 1,22814,191,1.40 [0.95-2.05],0.0892847209592778
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EPHA10,Ephrin type-A receptor 10,22176,182,1.11 [0.93-1.33],0.2298922197679563
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,21933,183,0.64 [0.41-1.01],0.0556751502356714
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EPHA4,Ephrin type-A receptor 4,19390,164,0.98 [0.58-1.67],0.94820494962257
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EPHB4,Ephrin type-B receptor 4,23014,190,0.99 [0.59-1.68],0.978838289713816
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EPHB6,Ephrin type-B receptor 6,22547,190,1.21 [0.80-1.82],0.3598711274911336
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EPHX2,Bifunctional epoxide hydrolase 2,22335,183,1.09 [0.90-1.33],0.3660963397139973
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EPN1,Epsin-1,19422,163,1.24 [0.94-1.64],0.1338569088901446
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EPO,Erythropoietin,22702,187,1.32 [1.16-1.52],4.812295941234385e-05
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EPPK1,Epiplakin,19304,165,0.91 [0.74-1.12],0.3535728780342233
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,22908,188,0.95 [0.61-1.47],0.8174959046873014
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ERBB2,Receptor tyrosine-protein kinase erbB-2,22813,190,1.89 [1.12-3.18],0.0165164897131144
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ERBB3,Receptor tyrosine-protein kinase erbB-3,22677,189,1.21 [0.61-2.37],0.584800963865975
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ERBB4,Receptor tyrosine-protein kinase erbB-4,22813,190,0.81 [0.48-1.38],0.4434979812384197
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ERBIN,Erbin,22638,187,0.93 [0.82-1.05],0.2246481596621477
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ERC2,ERC protein 2,19251,160,0.92 [0.74-1.14],0.4298370042012661
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ERCC1,DNA excision repair protein ERCC-1,19107,162,1.21 [0.82-1.80],0.3331742067755973
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EREG,Proepiregulin,22547,190,0.96 [0.81-1.13],0.5954893352073021
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ERI1,3'-5' exoribonuclease 1,19422,163,1.14 [0.74-1.75],0.5571741378200152
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ERMAP,Erythroid membrane-associated protein,19252,163,1.36 [0.98-1.89],0.0697164809580545
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,19698,167,1.36 [0.98-1.88],0.0684158387033646
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ERP29,Endoplasmic reticulum resident protein 29,19390,164,0.89 [0.79-1.01],0.0821215701613836
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ERP44,Endoplasmic reticulum resident protein 44,22598,187,0.85 [0.51-1.41],0.528374831576844
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,19204,165,0.77 [0.54-1.12],0.1691222940508241
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ESAM,Endothelial cell-selective adhesion molecule,23014,190,0.82 [0.54-1.23],0.3286216349756098
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ESM1,Endothelial cell-specific molecule 1,22738,190,0.96 [0.66-1.40],0.8200563165387227
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ESPL1,Separin,19107,162,1.16 [0.92-1.46],0.218744494621246
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ESR1,Estrogen receptor,19252,163,1.12 [0.88-1.42],0.366965680533125
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ESYT2,Extended synaptotagmin-2,19765,168,0.96 [0.80-1.15],0.6373857845386591
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EVI2B,Protein EVI2B,19107,162,1.02 [0.70-1.47],0.9349158799024192
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EVI5,Ecotropic viral integration site 5 protein homolog,19252,163,0.94 [0.79-1.11],0.4409633535467392
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EVPL,Envoplakin,19422,163,0.97 [0.62-1.53],0.9000440749526822
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EXOSC10,Exosome component 10,19204,165,0.98 [0.76-1.26],0.8741121136450807
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EXTL1,Exostosin-like 1,19204,165,1.05 [0.78-1.41],0.7509798610676237
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EZR,Ezrin,22944,191,0.76 [0.44-1.32],0.3335647555176818
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",F10,Coagulation factor X,19809,169,0.59 [0.34-1.02],0.0594903498934256
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",F11,Coagulation factor XI,19544,166,0.87 [0.52-1.46],0.5887905531723087
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",F11R,Junctional adhesion molecule A,22752,190,0.88 [0.70-1.11],0.283132669548033
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",F12,Coagulation factor XII,19834,169,0.89 [0.63-1.25],0.497282482264206
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",F13B,Coagulation factor XIII B chain,19716,168,1.12 [0.63-2.00],0.6992772327656884
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",F2,Prothrombin,19834,169,1.06 [0.40-2.79],0.9123583764320804
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",F2R,Proteinase-activated receptor 1,22809,191,0.85 [0.68-1.06],0.1525378819505297
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",F3,Tissue factor,22807,188,0.54 [0.34-0.86],0.0103442462740475
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",F7,Coagulation factor VII,22779,192,0.68 [0.45-1.03],0.0686114037776305
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",F9,Coagulation factor IX,22771,192,1.25 [0.61-2.57],0.5475453406633395
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FABP1,"Fatty acid-binding protein, liver",22738,190,0.97 [0.84-1.12],0.6870564361743065
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FABP2,"Fatty acid-binding protein, intestinal",22739,185,0.85 [0.71-1.01],0.0724203993730605
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FABP3,"Fatty acid-binding protein, heart",19806,170,1.16 [0.86-1.56],0.3227157431926357
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FABP4,"Fatty acid-binding protein, adipocyte",23014,190,1.14 [0.89-1.47],0.2903754219667454
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FABP5,Fatty acid-binding protein 5,22876,190,1.05 [0.87-1.26],0.6267233890784845
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FABP6,Gastrotropin,22302,183,0.81 [0.63-1.05],0.1070818545913545
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FABP9,Fatty acid-binding protein 9,22702,187,1.24 [0.99-1.56],0.0590740931533222
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FADD,FAS-associated death domain protein,22739,185,0.87 [0.73-1.04],0.1174590355145442
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FAM13A,Protein FAM13A,19705,168,0.93 [0.74-1.16],0.504129993092723
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FAM171A2,Protein FAM171A2,19775,169,0.97 [0.88-1.06],0.4732702068153744
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FAM171B,Protein FAM171B,19698,167,1.12 [0.69-1.84],0.6453823826598627
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FAM172A,Cotranscriptional regulator FAM172A,19304,165,0.87 [0.68-1.12],0.2845894943315178
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FAM20A,Pseudokinase FAM20A,19806,170,1.22 [0.73-2.04],0.456532362331147
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FAM3B,Protein FAM3B,22638,187,0.97 [0.68-1.39],0.8717526833940337
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FAM3C,Protein FAM3C,22705,185,1.20 [0.78-1.85],0.4125872515543802
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FAM3D,Protein FAM3D,19705,168,1.06 [0.89-1.26],0.5217681974187293
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FAP,Prolyl endopeptidase FAP,23014,190,1.24 [0.77-1.98],0.3743079314110988
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FARSA,Phenylalanine--tRNA ligase alpha subunit,19251,160,1.07 [0.87-1.32],0.528118168079822
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FAS,Tumor necrosis factor receptor superfamily member 6,22945,189,0.88 [0.57-1.35],0.5506024950844288
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FASLG,Tumor necrosis factor ligand superfamily member 6,22992,190,1.26 [0.89-1.78],0.1967897780844493
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FBLN2,Fibulin-2,19801,169,1.22 [0.78-1.92],0.3921263070652528
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FBN2,Fibrillin-2,19251,160,0.83 [0.65-1.07],0.1481472437483295
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FBP1,"Fructose-1,6-bisphosphatase 1",22739,185,0.95 [0.80-1.13],0.5627891080367837
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,19806,170,0.99 [0.81-1.21],0.93962332442135
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FCAR,Immunoglobulin alpha Fc receptor,22702,187,0.88 [0.67-1.16],0.379659080425889
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,19775,169,1.26 [0.69-2.29],0.4571370489595784
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,22752,190,0.81 [0.61-1.06],0.1300622082221821
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,22631,191,0.92 [0.76-1.12],0.4056270211636168
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,22228,185,1.16 [0.93-1.45],0.1893467341268055
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,22740,192,1.09 [0.84-1.41],0.5251977220893699
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FCN1,Ficolin-1,19767,168,1.34 [1.00-1.79],0.048871273277964
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FCN2,Ficolin-2,22619,192,0.80 [0.60-1.08],0.1431033639402309
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,22739,185,1.11 [0.82-1.49],0.5030313525042318
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,22884,189,1.09 [0.84-1.43],0.5142533662396842
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FCRL3,Fc receptor-like protein 3,22309,181,1.07 [0.84-1.36],0.5970289613418153
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FCRL5,Fc receptor-like protein 5,22752,190,0.93 [0.74-1.16],0.5067975506150815
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FCRL6,Fc receptor-like protein 6,22702,187,1.00 [0.83-1.21],0.9794681737612232
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FCRLB,Fc receptor-like B,22228,185,0.99 [0.79-1.24],0.9431814288084832
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FDX1,"Adrenodoxin, mitochondrial",19204,165,1.10 [0.89-1.38],0.3771201135784283
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FDX2,"Ferredoxin-2, mitochondrial",19204,165,1.03 [0.79-1.33],0.8410920436050062
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FEN1,Flap endonuclease 1,22228,185,1.10 [0.92-1.31],0.2869226544093357
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FES,Tyrosine-protein kinase Fes/Fps,22228,185,0.87 [0.65-1.16],0.3358019589609933
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FETUB,Fetuin-B,22771,192,1.39 [0.93-2.09],0.1088574661638319
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGA,Fibrinogen alpha chain,19362,165,1.05 [0.64-1.71],0.8568833155393931
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",19775,169,0.94 [0.78-1.13],0.487141439883653
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGF12,Fibroblast growth factor 12,19252,163,1.11 [0.84-1.45],0.4707525303837216
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGF16,Fibroblast growth factor 16,19252,163,0.93 [0.67-1.28],0.6470684721906926
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGF19,Fibroblast growth factor 19,22848,191,0.97 [0.83-1.15],0.760884216700258
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGF2,Fibroblast growth factor 2,22702,187,0.85 [0.70-1.04],0.1136968796047634
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGF20,Fibroblast growth factor 20,19252,163,0.78 [0.52-1.17],0.223723741470523
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGF21,Fibroblast growth factor 21,22903,188,1.04 [0.93-1.15],0.5340308224145822
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGF23,Fibroblast growth factor 23,22910,188,1.33 [1.12-1.58],0.000982500223932
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGF3,Fibroblast growth factor 3,19252,163,1.34 [0.91-1.98],0.1424620798870814
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGF5,Fibroblast growth factor 5,22309,181,1.25 [0.85-1.85],0.2575349843099124
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGF6,Fibroblast growth factor 6,19252,163,0.92 [0.62-1.35],0.6542524647924755
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGF7,Fibroblast growth factor 7,19107,162,1.04 [0.87-1.24],0.6719637622097023
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGF9,Fibroblast growth factor 9,19069,162,0.96 [0.67-1.40],0.847628056430848
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGFBP1,Fibroblast growth factor-binding protein 1,22813,190,0.90 [0.60-1.34],0.5955029468078907
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGFBP2,Fibroblast growth factor-binding protein 2,19801,169,0.99 [0.74-1.33],0.9545795599964968
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGFBP3,Fibroblast growth factor-binding protein 3,19765,168,1.15 [0.77-1.71],0.5060978712984632
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGFR2,Fibroblast growth factor receptor 2,22813,190,1.86 [1.07-3.24],0.0285420625728436
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGFR4,Fibroblast growth factor receptor 4,19390,164,0.85 [0.64-1.13],0.2525246350527
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGL1,Fibrinogen-like protein 1,19809,169,0.75 [0.60-0.94],0.0142691950529168
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGR,Tyrosine-protein kinase Fgr,22176,182,1.09 [0.89-1.34],0.4106897877034717
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FH,"Fumarate hydratase, mitochondrial",19195,164,1.01 [0.85-1.20],0.9065554999254388
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FHIP2A,FHF complex subunit HOOK interacting protein 2A,19204,165,0.92 [0.66-1.26],0.5958590537032573
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FHIT,Bis(5'-adenosyl)-triphosphatase,22176,182,0.89 [0.74-1.06],0.1858844081713465
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FIS1,Mitochondrial fission 1 protein,22745,190,0.84 [0.70-0.99],0.0374374688576737
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,19775,169,0.90 [0.77-1.04],0.1532987178555303
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,22808,187,0.94 [0.84-1.06],0.3188953914621291
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,22595,190,0.94 [0.70-1.25],0.6650360705020277
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,22595,190,0.92 [0.80-1.05],0.2046555014076802
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,22128,182,0.90 [0.67-1.21],0.4844240467745819
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FKBPL,FK506-binding protein-like,19705,168,0.95 [0.74-1.22],0.6718352221120674
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FLI1,Friend leukemia integration 1 transcription factor,22228,185,0.93 [0.83-1.05],0.2674545989035414
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,22595,190,1.37 [0.87-2.15],0.1740923945948216
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FLT1,Vascular endothelial growth factor receptor 1,22598,187,1.09 [0.60-1.99],0.7791734683594514
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FLT3,Receptor-type tyrosine-protein kinase FLT3,22228,185,1.23 [0.85-1.79],0.2666735035832086
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FLT3LG,Fms-related tyrosine kinase 3 ligand,22992,190,1.13 [0.76-1.67],0.5468908622840504
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FLT4,Vascular endothelial growth factor receptor 3,22813,190,0.85 [0.58-1.25],0.4164295461857453
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FMNL1,Formin-like protein 1,22176,182,0.99 [0.81-1.22],0.9613697944291208
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FMR1,Synaptic functional regulator FMR1,22228,185,1.14 [0.79-1.65],0.4886196673636633
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FN1,Fibronectin,19834,169,1.69 [0.99-2.90],0.0543307022266923
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FNDC1,Fibronectin type III domain-containing protein 1,19765,168,0.97 [0.71-1.33],0.853955652733948
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,19698,167,1.03 [0.68-1.56],0.8891969868502433
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FOLH1,Glutamate carboxypeptidase 2,19252,163,0.99 [0.86-1.15],0.9444469382504448
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FOLR1,Folate receptor alpha,22704,188,1.14 [0.72-1.80],0.5799244180019034
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FOLR2,Folate receptor beta,22944,191,0.90 [0.58-1.39],0.627379039370733
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FOLR3,Folate receptor gamma,22738,188,0.93 [0.86-1.01],0.0916149563413134
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FOS,Proto-oncogene c-Fos,19069,162,1.23 [0.81-1.87],0.3246844285439229
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FOSB,Protein fosB,22176,182,0.99 [0.71-1.39],0.9553725048956588
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FOXJ3,Forkhead box protein J3,19252,163,0.85 [0.59-1.23],0.388580049465276
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FOXO1,Forkhead box protein O1,22702,187,0.88 [0.75-1.03],0.1109699575360363
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FOXO3,Forkhead box protein O3,22228,185,1.01 [0.88-1.16],0.8711463721981167
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FRMD4B,FERM domain-containing protein 4B,19204,165,0.92 [0.73-1.15],0.4648241127998754
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FRMD7,FERM domain-containing protein 7,19251,160,1.21 [0.79-1.86],0.3797320600787691
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FRZB,Secreted frizzled-related protein 3,22519,189,2.00 [1.18-3.39],0.0098773141462261
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FSHB,Follitropin subunit beta,19304,165,0.91 [0.72-1.14],0.4076770307215863
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FST,Follistatin,22809,191,0.92 [0.71-1.19],0.5139564788814082
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FSTL1,Follistatin-related protein 1,19304,165,1.26 [0.65-2.42],0.4975265577801419
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FSTL3,Follistatin-related protein 3,22704,189,1.38 [0.93-2.06],0.1132486774920675
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FTCD,Formimidoyltransferase-cyclodeaminase,19737,168,1.12 [0.95-1.31],0.1704197441357403
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FUCA1,Tissue alpha-L-fucosidase,22887,190,0.96 [0.82-1.12],0.5895022124474798
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FUOM,Fucose mutarotase,19390,164,1.04 [0.83-1.31],0.7097962488851763
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FURIN,Furin,22813,190,1.48 [1.02-2.16],0.0409478058028622
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FUS,RNA-binding protein FUS,22196,184,0.85 [0.60-1.19],0.3365192832311612
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",19379,163,1.05 [0.84-1.31],0.6716816853527159
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,22944,191,0.86 [0.65-1.14],0.3013474070398548
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FUT8,"Alpha-(1,6)-fucosyltransferase",22595,190,1.05 [0.84-1.30],0.6912961514455727
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FXN,"Frataxin, mitochondrial",22943,189,0.85 [0.72-1.02],0.0795449032291784
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FXYD5,FXYD domain-containing ion transport regulator 5,22309,181,0.89 [0.72-1.09],0.2579947748273155
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FYB1,FYN-binding protein 1,22716,189,0.90 [0.78-1.04],0.1471652920287539
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FZD10,Frizzled-10,19251,160,1.18 [0.96-1.46],0.1093177147126808
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FZD8,Frizzled-8,19195,164,0.99 [0.70-1.41],0.9699690324223976
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GABARAP,Gamma-aminobutyric acid receptor-associated protein,19698,167,1.12 [0.85-1.48],0.4194766675007988
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,19422,163,1.12 [0.91-1.37],0.2838640487228527
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,19195,164,0.94 [0.74-1.21],0.6481207079788858
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GAD1,Glutamate decarboxylase 1,19107,162,1.58 [0.89-2.82],0.1202717304679557
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GAD2,Glutamate decarboxylase 2,19252,163,1.11 [0.83-1.47],0.4885522274504353
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,19422,163,1.14 [0.88-1.48],0.3094022000852103
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,19304,165,0.82 [0.61-1.10],0.1843041792670058
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GAGE2A,G antigen 2A,19107,162,1.15 [0.94-1.41],0.1614285075725562
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GAL,Galanin peptides,22848,191,1.34 [1.10-1.64],0.0042618227187393
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,22638,187,1.04 [0.65-1.65],0.8813932345632239
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,22943,189,1.31 [0.80-2.14],0.2796988728233198
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,22309,181,1.38 [1.01-1.88],0.0410539974275008
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,19806,170,1.04 [0.61-1.75],0.8930592229372825
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GALNT7,N-acetylgalactosaminyltransferase 7,22638,187,0.89 [0.48-1.64],0.7002378175492312
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GAMT,Guanidinoacetate N-methyltransferase,19204,165,1.30 [0.97-1.74],0.0753949254134411
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,18964,159,1.03 [0.65-1.64],0.8892512300099789
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GART,Trifunctional purine biosynthetic protein adenosine-3,19775,169,1.11 [0.64-1.91],0.7096295463740406
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GAS2,Growth arrest-specific protein 2,19422,163,1.13 [0.88-1.45],0.3502859995644864
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GAS6,Growth arrest-specific protein 6,22864,187,1.12 [0.68-1.86],0.6507153123622058
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GASK1A,Golgi-associated kinase 1A,19204,165,1.08 [0.77-1.53],0.6515293766225556
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GAST,Gastrin,19765,168,0.96 [0.86-1.07],0.4728279296110548
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,19107,162,1.10 [0.62-1.95],0.7328668226761206
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",19304,165,0.83 [0.68-1.02],0.0740650741972189
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GBA,Lysosomal acid glucosylceramidase,19251,160,0.96 [0.72-1.28],0.7887030089401342
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GBP1,Guanylate-binding protein 1,19728,168,0.79 [0.64-0.97],0.0277405001646266
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GBP2,Guanylate-binding protein 2,22309,181,0.75 [0.60-0.95],0.015103132829694
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GBP4,Guanylate-binding protein 4,22176,182,1.15 [0.90-1.49],0.2687315586733914
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GBP6,Guanylate-binding protein 6,19204,165,1.01 [0.73-1.39],0.9617068250927724
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GC,Vitamin D-binding protein,19834,169,1.22 [0.70-2.11],0.4894419524208436
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GCC1,GRIP and coiled-coil domain-containing protein 1,19765,168,0.92 [0.80-1.05],0.223522742630385
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GCG,Pro-glucagon,22228,185,1.08 [0.98-1.20],0.1270689967068108
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,18920,161,1.04 [0.77-1.40],0.8196063784355135
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GCLM,Glutamate--cysteine ligase regulatory subunit,19204,165,0.87 [0.62-1.23],0.4364910003797237
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",22638,187,1.40 [0.97-2.03],0.0751715118128892
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,23014,190,0.90 [0.65-1.23],0.4911420013834514
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GDF2,Growth/differentiation factor 2,22739,185,0.81 [0.56-1.17],0.2582938092775547
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GDNF,Glial cell line-derived neurotrophic factor,22176,182,1.41 [1.02-1.95],0.0359041327649448
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GET3,ATPase GET3,19806,170,1.21 [0.96-1.52],0.1071168491513162
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GFAP,Glial fibrillary acidic protein,22192,185,0.93 [0.70-1.24],0.6224181453307642
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GFER,FAD-linked sulfhydryl oxidase ALR,22228,185,0.96 [0.78-1.18],0.6837896262060952
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,22228,185,0.95 [0.85-1.06],0.3702089941185521
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,22903,188,0.94 [0.60-1.50],0.8063837063194612
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GFRA2,GDNF family receptor alpha-2,22638,187,1.00 [0.55-1.85],0.9891888776077068
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GFRA3,GDNF family receptor alpha-3,22527,188,1.26 [0.81-1.97],0.3100171092043238
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GFRAL,GDNF family receptor alpha-like,19174,166,0.91 [0.71-1.16],0.4452118740993879
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GGA1,ADP-ribosylation factor-binding protein GGA1,22176,182,0.86 [0.69-1.07],0.1757270805979695
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GGACT,Gamma-glutamylaminecyclotransferase,19806,170,0.80 [0.65-0.99],0.0390716703180347
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GGCT,Gamma-glutamylcyclotransferase,19762,169,0.84 [0.61-1.15],0.2721928743295709
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GGH,Gamma-glutamyl hydrolase,22343,189,1.15 [0.79-1.67],0.4601076828266954
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GGT1,Glutathione hydrolase 1 proenzyme,22718,190,1.25 [0.99-1.59],0.0626817188136456
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GGT5,Glutathione hydrolase 5 proenzyme,22595,190,1.51 [0.89-2.56],0.1275122450813526
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GH1,Somatotropin,22705,185,0.97 [0.90-1.05],0.4556678511809854
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GH2,Growth hormone variant,22228,185,1.03 [0.96-1.11],0.448691327020623
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GHR,Growth hormone receptor,19390,164,2.01 [1.17-3.45],0.0113855716460084
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GHRHR,Growth hormone-releasing hormone receptor,22176,182,0.95 [0.74-1.21],0.6533000359601191
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GHRL,Appetite-regulating hormone,22739,185,0.95 [0.81-1.12],0.5630724411399866
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GID8,Glucose-induced degradation protein 8 homolog,19775,169,1.23 [0.85-1.79],0.2776419640353033
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GIGYF2,GRB10-interacting GYF protein 2,19775,169,0.97 [0.80-1.18],0.766833540960213
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GIMAP7,GTPase IMAP family member 7,19390,164,0.51 [0.31-0.86],0.0116136803122144
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GIMAP8,GTPase IMAP family member 8,19107,162,1.13 [0.87-1.46],0.3784323179213392
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GIP,Gastric inhibitory polypeptide,19304,165,0.83 [0.62-1.10],0.1995608906484164
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GIPC2,PDZ domain-containing protein GIPC2,19765,168,0.85 [0.51-1.42],0.5389322968767294
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GIPC3,PDZ domain-containing protein GIPC3,19705,168,0.92 [0.79-1.06],0.2606007914919767
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GIPR,Gastric inhibitory polypeptide receptor,19252,163,0.83 [0.58-1.17],0.2869558017724152
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GIT1,ARF GTPase-activating protein GIT1,19252,163,0.93 [0.80-1.09],0.4011457892105718
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GJA8,Gap junction alpha-8 protein,19107,162,0.94 [0.73-1.21],0.6280178735496185
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GKN1,Gastrokine-1,21747,178,1.07 [0.66-1.75],0.7758879101884895
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GLA,Alpha-galactosidase A,19347,164,1.18 [0.79-1.76],0.417428055515665
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GLB1,Beta-galactosidase,22595,190,1.00 [0.73-1.37],0.988513697244671
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GLI2,Zinc finger protein GLI2,19252,163,1.09 [0.70-1.70],0.6964496731646252
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GLO1,Lactoylglutathione lyase,22335,183,1.07 [0.86-1.33],0.538893083520613
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GLOD4,Glyoxalase domain-containing protein 4,22706,190,0.89 [0.62-1.26],0.5020002862199455
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GLP1R,Glucagon-like peptide 1 receptor,19195,164,1.11 [0.77-1.60],0.5715806892953953
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GLRX,Glutaredoxin-1,22588,184,1.11 [0.89-1.39],0.3611990185360957
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",19390,164,0.82 [0.69-0.97],0.022521996991852
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,22176,182,1.07 [0.82-1.39],0.619766683171681
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GLYR1,Putative oxidoreductase GLYR1,19698,167,0.92 [0.70-1.20],0.5162458569744304
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GM2A,Ganglioside GM2 activator,19325,167,1.14 [0.82-1.59],0.4354308534800881
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GMFG,Glia maturation factor gamma,19806,170,0.87 [0.71-1.07],0.1756764325483374
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GMPR,GMP reductase 1,22992,190,0.96 [0.75-1.23],0.734174764860015
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GMPR2,GMP reductase 2,19390,164,0.97 [0.78-1.21],0.7844317358387924
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GNAS,Neuroendocrine secretory protein 55,19775,169,1.09 [0.93-1.28],0.2646971449311749
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,22228,185,0.90 [0.74-1.11],0.3290635790499605
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,19251,160,0.81 [0.58-1.15],0.2457537731667245
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GNLY,Granulysin,22752,190,1.07 [0.83-1.37],0.5963878119451012
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GNPDA1,Glucosamine-6-phosphate isomerase 1,19304,165,1.05 [0.68-1.63],0.8176610636141994
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GNPDA2,Glucosamine-6-phosphate isomerase 2,19390,164,0.74 [0.49-1.12],0.1571771090917929
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GOLGA3,Golgin subfamily A member 3,19775,169,1.15 [0.96-1.38],0.1248718827864373
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GOLM2,Protein GOLM2,22944,191,1.23 [0.70-2.17],0.4653089314532806
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,22702,187,0.91 [0.80-1.03],0.1219412196687675
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GORASP2,Golgi reassembly-stacking protein 2,19705,168,0.99 [0.72-1.35],0.9426610742102904
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GOT1,"Aspartate aminotransferase, cytoplasmic",19801,169,0.84 [0.58-1.21],0.3438579895419872
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GP1BA,Platelet glycoprotein Ib alpha chain,22619,192,0.76 [0.51-1.15],0.1938191888318478
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GP1BB,Platelet glycoprotein Ib beta chain,19204,165,0.90 [0.72-1.13],0.38102750546289
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,22057,179,1.26 [1.10-1.44],0.000931557069987
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GP5,Platelet glycoprotein V,19390,164,0.84 [0.56-1.27],0.4057149972259904
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GP6,Platelet glycoprotein VI,22716,189,0.87 [0.76-1.01],0.0700920517293632
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GPA33,Cell surface A33 antigen,22638,187,0.94 [0.86-1.03],0.1973003621997151
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GPC1,Glypican-1,22943,189,1.01 [0.65-1.56],0.9612049714566608
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GPC5,Glypican-5,22595,190,1.08 [0.86-1.35],0.5249531630408208
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GPD1,Glycerol-3-phosphate dehydrogenase,19698,167,1.26 [0.97-1.64],0.0822241545481861
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GPHA2,Glycoprotein hormone alpha-2,19705,168,1.23 [0.96-1.58],0.1064828001055915
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GPI,Glucose-6-phosphate isomerase,19809,169,0.81 [0.58-1.11],0.1907552113731883
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,19705,168,1.00 [0.81-1.23],0.9705231050956512
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GPKOW,G-patch domain and KOW motifs-containing protein,22176,182,0.97 [0.61-1.54],0.8899692364584699
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GPNMB,Transmembrane glycoprotein NMB,22121,180,1.15 [0.72-1.84],0.5581737735699864
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GPR101,Probable G-protein coupled receptor 101,19195,164,0.99 [0.77-1.27],0.9233543542585037
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GPR158,Probable G-protein coupled receptor 158,19775,169,1.20 [0.84-1.72],0.3220126770968586
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GPR15L,Protein GPR15L,19705,168,1.08 [0.85-1.37],0.5340521637005978
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GPR37,Prosaposin receptor GPR37,22335,183,1.29 [1.06-1.57],0.0112045980129115
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GPRC5C,G-protein coupled receptor family C group 5 member C,19698,167,1.05 [0.81-1.35],0.7194701709003022
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GRAP2,GRB2-related adapter protein 2,22739,185,0.93 [0.84-1.03],0.1818935732831754
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,19806,170,0.91 [0.72-1.14],0.4150225765493016
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GRIK2,"Glutamate receptor ionotropic, kainate 2",19775,169,1.27 [0.95-1.70],0.1113849711152059
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",19195,164,1.10 [0.87-1.38],0.4425212176935702
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GRK5,G protein-coupled receptor kinase 5,22335,183,1.16 [0.92-1.46],0.2096613761339023
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,22653,188,0.78 [0.45-1.35],0.3831683465432742
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GRP,Gastrin-releasing peptide,19304,165,1.35 [1.03-1.76],0.0286101313819379
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GRPEL1,"GrpE protein homolog 1, mitochondrial",22638,187,0.80 [0.64-1.01],0.0642188568538813
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GRSF1,G-rich sequence factor 1,19001,162,0.92 [0.76-1.12],0.389076210751188
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GSAP,Gamma-secretase-activating protein,22228,185,1.06 [0.93-1.22],0.3668687274335491
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GSN,Gelsolin,19740,169,0.84 [0.40-1.77],0.6495630553106329
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GSR,"Glutathione reductase, mitochondrial",19687,166,1.12 [0.56-2.24],0.7458434692422998
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GSTA1,Glutathione S-transferase A1,22704,185,1.09 [0.94-1.26],0.2525980189778249
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GSTA3,Glutathione S-transferase A3,22228,185,1.18 [1.01-1.37],0.035711064670991
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GSTM4,Glutathione S-transferase Mu 4,19204,165,1.05 [0.87-1.28],0.5980483045163456
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GSTP1,Glutathione S-transferase P,22039,181,0.93 [0.76-1.13],0.4476116809809471
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GSTT2B,Glutathione S-transferase theta-2B,19765,168,1.03 [0.97-1.09],0.3567352016903303
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,19422,163,1.11 [0.93-1.33],0.2590461070357928
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GTPBP2,GTP-binding protein 2,19251,160,0.90 [0.74-1.09],0.2767161475862328
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GUCA2A,Guanylin,22641,188,1.02 [0.69-1.50],0.91513205779983
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GUCY2C,Heat-stable enterotoxin receptor,19422,163,1.08 [0.92-1.27],0.3412663041663882
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GUK1,Guanylate kinase,19204,165,0.87 [0.57-1.33],0.5202795828012357
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GUSB,Beta-glucuronidase,22851,189,1.13 [0.92-1.38],0.236166146536871
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GYS1,"Glycogen [starch] synthase, muscle",22335,183,0.90 [0.78-1.04],0.1382610458047909
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GZMA,Granzyme A,22992,190,0.90 [0.63-1.30],0.5769500124780367
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GZMB,Granzyme B,22702,187,0.96 [0.77-1.18],0.6716030101825745
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GZMH,Granzyme H,22335,183,0.91 [0.75-1.09],0.2960546504561502
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",H2AP,Huntingtin-interacting protein M,19107,162,0.97 [0.71-1.34],0.8734929905345207
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",19204,165,1.06 [0.86-1.30],0.591613919301434
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",22870,188,1.08 [0.91-1.28],0.3639861871295428
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HAO1,Hydroxyacid oxidase 1,22943,189,0.96 [0.87-1.06],0.398990645009757
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HARS1,"Histidine--tRNA ligase, cytoplasmic",22752,190,0.86 [0.73-1.02],0.0826410023856021
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HAVCR1,Hepatitis A virus cellular receptor 1,22910,189,0.96 [0.78-1.19],0.7207771946013155
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,22752,190,1.02 [0.70-1.47],0.9348605342502124
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HBEGF,Proheparin-binding EGF-like growth factor,22870,188,1.05 [0.88-1.25],0.5672755455522174
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HBQ1,Hemoglobin subunit theta-1,22943,189,1.09 [0.88-1.34],0.4300604966192156
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HBZ,Hemoglobin subunit zeta,19806,170,0.95 [0.82-1.09],0.4333408249922913
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HCG22,Protein PBMUCL2,19204,165,0.94 [0.69-1.27],0.6834944593866199
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HCLS1,Hematopoietic lineage cell-specific protein,22992,190,0.88 [0.70-1.10],0.2639204208528799
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HDAC8,Histone deacetylase 8,19252,163,1.03 [0.81-1.31],0.8186754608446581
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HDAC9,Histone deacetylase 9,19195,164,0.90 [0.69-1.16],0.4086192115841414
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HDDC2,5'-deoxynucleotidase HDDC2,19705,168,1.00 [0.72-1.39],0.993546236939978
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HDGF,Hepatoma-derived growth factor,22913,188,1.06 [0.92-1.21],0.4170242469021141
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HDGFL2,Hepatoma-derived growth factor-related protein 2,19765,168,1.00 [0.80-1.27],0.9672655742118264
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HEBP1,Heme-binding protein 1,22335,183,0.92 [0.72-1.18],0.5236715625389914
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HEG1,Protein HEG homolog 1,19390,164,0.60 [0.34-1.05],0.0721559263306515
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HEPACAM2,HEPACAM family member 2,19765,168,1.13 [0.79-1.62],0.500817977064138
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HEPH,Hephaestin,19806,170,1.74 [0.98-3.12],0.0607550432726365
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HEXIM1,Protein HEXIM1,22702,187,0.98 [0.83-1.14],0.7599698133266026
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HGF,Hepatocyte growth factor,22992,190,1.48 [1.03-2.11],0.0343191063235043
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HGFAC,Hepatocyte growth factor activator,19614,167,0.87 [0.53-1.42],0.5832343150794868
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,22228,185,0.94 [0.79-1.12],0.4935346874666533
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HHEX,Hematopoietically-expressed homeobox protein HHEX,19765,168,1.02 [0.84-1.24],0.8314508787751644
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HIF1A,Hypoxia-inducible factor 1-alpha,19252,163,1.04 [0.83-1.29],0.7460981931473298
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HIP1,Huntingtin-interacting protein 1,19204,165,0.97 [0.62-1.52],0.9001872420304838
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HIP1R,Huntingtin-interacting protein 1-related protein,19729,167,0.93 [0.66-1.32],0.6807335657740995
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HJV,Hemojuvelin,19775,169,1.14 [0.84-1.53],0.3998147861913197
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HK2,Hexokinase-2,22335,183,0.86 [0.54-1.39],0.5480674835703113
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",19775,169,1.25 [0.79-1.96],0.3421327095779445
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",22635,186,1.17 [0.82-1.67],0.3788122648571569
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",22702,187,1.04 [0.66-1.63],0.8651757688037996
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HMBS,Porphobilinogen deaminase,22943,189,1.22 [0.93-1.62],0.1546375509808136
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HMCN2,Hemicentin-2,19354,164,1.00 [0.77-1.30],0.9820262057198706
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",19304,165,0.76 [0.55-1.04],0.0886121848474512
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",19204,165,0.99 [0.71-1.39],0.9572656091400986
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HMMR,Hyaluronan mediated motility receptor,19079,162,0.92 [0.66-1.28],0.6143978223164018
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HMOX1,Heme oxygenase 1,22488,183,1.02 [0.76-1.35],0.9134679292603972
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HMOX2,Heme oxygenase 2,22176,182,0.88 [0.65-1.20],0.4204669341418375
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HNF1A,Hepatocyte nuclear factor 1-alpha,19251,160,1.16 [0.97-1.38],0.0982922195492143
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HNMT,Histamine N-methyltransferase,22476,189,0.87 [0.67-1.14],0.3273310924127734
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,22269,182,0.96 [0.81-1.14],0.6695574960590565
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,19775,169,0.87 [0.64-1.20],0.4103180080723907
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HPCAL1,Hippocalcin-like protein 1,22992,190,0.86 [0.72-1.01],0.072175203867111
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HPGDS,Hematopoietic prostaglandin D synthase,22228,185,1.13 [0.80-1.58],0.4836884512977142
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HPSE,Heparanase,19521,166,0.98 [0.83-1.15],0.7939872081200474
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HRAS,GTPase Hras,19385,162,0.99 [0.85-1.15],0.9108605900622876
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,19304,165,1.02 [0.67-1.55],0.9420633201330672
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HRG,Histidine-rich glycoprotein,19716,168,1.14 [0.71-1.82],0.5924168550312674
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HS1BP3,HCLS1-binding protein 3,19304,165,0.91 [0.76-1.08],0.2682302724696365
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,22638,187,1.02 [0.72-1.43],0.9262045366079964
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,22943,189,1.19 [0.82-1.71],0.3613597832084256
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,19252,163,1.63 [1.04-2.57],0.0343326766053384
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HSBP1,Heat shock factor-binding protein 1,19304,165,0.98 [0.84-1.15],0.8069804733453203
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,22702,187,0.68 [0.50-0.94],0.0178433783807271
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,19765,168,1.07 [0.85-1.35],0.5765272613823107
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HSD17B3,Testosterone 17-beta-dehydrogenase 3,19204,165,0.73 [0.52-1.03],0.0734222539263043
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,19304,165,0.88 [0.64-1.21],0.4349760601922704
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HSP90B1,Endoplasmin,22073,181,1.04 [0.87-1.25],0.6637305244629117
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HSPA1A,Heat shock 70 kDa protein 1A,22814,191,0.86 [0.72-1.04],0.1138273014327865
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HSPA2,Heat shock-related 70 kDa protein 2,19698,167,0.83 [0.52-1.33],0.4385602046765885
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HSPB1,Heat shock protein beta-1,22371,183,0.91 [0.75-1.10],0.3218464180326156
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HSPB6,Heat shock protein beta-6,22943,189,1.35 [0.96-1.90],0.080583431362884
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,22549,190,1.70 [1.08-2.67],0.0216109556272286
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HTR1A,5-hydroxytryptamine receptor 1A,19195,164,1.00 [0.83-1.20],0.9858138679096968
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HTR1B,5-hydroxytryptamine receptor 1B,19195,164,1.08 [0.77-1.52],0.64342649764775
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HTRA2,"Serine protease HTRA2, mitochondrial",22813,190,0.87 [0.70-1.07],0.1831659223818836
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HYAL1,Hyaluronidase-1,22580,191,0.68 [0.39-1.20],0.1805999873060513
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HYOU1,Hypoxia up-regulated protein 1,23014,190,0.75 [0.42-1.35],0.3431515957273269
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ICA1,Islet cell autoantigen 1,22309,181,0.93 [0.78-1.10],0.3998476068556198
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,22629,191,0.99 [0.63-1.55],0.95674787450152
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ICAM2,Intercellular adhesion molecule 2,23014,190,0.64 [0.43-0.96],0.0320198309912538
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ICAM3,Intercellular adhesion molecule 3,23014,190,0.69 [0.41-1.16],0.1646181777088678
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ICAM4,Intercellular adhesion molecule 4,22702,187,0.88 [0.69-1.12],0.2871805750913746
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ICAM5,Intercellular adhesion molecule 5,22739,185,0.90 [0.67-1.21],0.4856916424319363
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ICOSLG,ICOS ligand,22638,187,0.76 [0.38-1.50],0.4267051535952805
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ID4,DNA-binding protein inhibitor ID-4,19422,163,0.95 [0.68-1.34],0.7889388251739813
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IDI2,Isopentenyl-diphosphate delta-isomerase 2,22176,182,1.12 [0.86-1.46],0.4146676648211662
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IDO1,"Indoleamine 2,3-dioxygenase 1",19304,165,0.99 [0.79-1.26],0.9604827768769
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IDS,Iduronate 2-sulfatase,22992,190,0.45 [0.11-1.87],0.2719510623008023
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IDUA,Alpha-L-iduronidase,22943,189,1.25 [0.94-1.66],0.1237170713162506
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,19219,163,0.89 [0.60-1.33],0.5784551479430107
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,19422,163,1.17 [0.92-1.50],0.2017607169024364
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,19422,163,0.87 [0.58-1.32],0.5217941409678711
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IFNAR1,Interferon alpha/beta receptor 1,19705,168,1.36 [0.82-2.27],0.2382334797615501
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IFNG,Interferon gamma,22309,181,0.93 [0.83-1.05],0.2396695603709878
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,22848,191,1.36 [0.73-2.53],0.3344875511962034
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IFNGR2,Interferon gamma receptor 2,22595,190,1.18 [0.93-1.50],0.1717610731514332
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IFNL1,Interferon lambda-1,22176,182,0.90 [0.67-1.21],0.4742631008923594
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IFNL2,Interferon lambda-2,19195,164,0.87 [0.66-1.13],0.2907842759896309
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IFNLR1,Interferon lambda receptor 1,22702,187,1.34 [0.99-1.81],0.0551377745861383
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IFNW1,Interferon omega-1,19204,165,0.94 [0.62-1.43],0.7771158794918972
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IFT20,Intraflagellar transport protein 20 homolog,19251,160,1.06 [0.75-1.50],0.7391853417612844
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGBP1,Immunoglobulin-binding protein 1,19775,169,0.99 [0.78-1.25],0.9067757464581828
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,19195,164,1.32 [1.06-1.65],0.0125705320345271
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,19801,169,0.95 [0.54-1.68],0.8703974726637722
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGF1R,Insulin-like growth factor 1 receptor,22638,187,0.69 [0.37-1.29],0.2501733044714356
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,19204,165,1.07 [0.79-1.45],0.6629256040984843
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGF2R,Cation-independent mannose-6-phosphate receptor,22752,190,0.79 [0.45-1.39],0.4154992959676653
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGFBP1,Insulin-like growth factor-binding protein 1,22975,190,0.87 [0.78-0.97],0.0131913294426212
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGFBP2,Insulin-like growth factor-binding protein 2,22974,189,0.80 [0.66-0.97],0.0226386821259005
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGFBP3,Insulin-like growth factor-binding protein 3,22808,192,1.50 [0.95-2.37],0.079542544318588
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGFBP4,Insulin-like growth factor-binding protein 4,22457,190,1.21 [0.90-1.63],0.205875994089344
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGFBP6,Insulin-like growth factor-binding protein 6,22625,191,1.48 [0.98-2.25],0.06345856186879
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGFBP7,Insulin-like growth factor-binding protein 7,23014,190,1.28 [0.85-1.93],0.233998108793785
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGFBPL1,Insulin-like growth factor-binding protein-like 1,22739,185,1.29 [0.90-1.84],0.1642723925199274
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGFL4,Insulin growth factor-like family member 4,19252,163,0.98 [0.79-1.20],0.8147094483108392
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGHMBP2,DNA-binding protein SMUBP-2,19204,165,1.07 [0.83-1.39],0.5949516017947787
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGLC2,Immunoglobulin lambda constant 2,19795,169,1.18 [0.70-1.99],0.5417804218493156
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGLON5,IgLON family member 5,19107,162,0.94 [0.79-1.12],0.4856469947785042
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGSF21,Immunoglobulin superfamily member 21,19304,165,1.15 [0.82-1.62],0.4217204786614621
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,22638,187,1.25 [0.89-1.76],0.1915379028721985
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGSF8,Immunoglobulin superfamily member 8,22739,185,0.80 [0.52-1.25],0.3328940835376664
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGSF9,Protein turtle homolog A,19806,170,1.11 [0.93-1.31],0.237061258216111
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IKBKG,NF-kappa-B essential modulator,22702,187,0.95 [0.82-1.09],0.4690999863921367
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IKZF2,Zinc finger protein Helios,22228,185,1.01 [0.87-1.16],0.913994987146014
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL10,Interleukin-10,22309,181,1.03 [0.88-1.20],0.7183286308884692
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL10RA,Interleukin-10 receptor subunit alpha,22309,181,0.99 [0.79-1.25],0.9567891585936869
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,22848,191,1.23 [0.80-1.91],0.3502433795880864
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL11,Interleukin-11,22309,181,0.99 [0.81-1.22],0.9548588937013064
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL12A_IL12B,Interleukin-12,22638,187,1.05 [0.89-1.24],0.5556225808935977
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL12B,Interleukin-12 subunit beta,22992,190,1.03 [0.81-1.30],0.826452229821953
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL12RB1,Interleukin-12 receptor subunit beta-1,22309,181,0.71 [0.50-1.02],0.0652064235019254
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL12RB2,Interleukin-12 receptor subunit beta-2,19252,163,1.02 [0.71-1.46],0.9185282002954496
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL13,Interleukin-13,22309,181,1.00 [0.76-1.32],0.9818093526183634
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL13RA1,Interleukin-13 receptor subunit alpha-1,22454,185,1.55 [0.83-2.91],0.1676505082128899
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL13RA2,Interleukin-13 receptor subunit alpha-2,19195,164,0.99 [0.59-1.67],0.9761722914369448
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL15,Interleukin-15,22702,187,0.73 [0.49-1.10],0.1315569046257938
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL15RA,Interleukin-15 receptor subunit alpha,22309,181,1.25 [0.86-1.82],0.2481164003212702
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL16,Pro-interleukin-16,22992,190,0.95 [0.69-1.29],0.7299876365987736
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL17A,Interleukin-17A,22285,181,0.78 [0.56-1.10],0.1606785722530221
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL17C,Interleukin-17C,22309,181,0.98 [0.81-1.18],0.80390472506299
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL17D,Interleukin-17D,22309,181,1.24 [0.88-1.74],0.2267657838202202
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL17F,Interleukin-17F,22309,181,1.00 [0.84-1.18],0.9533635908034171
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL17RA,Interleukin-17 receptor A,22752,190,0.98 [0.73-1.31],0.884321570005988
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL17RB,Interleukin-17 receptor B,22408,186,0.84 [0.66-1.07],0.1589624700554837
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL18,Interleukin-18,22663,190,0.92 [0.70-1.21],0.552556106485778
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,22808,192,0.97 [0.63-1.47],0.8722911296655466
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL18R1,Interleukin-18 receptor 1,22992,190,1.19 [0.82-1.74],0.3612422403184235
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL18RAP,Interleukin-18 receptor accessory protein,22448,189,1.02 [0.95-1.10],0.6082246497379272
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL19,Interleukin-19,22171,181,1.16 [0.97-1.39],0.0973491491162617
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL1A,Interleukin-1 alpha,22309,181,1.11 [0.90-1.36],0.3230626006367934
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL1B,Interleukin-1 beta,22207,180,1.06 [0.85-1.33],0.5901698297795386
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL1R1,Interleukin-1 receptor type 1,22718,190,0.73 [0.42-1.28],0.2747143438666848
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL1R2,Interleukin-1 receptor type 2,22709,190,1.52 [0.78-2.95],0.2154460142075919
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL1RAP,Interleukin-1 receptor accessory protein,22752,190,1.17 [0.88-1.56],0.2899584577141272
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL1RL1,Interleukin-1 receptor-like 1,22945,189,1.13 [0.84-1.50],0.4197792239152416
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL1RL2,Interleukin-1 receptor-like 2,22309,181,1.45 [1.03-2.05],0.0333617562604231
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL1RN,Interleukin-1 receptor antagonist protein,22703,189,0.97 [0.77-1.21],0.7554068008637018
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL2,Interleukin-2,22309,181,1.01 [0.66-1.55],0.9647538704367894
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL20,Interleukin-20,22309,181,1.03 [0.80-1.31],0.8378009427378069
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL20RA,Interleukin-20 receptor subunit alpha,22309,181,0.94 [0.70-1.27],0.7014498566878878
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL20RB,Interleukin-20 receptor subunit beta,19252,163,0.88 [0.61-1.27],0.4981352839707579
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL21R,Interleukin-21 receptor,19252,163,1.00 [0.76-1.30],0.971156235000435
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL22,Interleukin-22,19698,167,1.07 [0.86-1.33],0.5277631668099161
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL22RA1,Interleukin-22 receptor subunit alpha-1,22309,181,0.92 [0.67-1.28],0.6327854897128077
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL24,Interleukin-24,22309,181,1.04 [0.80-1.35],0.7790732523323952
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL25,Interleukin-25,19037,162,0.95 [0.61-1.47],0.8257075941257561
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,22569,185,1.04 [0.75-1.44],0.8346434844870951
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL2RB,Interleukin-2 receptor subunit beta,22309,181,1.17 [0.87-1.56],0.3055437896166819
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL2RG,Cytokine receptor common subunit gamma,19698,167,1.38 [1.08-1.76],0.0090094059885854
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL3,Interleukin-3,19107,162,0.94 [0.74-1.20],0.6260487363241473
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL31,Interleukin-31,19252,163,1.16 [0.92-1.45],0.2020736384050763
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL31RA,Interleukin-31 receptor subunit alpha,19176,162,1.20 [0.83-1.74],0.3352195323091769
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL32,Interleukin-32,22702,187,0.63 [0.46-0.87],0.0044322815995861
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL33,Interleukin-33,22309,181,0.89 [0.63-1.25],0.4957722626929173
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL34,Interleukin-34,22146,182,1.64 [1.12-2.38],0.0102425732006451
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL36A,Interleukin-36 alpha,19252,163,0.90 [0.67-1.19],0.4567223205209119
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL36G,Interleukin-36 gamma,19169,162,0.93 [0.74-1.18],0.5660049594436491
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL3RA,Interleukin-3 receptor subunit alpha,22309,181,0.91 [0.60-1.37],0.6426287520411089
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL4,Interleukin-4,22309,181,0.95 [0.83-1.08],0.4352517481814852
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,22702,187,0.78 [0.54-1.14],0.2024120475236037
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL5,Interleukin-5,22309,181,1.08 [0.99-1.17],0.0791687947302533
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL5RA,Interleukin-5 receptor subunit alpha,22702,187,0.84 [0.66-1.07],0.1528612827926226
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL6,Interleukin-6,22638,187,1.04 [0.87-1.23],0.6950358173011806
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL6R,Interleukin-6 receptor subunit alpha,22585,191,0.92 [0.63-1.33],0.6453119221916296
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL6ST,Interleukin-6 receptor subunit beta,22739,185,1.01 [0.49-2.05],0.9881876784902752
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL7,Interleukin-7,22702,187,0.91 [0.75-1.12],0.3829257040146394
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL7R,Interleukin-7 receptor subunit alpha,22752,190,0.76 [0.59-0.96],0.0221201326094064
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL9,Interleukin-9,19422,163,1.10 [0.87-1.39],0.4309269765982081
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,22150,181,0.91 [0.72-1.16],0.458141750853224
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IMMT,MICOS complex subunit MIC60,19698,167,1.13 [0.82-1.55],0.4677153007365637
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IMPA1,Inositol monophosphatase 1,22595,190,0.79 [0.63-0.98],0.0317931585049426
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IMPACT,Protein IMPACT,19765,168,1.03 [0.79-1.33],0.8424286093344251
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IMPG1,Interphotoreceptor matrix proteoglycan 1,19195,164,1.22 [0.80-1.88],0.3584019358325784
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ING1,Inhibitor of growth protein 1,22128,182,0.83 [0.61-1.13],0.2380423003328058
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",INHBB,Inhibin beta B chain,19390,164,1.28 [0.97-1.70],0.0828641631311431
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",INHBC,Inhibin beta C chain,22752,190,1.59 [1.15-2.20],0.0047294442514508
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",INPP1,Inositol polyphosphate 1-phosphatase,22638,187,0.91 [0.72-1.17],0.4678974577679208
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",19304,165,1.10 [0.85-1.43],0.4648286357177152
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",19775,169,1.18 [0.88-1.59],0.2759383682400965
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",22638,187,0.93 [0.81-1.06],0.2877515041227646
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",INSL3,Insulin-like 3,19765,168,0.77 [0.62-0.96],0.0213365307863285
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",INSL4,Early placenta insulin-like peptide,19698,167,1.08 [0.83-1.41],0.5559043596051794
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",INSL5,Insulin-like peptide INSL5,19705,168,1.23 [1.07-1.42],0.0039857490818978
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",INSR,Insulin receptor,19252,163,0.82 [0.34-2.01],0.6698741375724837
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IPCEF1,Interactor protein for cytohesin exchange factors 1,22559,189,0.89 [0.77-1.02],0.0969539348320044
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IQGAP2,Ras GTPase-activating-like protein IQGAP2,22638,187,0.92 [0.72-1.18],0.5155601779656847
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",22335,183,0.95 [0.81-1.11],0.4885136111799125
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IRAK1,Interleukin-1 receptor-associated kinase 1,22309,181,1.00 [0.82-1.21],0.9756017687323648
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IRAK4,Interleukin-1 receptor-associated kinase 4,22702,187,0.92 [0.81-1.04],0.1727081282728319
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,21866,180,1.07 [0.75-1.52],0.702229231458334
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ISM1,Isthmin-1,22702,187,1.54 [1.12-2.12],0.0086708475715972
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ISM2,Isthmin-2,19801,169,0.97 [0.68-1.37],0.8559512529478215
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IST1,IST1 homolog,19563,166,0.91 [0.79-1.06],0.2287215402696644
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGA11,Integrin alpha-11,22702,187,0.79 [0.55-1.15],0.2201438498692804
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGA2,Integrin alpha-2,19390,164,0.69 [0.44-1.08],0.1016873485439973
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGA5,Integrin alpha-5,22752,190,0.93 [0.56-1.54],0.7706602422146676
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGA6,Integrin alpha-6,22702,187,0.83 [0.64-1.08],0.1598799990191248
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGAL,Integrin alpha-L,19252,163,0.98 [0.69-1.39],0.9156365139729438
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGAM,Integrin alpha-M,22752,190,0.59 [0.39-0.90],0.0132932384130555
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGAV,Integrin alpha-V,22943,189,0.64 [0.29-1.39],0.2601276147405101
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGAX,Integrin alpha-X,19422,163,0.90 [0.67-1.21],0.4924621178861514
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGB1,Integrin beta-1,22699,191,0.79 [0.43-1.44],0.4360502358518081
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGB1BP1,Integrin beta-1-binding protein 1,22228,185,0.94 [0.69-1.28],0.6993506360842452
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGB1BP2,Integrin beta-1-binding protein 2,22335,183,0.92 [0.82-1.03],0.1482865897159876
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGB2,Integrin beta-2,22592,186,0.68 [0.42-1.07],0.0967835830999507
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGB5,Integrin beta-5,22813,190,0.73 [0.51-1.04],0.0768048953273443
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGB6,Integrin beta-6,22309,181,1.15 [0.74-1.79],0.5370621644908089
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGB7,Integrin beta-7,22943,189,1.12 [0.85-1.48],0.4188563978406541
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGBL1,Integrin beta-like protein 1,19801,169,1.11 [0.75-1.65],0.5987852569479517
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,19834,169,1.55 [0.74-3.24],0.2424310687314232
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,22808,192,0.79 [0.57-1.10],0.1645995224918806
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,19834,169,0.90 [0.52-1.56],0.712277065221634
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,19698,167,1.31 [1.00-1.71],0.0509848377673938
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITM2A,Integral membrane protein 2A,22702,187,1.13 [0.91-1.40],0.284840843896262
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITPA,Inosine triphosphate pyrophosphatase,19204,165,0.90 [0.72-1.14],0.3849734474869936
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",19304,165,1.05 [0.85-1.29],0.6515783094287851
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",19195,164,0.81 [0.56-1.17],0.2643720156138701
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",22176,182,1.22 [0.96-1.55],0.1030237471703702
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IZUMO1,Izumo sperm-egg fusion protein 1,19107,162,1.23 [0.95-1.59],0.1170490534885983
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",JAM2,Junctional adhesion molecule B,22944,191,0.87 [0.53-1.43],0.5962843844192134
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",JAM3,Junctional adhesion molecule C,19390,164,0.84 [0.62-1.14],0.2672985610926292
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",JCHAIN,Immunoglobulin J chain,22309,181,0.98 [0.79-1.22],0.8688403271102131
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,19107,162,0.85 [0.63-1.15],0.2896401835221839
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",JPT2,Jupiter microtubule associated homolog 2,19705,168,0.88 [0.74-1.04],0.1368302644610401
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",JUN,Transcription factor AP-1,22309,181,1.06 [0.82-1.35],0.6725744761723047
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,22638,187,1.32 [0.98-1.79],0.0707051660568326
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KAZN,Kazrin,19705,168,0.98 [0.85-1.13],0.7652421515889578
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KCNC4,Potassium voltage-gated channel subfamily C member 4,19195,164,0.75 [0.54-1.04],0.0813417561754162
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KCNH2,Potassium voltage-gated channel subfamily H member 2,19251,160,0.97 [0.79-1.19],0.7560178117642595
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KCNIP4,Kv channel-interacting protein 4,22176,182,0.81 [0.59-1.11],0.1863215943355559
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KCTD5,BTB/POZ domain-containing protein KCTD5,19401,166,0.74 [0.51-1.07],0.1082778520182156
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KDM3A,Lysine-specific demethylase 3A,19252,163,1.04 [0.89-1.22],0.6232659840829566
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KDR,Vascular endothelial growth factor receptor 2,22813,190,0.87 [0.53-1.45],0.6055177128308704
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KEL,Kell blood group glycoprotein,22176,182,1.31 [0.91-1.90],0.145197983165682
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KHDC3L,KH domain-containing protein 3,19107,162,0.98 [0.78-1.23],0.8749500833799677
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KHK,Ketohexokinase,19304,165,0.94 [0.74-1.18],0.5842705591550179
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIAA0319,Dyslexia-associated protein KIAA0319,19765,168,0.76 [0.46-1.25],0.2827078512808482
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIAA1549,UPF0606 protein KIAA1549,19422,163,1.06 [0.86-1.30],0.6003657553501365
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIAA1549L,UPF0606 protein KIAA1549L,19422,163,1.11 [0.67-1.84],0.673838866702941
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIAA2013,Uncharacterized protein KIAA2013,19698,167,1.12 [0.90-1.41],0.3150412956138005
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIF1C,Kinesin-like protein KIF1C,19204,165,0.90 [0.58-1.40],0.6340710796988113
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIF20B,Kinesin-like protein KIF20B,19195,164,1.14 [0.96-1.35],0.1253299241858217
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIF22,Kinesin-like protein KIF22,19204,165,1.05 [0.93-1.19],0.4290821163271469
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIFBP,KIF-binding protein,22638,187,0.87 [0.75-1.02],0.0832682156508403
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,19698,167,0.99 [0.84-1.18],0.948169558816317
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,22228,185,1.07 [0.91-1.26],0.4317236284903138
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,19705,168,1.03 [0.95-1.12],0.4675854915459566
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,22228,185,0.99 [0.89-1.10],0.8112360458530999
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,19107,162,0.98 [0.82-1.17],0.8111914309263115
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIRREL1,Kin of IRRE-like protein 1,19195,164,1.19 [0.98-1.44],0.0821423365886831
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIRREL2,Kin of IRRE-like protein 2,22176,182,1.03 [0.74-1.44],0.8604883111575505
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIT,Mast/stem cell growth factor receptor Kit,22771,192,0.76 [0.50-1.17],0.2128247001184349
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KITLG,Kit ligand,22739,185,1.22 [0.85-1.76],0.27233947522623
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLB,Beta-klotho,22176,182,0.82 [0.68-0.99],0.0367699732727293
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLF4,Krueppel-like factor 4,19195,164,0.82 [0.55-1.22],0.3232565982420787
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLHL41,Kelch-like protein 41,19775,169,1.13 [0.84-1.52],0.4126360442283902
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLK1,Kallikrein-1,22504,189,1.05 [0.95-1.16],0.3054500474854614
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLK10,Kallikrein-10,22740,189,1.20 [0.88-1.63],0.2596365950345013
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLK11,Kallikrein-11,22588,188,0.89 [0.58-1.38],0.5991071590541269
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLK12,Kallikrein-12,22228,185,1.08 [0.98-1.19],0.1054792244752538
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLK13,Kallikrein-13,22237,183,1.06 [0.79-1.43],0.690562924777232
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLK14,Kallikrein-14,22943,189,0.91 [0.69-1.20],0.4855120186878562
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLK15,Kallikrein-15,19673,167,1.42 [1.08-1.86],0.0117233062158315
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLK3,Prostate-specific antigen,19801,169,0.77 [0.60-1.00],0.0456945279069411
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLK4,Kallikrein-4,22943,189,1.62 [1.36-1.93],5.51873356947727e-08
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLK6,Kallikrein-6,22785,189,1.47 [0.96-2.24],0.0783159956616958
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLK7,Kallikrein-7,18866,160,0.89 [0.60-1.33],0.5630184744209092
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLK8,Kallikrein-8,21976,180,1.08 [0.74-1.56],0.687718476251453
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLKB1,Plasma kallikrein,19431,164,1.43 [0.79-2.59],0.2352424998727392
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLRB1,Killer cell lectin-like receptor subfamily B member 1,22992,190,1.37 [0.98-1.91],0.0635244224235327
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,19195,164,1.18 [0.95-1.46],0.1346542968836636
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLRD1,Natural killer cells antigen CD94,22992,190,1.06 [0.80-1.41],0.6682309187837159
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLRF1,Killer cell lectin-like receptor subfamily F member 1,19252,163,1.11 [0.82-1.50],0.519478138986929
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLRK1,NKG2-D type II integral membrane protein,19765,168,1.13 [0.82-1.55],0.4551809960231145
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KRT14,"Keratin, type I cytoskeletal 14",21445,174,0.88 [0.53-1.46],0.6290182185322724
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KRT17,"Keratin, type I cytoskeletal 17",19204,165,0.86 [0.57-1.30],0.4729145367276985
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KRT18,"Keratin, type I cytoskeletal 18",22638,187,1.01 [0.86-1.18],0.8969155843149107
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KRT19,"Keratin, type I cytoskeletal 19",22669,187,0.98 [0.80-1.19],0.8207850944686306
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KRT5,"Keratin, type II cytoskeletal 5",22176,182,1.06 [0.81-1.39],0.6633204714718715
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KRT6C,"Keratin, type II cytoskeletal 6C",19204,165,0.83 [0.54-1.26],0.3814856416924304
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KRT8,"Keratin, type II cytoskeletal 8",19195,164,0.82 [0.64-1.04],0.1077066491649728
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KYAT1,Kynurenine--oxoglutarate transaminase 1,22699,184,0.88 [0.70-1.11],0.2738590380996781
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KYNU,Kynureninase,22992,190,0.89 [0.67-1.18],0.4063155960436068
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",L1CAM,Neural cell adhesion molecule L1,22813,190,0.85 [0.54-1.33],0.4675734014132413
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,19806,170,0.84 [0.72-1.00],0.0444198638963408
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LACRT,Extracellular glycoprotein lacritin,19661,167,0.90 [0.66-1.23],0.4969426652175084
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LACTB2,Endoribonuclease LACTB2,22739,185,0.89 [0.73-1.08],0.2379592886797474
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,22638,187,1.04 [0.76-1.43],0.8077466110432856
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,22738,190,0.96 [0.68-1.37],0.8356262506503935
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,22595,190,0.97 [0.86-1.10],0.6589017941147779
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LAMA1,Laminin subunit alpha-1,19204,165,0.96 [0.72-1.28],0.7645977564886801
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LAMA4,Laminin subunit alpha-4,22848,191,1.00 [0.68-1.46],0.9938960687964076
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LAMB1,Laminin subunit beta-1,19304,165,1.01 [0.62-1.67],0.9603892111979802
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LAMP1,Lysosome-associated membrane glycoprotein 1,19249,166,1.11 [0.70-1.75],0.6669144022102007
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LAMP2,Lysosome-associated membrane glycoprotein 2,22052,183,1.09 [0.53-2.24],0.8055260780155408
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LAMP3,Lysosome-associated membrane glycoprotein 3,22951,189,0.96 [0.74-1.23],0.7370999140374226
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LAMTOR5,Ragulator complex protein LAMTOR5,19698,167,1.07 [0.76-1.51],0.6978547129815924
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LAP3,Cytosol aminopeptidase,22309,181,0.88 [0.66-1.17],0.3685077407107309
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LARP1,La-related protein 1,19698,167,0.99 [0.79-1.26],0.9612780751213618
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LAT,Linker for activation of T-cells family member 1,22992,190,0.93 [0.79-1.10],0.4111447414836907
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LAT2,Linker for activation of T-cells family member 2,22638,187,0.97 [0.87-1.07],0.5091357429556524
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LATS1,Serine/threonine-protein kinase LATS1,19252,163,1.01 [0.84-1.21],0.909181521767198
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LAYN,Layilin,22547,190,1.12 [0.77-1.62],0.5469161256963737
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LBP,Lipopolysaccharide-binding protein,22808,192,0.94 [0.76-1.17],0.5850274751308506
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LBR,Delta(14)-sterol reductase LBR,22944,191,0.91 [0.74-1.10],0.3305256321974502
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LCAT,Phosphatidylcholine-sterol acyltransferase,19809,169,1.76 [0.88-3.53],0.1087638001367767
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LCN15,Lipocalin-15,19775,169,0.89 [0.69-1.14],0.3588732181866945
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LCN2,Neutrophil gelatinase-associated lipocalin,22036,185,0.86 [0.60-1.23],0.4045698380331306
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LCP1,Plastin-2,19801,169,0.96 [0.70-1.32],0.8078003146164754
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LDLR,Low-density lipoprotein receptor,22803,188,1.07 [0.84-1.37],0.5599417032487692
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LDLRAP1,Low density lipoprotein receptor adapter protein 1,19775,169,0.95 [0.82-1.11],0.5233477827022543
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LECT2,Leukocyte cell-derived chemotaxin-2,19806,170,1.11 [0.89-1.39],0.3360440232180287
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LEFTY2,Left-right determination factor 2,22903,188,1.46 [1.14-1.86],0.0026056722525113
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LEG1,Protein LEG1 homolog,18725,158,0.85 [0.68-1.07],0.1743932852215752
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LELP1,Late cornified envelope-like proline-rich protein 1,19195,164,1.13 [0.94-1.35],0.1857055331850942
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LEO1,RNA polymerase-associated protein LEO1,19775,169,1.06 [0.69-1.61],0.7989464725197051
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LEP,Leptin,22739,185,1.13 [0.91-1.41],0.2769889481454293
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LEPR,Leptin receptor,22739,185,0.75 [0.48-1.17],0.2021173349660227
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LETM1,Mitochondrial proton/calcium exchanger protein,19775,169,1.00 [0.76-1.33],0.9773700728350576
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LGALS1,Galectin-1,22739,185,0.91 [0.61-1.35],0.6443116231407429
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LGALS3,Galectin-3,22794,187,0.81 [0.53-1.26],0.354644235926334
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LGALS3BP,Galectin-3-binding protein,19834,169,1.33 [0.87-2.04],0.1850215475598887
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LGALS4,Galectin-4,22738,190,0.74 [0.58-0.95],0.0168659221842897
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LGALS7_LGALS7B,Galectin-7,22701,184,1.32 [0.99-1.77],0.0619507736539006
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LGALS8,Galectin-8,22944,191,0.83 [0.66-1.03],0.0896100496944226
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,22740,190,1.02 [0.68-1.52],0.9291989795894448
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LGMN,Legumain,22848,191,0.81 [0.57-1.17],0.2604953211678643
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LHB,Lutropin subunit beta,22228,185,1.02 [0.88-1.19],0.7547438132870115
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,22772,190,0.96 [0.78-1.20],0.7363303116901045
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LIF,Leukemia inhibitory factor,22176,182,0.91 [0.69-1.19],0.4776959561516888
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LIFR,Leukemia inhibitory factor receptor,22702,187,0.93 [0.54-1.58],0.7864915939404222
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,22752,190,0.88 [0.62-1.24],0.4658721163864349
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,19801,169,0.95 [0.87-1.04],0.2823705862018638
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,19204,165,0.92 [0.68-1.25],0.5963277426105955
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,22705,185,0.76 [0.50-1.14],0.1859226247539999
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,19806,170,1.02 [0.84-1.24],0.8277529396258259
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,23014,190,1.05 [0.66-1.68],0.8414158493107338
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,22905,188,0.94 [0.65-1.36],0.7424603857046372
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,22309,181,1.27 [0.94-1.71],0.1162653761868306
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,23014,190,0.96 [0.81-1.15],0.6852028214818402
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LIPF,Gastric triacylglycerol lipase,19304,165,1.14 [0.90-1.45],0.2740333898510044
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LMNB1,Lamin-B1,19662,168,1.04 [0.82-1.31],0.7653691058820606
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,19765,168,1.25 [0.75-2.09],0.3956165094746799
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LMOD1,Leiomodin-1,19775,169,1.43 [1.01-2.01],0.0431600257562582
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LMOD2,Leiomodin-2,19195,164,0.90 [0.70-1.16],0.4130927829294465
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LONP1,"Lon protease homolog, mitochondrial",19304,165,0.89 [0.75-1.06],0.2014365317984628
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LPA,Apolipoprotein(a),19338,165,1.00 [0.92-1.09],0.9485075236221788
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LPCAT2,Lysophosphatidylcholine acyltransferase 2,22638,187,0.90 [0.64-1.27],0.5649950028675017
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LPL,Lipoprotein lipase,22739,185,0.82 [0.63-1.07],0.1420064278693992
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LPO,Lactoperoxidase,22040,185,0.92 [0.74-1.14],0.4395056103958777
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LPP,Lipoma-preferred partner,19204,165,0.90 [0.72-1.14],0.3851079079212268
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,19204,165,1.03 [0.82-1.28],0.8119675204563581
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,19251,160,1.15 [0.88-1.51],0.3180233069216392
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRG1,Leucine-rich alpha-2-glycoprotein,19834,169,0.70 [0.40-1.21],0.2009723401223596
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,22870,188,0.85 [0.59-1.24],0.4111556732357603
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,19176,162,1.29 [0.83-2.02],0.2544857600570502
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRP1,Prolow-density lipoprotein receptor-related protein 1,22638,187,0.81 [0.49-1.34],0.4200337094661022
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRP11,Low-density lipoprotein receptor-related protein 11,22739,185,1.39 [0.98-1.99],0.068336469551228
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRP2,Low-density lipoprotein receptor-related protein 2,19251,160,1.01 [0.67-1.51],0.9698318348891988
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRP2BP,LRP2-binding protein,19251,160,0.98 [0.82-1.17],0.8002860743977767
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,22944,191,0.94 [0.74-1.18],0.5743699414387868
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRRC25,Leucine-rich repeat-containing protein 25,22638,187,1.14 [0.82-1.58],0.4415029471784799
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRRC37A2,Leucine-rich repeat-containing protein 37A2,19705,168,0.95 [0.67-1.35],0.7700468891673546
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRRC38,Leucine-rich repeat-containing protein 38,19251,160,1.23 [0.94-1.61],0.1307906116731612
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRRC59,Leucine-rich repeat-containing protein 59,19806,170,0.97 [0.72-1.33],0.8718578043109527
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,19698,167,1.01 [0.74-1.37],0.9472559952527352
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRRN1,Leucine-rich repeat neuronal protein 1,22309,181,1.13 [0.79-1.59],0.5062277602150167
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,19251,160,0.85 [0.57-1.27],0.4255512257535769
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,19775,169,0.98 [0.56-1.72],0.9576077163734806
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LSM1,U6 snRNA-associated Sm-like protein LSm1,22228,185,1.06 [0.85-1.33],0.5944149998594578
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LSM8,U6 snRNA-associated Sm-like protein LSm8,19422,163,1.13 [0.98-1.30],0.1045954299186082
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LSP1,Lymphocyte-specific protein 1,22702,187,1.13 [0.82-1.56],0.4420954980018844
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LTA,Lymphotoxin-alpha,22702,187,1.12 [0.81-1.54],0.4975220285329825
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LTA4H,Leukotriene A-4 hydrolase,22943,189,0.80 [0.63-1.01],0.0579620713147215
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LTB,Lymphotoxin-beta,19698,167,0.78 [0.49-1.24],0.2894218886882732
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,23014,190,1.03 [0.69-1.54],0.8806501341560943
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LTBP3,Latent-transforming growth factor beta-binding protein 3,22228,185,1.29 [1.06-1.57],0.0123753118665187
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,22635,189,1.23 [0.78-1.94],0.3802805123353765
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LTO1,Protein LTO1 homolog,22309,181,0.79 [0.56-1.13],0.1921770361418272
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LUZP2,Leucine zipper protein 2,19698,167,0.95 [0.68-1.32],0.7661308634310651
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LXN,Latexin,22492,190,0.99 [0.82-1.21],0.9572527033774658
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LY6D,Lymphocyte antigen 6D,22635,188,1.29 [0.93-1.80],0.1303528221104021
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LY75,Lymphocyte antigen 75,22702,187,0.96 [0.69-1.34],0.8141936178933326
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LY9,T-lymphocyte surface antigen Ly-9,22522,186,1.02 [0.64-1.60],0.9420914227783296
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LY96,Lymphocyte antigen 96,22595,190,0.91 [0.62-1.34],0.6440038816678838
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LYAR,Cell growth-regulating nucleolar protein,22228,185,0.98 [0.76-1.26],0.8604643402096263
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LYN,Tyrosine-protein kinase Lyn,22638,187,0.90 [0.77-1.04],0.154834287955559
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LYPD1,Ly6/PLAUR domain-containing protein 1,22176,182,0.98 [0.79-1.21],0.8219958284760372
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LYPD3,Ly6/PLAUR domain-containing protein 3,22623,187,1.44 [0.99-2.08],0.0554163049275967
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LYPD8,Ly6/PLAUR domain-containing protein 8,22228,185,0.86 [0.66-1.13],0.2858963748163282
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LYPLA2,Acyl-protein thioesterase 2,19195,164,1.10 [0.98-1.24],0.0987450203028368
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,19251,160,1.18 [1.04-1.33],0.0099514156580653
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,19834,169,1.09 [0.52-2.26],0.826593714467037
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LYZL2,Lysozyme-like protein 2,19107,162,0.88 [0.56-1.38],0.5694372193967407
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LZTFL1,Leucine zipper transcription factor-like protein 1,19390,164,0.88 [0.71-1.10],0.2589024755736768
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",M6PR,Cation-dependent mannose-6-phosphate receptor,19304,165,1.26 [0.93-1.71],0.132420879142488
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,22510,189,0.90 [0.68-1.20],0.4815942192706076
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAEA,E3 ubiquitin-protein transferase MAEA,22228,185,0.89 [0.64-1.26],0.5205171193550628
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAG,Myelin-associated glycoprotein,19251,160,0.94 [0.68-1.30],0.7089276407059132
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAGEA3,Melanoma-associated antigen 3,19422,163,0.89 [0.76-1.05],0.1602898121832698
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAGED1,Melanoma-associated antigen D1,22228,185,1.03 [0.79-1.35],0.8333327124258308
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAMDC2,MAM domain-containing protein 2,19806,170,1.22 [0.81-1.86],0.3442821329506367
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAMDC4,Apical endosomal glycoprotein,19698,167,1.26 [0.97-1.63],0.0885039929616788
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",19304,165,0.58 [0.32-1.04],0.0677949108634686
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAN2B2,Epididymis-specific alpha-mannosidase,19806,170,1.30 [1.01-1.66],0.0381602922525217
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",19107,162,1.05 [0.78-1.41],0.7635282352866708
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MANF,Mesencephalic astrocyte-derived neurotrophic factor,22848,191,0.92 [0.83-1.02],0.1272663503519613
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MANSC1,MANSC domain-containing protein 1,22813,190,1.04 [0.65-1.66],0.8763576342531525
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MANSC4,MANSC domain-containing protein 4,19204,165,0.83 [0.65-1.05],0.1125920185187348
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,19195,164,0.89 [0.56-1.44],0.6470570345174115
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,19204,165,0.98 [0.78-1.23],0.8466430844147671
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAP2,Microtubule-associated protein 2,19765,168,0.98 [0.71-1.36],0.9096450646953442
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,19705,168,0.85 [0.67-1.07],0.1635602109869276
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,22702,187,0.93 [0.82-1.06],0.2886985160655554
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,22228,185,1.00 [0.88-1.15],0.9521484527475336
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,22547,190,0.93 [0.83-1.04],0.2068603433214978
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAPK13,Mitogen-activated protein kinase 13,19107,162,1.09 [0.78-1.50],0.6221791368242611
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAPK9,Mitogen-activated protein kinase 9,22702,187,0.80 [0.59-1.08],0.1454222109806885
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAPKAPK2,MAP kinase-activated protein kinase 2,19422,163,0.92 [0.74-1.13],0.4102716639455678
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAPRE3,Microtubule-associated protein RP/EB family member 3,19107,162,1.04 [0.95-1.15],0.4010798090401476
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAPT,Microtubule-associated protein tau,22176,182,1.01 [0.79-1.30],0.9213193333580364
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MARCO,Macrophage receptor MARCO,22739,185,1.06 [0.65-1.74],0.8148980153263962
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MARS1,"Methionine--tRNA ligase, cytoplasmic",19347,164,0.90 [0.75-1.07],0.2398833790370172
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MASP1,Mannan-binding lectin serine protease 1,22547,190,1.18 [0.68-2.05],0.5473664160966015
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MATN2,Matrilin-2,22780,190,1.31 [0.86-2.01],0.2098492359856574
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MATN3,Matrilin-3,22559,189,0.95 [0.63-1.44],0.8160957937486609
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAVS,Mitochondrial antiviral-signaling protein,22228,185,0.98 [0.85-1.13],0.7388373806914101
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAX,Protein max,22176,182,0.89 [0.78-1.01],0.0758141304603967
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MB,Myoglobin,23014,190,0.98 [0.76-1.27],0.885007875970562
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MBL2,Mannose-binding protein C,19543,165,0.89 [0.77-1.02],0.0905407860632346
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MCAM,Cell surface glycoprotein MUC18,22808,192,0.88 [0.61-1.28],0.5154667243062178
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",19775,169,0.98 [0.69-1.39],0.913601708815529
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MCEMP1,Mast cell-expressed membrane protein 1,19252,163,0.95 [0.81-1.13],0.5849277843360133
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MCFD2,Multiple coagulation factor deficiency protein 2,22642,185,0.83 [0.62-1.13],0.2391239987936129
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MCTS1,Malignant T-cell-amplified sequence 1,19705,168,0.66 [0.35-1.25],0.204574677753144
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,22595,190,0.99 [0.83-1.18],0.905159667196028
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MDH1,"Malate dehydrogenase, cytoplasmic",19686,167,0.93 [0.64-1.34],0.6962415692948403
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MDK,Midkine,22753,189,0.87 [0.68-1.13],0.3032211532764655
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MDM1,Nuclear protein MDM1,19251,160,1.47 [0.92-2.34],0.1101732539487028
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",19304,165,0.85 [0.72-1.00],0.0517847339526173
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MED18,Mediator of RNA polymerase II transcription subunit 18,22228,185,0.90 [0.76-1.07],0.2190812818031276
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MED21,Mediator of RNA polymerase II transcription subunit 21,19204,165,1.24 [0.97-1.59],0.0837967586742397
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MEGF10,Multiple epidermal growth factor-like domains protein 10,22738,190,0.99 [0.70-1.38],0.9321682962445382
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MEGF11,Multiple epidermal growth factor-like domains protein 11,19204,165,1.14 [0.76-1.72],0.5162572857840413
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MEGF9,Multiple epidermal growth factor-like domains protein 9,22945,189,0.92 [0.48-1.74],0.7882024005791566
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MELTF,Melanotransferrin,19806,170,0.68 [0.41-1.11],0.1238374436519819
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MENT,Protein MENT,19390,164,0.57 [0.30-1.09],0.0888553641550564
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MEP1A,Meprin A subunit alpha,19705,168,1.01 [0.82-1.24],0.931699017296147
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MEP1B,Meprin A subunit beta,22739,185,1.00 [0.90-1.11],0.995951261427117
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MEPE,Matrix extracellular phosphoglycoprotein,22738,190,1.70 [1.01-2.85],0.0443826588063625
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MERTK,Tyrosine-protein kinase Mer,22992,190,0.54 [0.33-0.89],0.0158550174748923
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MESD,LRP chaperone MESD,22752,190,0.91 [0.82-1.01],0.0787027667669832
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MET,Hepatocyte growth factor receptor,22800,189,0.51 [0.27-0.95],0.0338124666840077
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",METAP1,Methionine aminopeptidase 1,22176,182,0.81 [0.51-1.28],0.3637961716399247
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",22702,187,0.80 [0.69-0.94],0.0075551939494482
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",METAP2,Methionine aminopeptidase 2,22903,188,0.97 [0.78-1.21],0.7881648971909478
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MFAP3,Microfibril-associated glycoprotein 3,22335,183,1.32 [1.08-1.61],0.0075752380629079
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MFAP3L,Microfibrillar-associated protein 3-like,19251,160,1.05 [0.85-1.29],0.6447465066204906
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MFAP4,Microfibril-associated glycoprotein 4,19390,164,1.07 [0.67-1.71],0.779143973216343
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MFAP5,Microfibrillar-associated protein 5,23014,190,1.33 [0.97-1.82],0.0755713108503523
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MFGE8,Lactadherin,22752,190,1.06 [0.79-1.42],0.7101452902355694
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MGLL,Monoglyceride lipase,22809,191,0.90 [0.78-1.04],0.1641160039001553
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MGMT,Methylated-DNA--protein-cysteine methyltransferase,22702,187,0.90 [0.82-1.00],0.052904367514916
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MIA,Melanoma-derived growth regulatory protein,22813,190,0.93 [0.65-1.32],0.6725568393130688
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MICALL2,MICAL-like protein 2,19251,160,1.00 [0.80-1.25],0.9928818394746672
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,22702,187,0.99 [0.91-1.08],0.8417589081630331
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MIF,Macrophage migration inhibitory factor,22722,190,0.93 [0.77-1.12],0.4224787022936931
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MILR1,Allergin-1,22309,181,0.99 [0.76-1.29],0.9531924159201308
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,19698,167,0.92 [0.80-1.05],0.2119252884352092
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MINK1,Misshapen-like kinase 1,19765,168,0.92 [0.78-1.07],0.275259633767736
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MITD1,MIT domain-containing protein 1,22595,190,0.94 [0.82-1.07],0.3474990251049416
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MKI67,Proliferation marker protein Ki-67,19252,163,0.95 [0.65-1.41],0.8126324782021327
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MLLT1,Protein ENL,19107,162,1.14 [0.94-1.38],0.1742851950956179
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MLN,Promotilin,22702,187,1.00 [0.87-1.16],0.9515137473802608
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MME,Neprilysin,22638,187,1.03 [0.88-1.20],0.7040640036905816
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MMP1,Interstitial collagenase,21870,181,0.96 [0.83-1.10],0.5466765616151026
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MMP10,Stromelysin-2,22706,189,1.01 [0.81-1.26],0.9211444667743124
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MMP12,Macrophage metalloelastase,22760,186,1.03 [0.80-1.33],0.8068850155838804
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MMP13,Collagenase 3,22176,182,0.83 [0.56-1.26],0.3857808183792905
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MMP15,Matrix metalloproteinase-15,19806,170,1.21 [0.96-1.52],0.1090722333502444
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MMP3,Stromelysin-1,22752,190,1.03 [0.79-1.34],0.8136897721097796
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MMP7,Matrilysin,22294,183,1.27 [0.96-1.68],0.0968908419493251
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MMP8,Neutrophil collagenase,22903,190,0.92 [0.77-1.10],0.3525264245319903
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MMP9,Matrix metalloproteinase-9,22710,189,0.98 [0.79-1.21],0.8403517824385519
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",19204,165,0.60 [0.43-0.85],0.0037778568062967
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MN1,Transcriptional activator MN1,19251,160,1.13 [0.90-1.42],0.2856649336293869
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MNAT1,CDK-activating kinase assembly factor MAT1,19422,163,1.07 [0.77-1.49],0.6884233796257224
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MNDA,Myeloid cell nuclear differentiation antigen,22704,185,1.02 [0.90-1.15],0.7957977972772112
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MOCS2,Molybdopterin synthase catalytic subunit,19390,164,0.81 [0.64-1.02],0.0735779068657432
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MOG,Myelin-oligodendrocyte glycoprotein,22943,189,1.00 [0.67-1.48],0.988301787915876
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MORC3,MORC family CW-type zinc finger protein 3,19765,168,1.21 [0.76-1.94],0.4161165961941593
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MORF4L1,Mortality factor 4-like protein 1,19422,163,0.95 [0.65-1.39],0.7913145934193582
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MORF4L2,Mortality factor 4-like protein 2,19107,162,1.22 [0.84-1.76],0.2926988293141158
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MORN4,MORN repeat-containing protein 4,19107,162,1.14 [0.97-1.34],0.1098364141501159
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MPHOSPH8,M-phase phosphoprotein 8,22335,183,0.94 [0.79-1.12],0.4858471473559026
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MPI,Mannose-6-phosphate isomerase,22638,187,0.85 [0.73-1.00],0.0464235786293183
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,22809,191,0.91 [0.78-1.07],0.2768699224441571
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MPO,Myeloperoxidase,22752,190,0.95 [0.72-1.26],0.725385778550391
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MPRIP,Myosin phosphatase Rho-interacting protein,19655,167,1.47 [1.12-1.94],0.0054485922955783
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MRC1,Macrophage mannose receptor 1,19809,169,0.93 [0.55-1.55],0.7671251200245266
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MRI1,Methylthioribose-1-phosphate isomerase,19251,160,1.06 [0.85-1.33],0.5915009009022553
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MRPL24,"39S ribosomal protein L24, mitochondrial",19204,165,0.54 [0.33-0.86],0.0103436926434258
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MRPL28,"39S ribosomal protein L28, mitochondrial",19775,169,1.17 [0.84-1.63],0.3509246424262027
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MRPL46,"39S ribosomal protein L46, mitochondrial",22176,182,0.85 [0.51-1.40],0.5130262117056873
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MRPL52,"39S ribosomal protein L52, mitochondrial",19079,162,0.80 [0.43-1.48],0.4750513396379228
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",19775,169,1.00 [0.82-1.22],0.9649513824886976
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MRPS16,"28S ribosomal protein S16, mitochondrial",19252,163,1.11 [0.70-1.74],0.6621220135503283
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MSLN,Mesothelin,22606,186,0.96 [0.76-1.22],0.7256377312412201
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MSLNL,Mesothelin-like protein,19251,160,0.88 [0.58-1.33],0.5406639903974082
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MSMB,Beta-microseminoprotein,22652,186,0.98 [0.82-1.18],0.8398018317999834
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MSR1,Macrophage scavenger receptor types I and II,22944,191,0.94 [0.71-1.24],0.6547564010163528
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MSRA,Mitochondrial peptide methionine sulfoxide reductase,22813,190,0.89 [0.75-1.07],0.2175633599046083
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MST1,Hepatocyte growth factor-like protein,19493,165,0.92 [0.75-1.14],0.4566579755188014
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MSTN,Growth/differentiation factor 8,22335,183,1.20 [0.93-1.55],0.1611525186516771
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MTDH,Protein LYRIC,19252,163,0.92 [0.78-1.08],0.3210053199019627
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",19765,168,1.08 [0.62-1.86],0.7936587376678541
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,19422,163,0.97 [0.85-1.11],0.6874157360763683
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MTIF3,"Translation initiation factor IF-3, mitochondrial",19705,168,0.84 [0.71-1.00],0.0455089359183611
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MTPN,Myotrophin,22335,183,0.80 [0.52-1.24],0.3137316483695765
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MTR,Methionine synthase,19204,165,0.97 [0.77-1.22],0.8079692923591659
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MTSS1,Protein MTSS 1,19705,168,0.98 [0.86-1.12],0.7537982270305731
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MTSS2,Protein MTSS 2,19698,167,1.01 [0.87-1.17],0.9167409599889812
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MTUS1,Microtubule-associated tumor suppressor 1,19422,163,0.80 [0.60-1.07],0.1287714047175652
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MUC13,Mucin-13,22176,182,0.87 [0.67-1.14],0.3031489477403135
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MUC16,Mucin-16,22638,187,0.99 [0.93-1.06],0.8036084285840371
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MUC2,Mucin-2,19801,169,1.01 [0.86-1.19],0.8924643851811301
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MUCL3,Mucin-like protein 3,19107,162,1.12 [0.84-1.51],0.4431887822532693
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MVK,Mevalonate kinase,22309,181,0.99 [0.84-1.17],0.9265837442057284
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MXRA8,Matrix remodeling-associated protein 8,19390,164,0.54 [0.34-0.87],0.0107334068216426
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYBPC1,"Myosin-binding protein C, slow-type",19806,170,0.97 [0.77-1.22],0.7796108491211085
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYBPC2,"Myosin-binding protein C, fast-type",19304,165,0.91 [0.75-1.11],0.3360375758869779
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,19775,169,1.07 [0.88-1.32],0.4916160070206321
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYDGF,Myeloid-derived growth factor,19806,170,0.93 [0.80-1.08],0.3306426657352842
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYH4,Myosin-4,19204,165,0.97 [0.70-1.36],0.874711504920905
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYH7B,Myosin-7B,19107,162,1.04 [0.75-1.44],0.8243886732770442
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYH9,Myosin-9,19801,169,1.00 [0.88-1.14],0.9856671311212746
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",19204,165,1.16 [0.84-1.59],0.3732094696118131
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYL3,Myosin light chain 3,19304,165,1.01 [0.82-1.26],0.9099813235026916
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYL4,Myosin light chain 4,19304,165,1.14 [0.88-1.49],0.314275381307506
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYL6B,Myosin light chain 6B,19251,160,1.08 [0.93-1.26],0.293123306434346
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",19251,160,0.88 [0.60-1.30],0.5276407796358182
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYO6,Unconventional myosin-VI,19775,169,1.05 [0.72-1.54],0.7945104929822223
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYO9B,Unconventional myosin-IXb,22309,181,0.95 [0.77-1.16],0.6178683974729421
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYOC,Myocilin,22752,190,1.00 [0.76-1.32],0.991435527611674
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYOM1,Myomesin-1,19195,164,1.06 [0.78-1.42],0.721725236490268
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYOM2,Myomesin-2,19204,165,0.73 [0.51-1.04],0.0824911167400288
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYOM3,Myomesin-3,19390,164,0.94 [0.79-1.11],0.4533501241016864
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MZB1,Marginal zone B- and B1-cell-specific protein,22819,190,0.77 [0.59-0.99],0.045541433052612
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MZT1,Mitotic-spindle organizing protein 1,22228,185,0.88 [0.68-1.15],0.3590141169919906
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NAA10,N-alpha-acetyltransferase 10,19204,165,0.85 [0.64-1.14],0.2823884058549633
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NAA80,N-alpha-acetyltransferase 80,19251,160,0.96 [0.85-1.09],0.5491514395159032
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NAAA,N-acylethanolamine-hydrolyzing acid amidase,22487,187,0.96 [0.76-1.20],0.7162462134168064
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NACC1,Nucleus accumbens-associated protein 1,19698,167,0.89 [0.67-1.18],0.4186513481511903
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NADK,NAD kinase,22739,185,1.02 [0.81-1.28],0.8952486892354474
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NAGA,Alpha-N-acetylgalactosaminidase,19213,163,1.05 [0.81-1.35],0.7205311124735876
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NAGK,N-acetyl-D-glucosamine kinase,19267,165,0.83 [0.63-1.09],0.1891683506428064
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,19390,164,1.14 [0.57-2.29],0.709401586434238
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NAMPT,Nicotinamide phosphoribosyltransferase,22228,185,1.10 [0.89-1.37],0.3802831762191924
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NAP1L4,Nucleosome assembly protein 1-like 4,19677,168,0.77 [0.55-1.08],0.1357457452238413
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NAPRT,Nicotinate phosphoribosyltransferase,19765,168,1.16 [0.77-1.76],0.4820627846801536
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NARS1,"Asparagine--tRNA ligase, cytoplasmic",19775,169,0.97 [0.71-1.32],0.8531336417608621
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NBL1,Neuroblastoma suppressor of tumorigenicity 1,22813,190,1.90 [1.19-3.02],0.0070587058331277
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NBN,Nibrin,22309,181,0.92 [0.70-1.20],0.5180976869247329
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NCAM1,Neural cell adhesion molecule 1,22808,192,1.10 [0.70-1.73],0.6701698239043437
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NCAM2,Neural cell adhesion molecule 2,22752,190,1.02 [0.63-1.63],0.9487954789991278
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NCAN,Neurocan core protein,22944,191,1.06 [0.76-1.49],0.7285216530714347
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NCF2,Neutrophil cytosol factor 2,22673,186,1.09 [0.95-1.26],0.2222268865008975
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NCK2,Cytoplasmic protein NCK2,22848,191,0.94 [0.83-1.06],0.2822333633571746
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NCLN,Nicalin,22309,181,0.90 [0.67-1.19],0.4500454129190683
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NCR1,Natural cytotoxicity triggering receptor 1,22668,186,1.07 [0.75-1.52],0.7228709886787716
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,19705,168,0.79 [0.50-1.24],0.3043290077362242
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NCS1,Neuronal calcium sensor 1,22943,189,1.33 [0.85-2.09],0.2075908848722509
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NDRG1,Protein NDRG1,22176,182,0.87 [0.70-1.08],0.2055628508332912
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,19698,167,1.10 [0.91-1.34],0.3234898328720304
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,19218,163,0.97 [0.64-1.49],0.9073222211123544
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,19705,168,0.88 [0.75-1.04],0.1375453298181256
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",22228,185,0.95 [0.79-1.13],0.5456541510518342
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NEB,Nebulin,19204,165,1.36 [1.00-1.85],0.0491248080770349
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NECAP2,Adaptin ear-binding coat-associated protein 2,19204,165,0.94 [0.74-1.18],0.5793275183559006
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NECTIN1,Nectin-1,19252,163,0.91 [0.56-1.48],0.717200233696637
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NECTIN2,Nectin-2,22705,185,0.91 [0.58-1.43],0.6789159610274048
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NECTIN4,Nectin-4,22813,190,1.19 [0.79-1.81],0.4097469402741917
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,19252,163,0.89 [0.66-1.20],0.447406774515529
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NEDD9,Enhancer of filamentation 1,19252,163,0.75 [0.45-1.23],0.2516171933246645
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NEFL,Neurofilament light polypeptide,22097,182,1.33 [0.98-1.80],0.0688402574886312
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NEK7,Serine/threonine-protein kinase Nek7,19422,163,0.82 [0.65-1.04],0.0966146999662514
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NELL1,Protein kinase C-binding protein NELL1,22813,190,0.92 [0.68-1.24],0.5693641649047201
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NELL2,Protein kinase C-binding protein NELL2,22848,191,1.00 [0.63-1.57],0.9861999541420104
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NENF,Neudesin,19698,167,1.08 [0.96-1.21],0.1923952922439771
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NEO1,Neogenin,19775,169,1.24 [0.66-2.35],0.5059704418119331
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NEXN,Nexilin,19809,169,0.96 [0.77-1.19],0.6962189732831638
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NFASC,Neurofascin,22992,190,1.10 [0.70-1.73],0.6890936623609848
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NFAT5,Nuclear factor of activated T-cells 5,19252,163,1.05 [0.89-1.25],0.5450732973069945
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",22702,187,0.94 [0.82-1.08],0.3805795134041082
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",22309,181,1.04 [0.84-1.30],0.7183627216249976
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NFE2,Transcription factor NF-E2 45 kDa subunit,19304,165,0.92 [0.75-1.13],0.4384971697313768
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NFIC,Nuclear factor 1 C-type,19775,169,1.21 [0.94-1.57],0.1369363665221873
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NFKB1,Nuclear factor NF-kappa-B p105 subunit,19204,165,0.91 [0.74-1.12],0.3867492639943405
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NFKB2,Nuclear factor NF-kappa-B p100 subunit,19422,163,1.00 [0.77-1.31],0.990208865464817
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NFKBIE,NF-kappa-B inhibitor epsilon,22228,185,0.99 [0.76-1.29],0.9416906113024004
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",19705,168,0.86 [0.75-1.00],0.0470177069385648
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NFX1,Transcriptional repressor NF-X1,19204,165,1.13 [0.91-1.40],0.2725740724188302
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NFYA,Nuclear transcription factor Y subunit alpha,19204,165,1.22 [0.87-1.70],0.2453641785502646
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NGF,Beta-nerve growth factor,22595,190,1.10 [0.39-3.13],0.861051494349335
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NGFR,Tumor necrosis factor receptor superfamily member 16,19806,170,1.14 [0.71-1.84],0.5923882630753193
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NGRN,Neugrin,19765,168,0.85 [0.43-1.68],0.6363294976446396
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NHLRC3,NHL repeat-containing protein 3,18907,160,1.13 [0.69-1.84],0.6242559054306809
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NID1,Nidogen-1,22731,192,0.81 [0.59-1.12],0.2019183882509193
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NID2,Nidogen-2,22752,190,1.03 [0.88-1.22],0.6932409667760915
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NINJ1,Ninjurin-1,22228,185,0.96 [0.75-1.23],0.7441516463613007
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NIT1,Deaminated glutathione amidase,19304,165,0.90 [0.66-1.21],0.479805603810073
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NIT2,Omega-amidase NIT2,19737,170,0.90 [0.74-1.10],0.3066669878300239
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NLGN1,Neuroligin-1,19251,160,1.03 [0.84-1.27],0.7698035605130622
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NLGN2,Neuroligin-2,19195,164,0.88 [0.63-1.23],0.4503420801192522
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NME1,Nucleoside diphosphate kinase A,19252,163,1.36 [0.71-2.64],0.3555337765534986
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NME3,Nucleoside diphosphate kinase 3,22780,190,1.17 [0.69-1.99],0.5529342885709574
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NMI,N-myc-interactor,19626,166,0.88 [0.71-1.09],0.2359068276528747
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,22595,190,1.04 [0.88-1.23],0.6782890590125468
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NMRK2,Nicotinamide riboside kinase 2,19107,162,0.98 [0.68-1.43],0.9283021632886892
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,19775,169,0.99 [0.80-1.24],0.962781142288435
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NOMO1,Nodal modulator 1,22752,190,1.26 [0.74-2.14],0.3877058116261218
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NOP56,Nucleolar protein 56,19204,165,1.04 [0.92-1.18],0.5419769964193085
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NOS1,"Nitric oxide synthase, brain",22176,182,0.99 [0.76-1.29],0.9576179633298204
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NOS2,"Nitric oxide synthase, inducible",19204,165,1.00 [0.68-1.47],0.9894483931886264
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NOS3,"Nitric oxide synthase, endothelial",22176,182,1.13 [0.90-1.42],0.2824484937592726
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,23014,190,1.82 [0.81-4.11],0.1480573026534645
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NOTCH2,Neurogenic locus notch homolog protein 2,19801,169,1.10 [0.56-2.15],0.7877447086780445
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NOTCH3,Neurogenic locus notch homolog protein 3,23014,190,1.15 [0.80-1.66],0.4593888681504006
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NPC2,NPC intracellular cholesterol transporter 2,19464,167,1.24 [0.80-1.95],0.3385238820234558
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NPDC1,Neural proliferation differentiation and control protein 1,22739,185,1.43 [0.96-2.12],0.0776831614958097
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NPHS1,Nephrin,19252,163,1.12 [0.72-1.74],0.6062236928486671
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NPHS2,Podocin,19252,163,0.99 [0.86-1.15],0.9308188321992064
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NPL,N-acetylneuraminate lyase,19806,170,1.38 [1.02-1.89],0.0397844126805064
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NPPB,Natriuretic peptides B,22335,183,1.06 [0.96-1.18],0.2571980085130986
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NPPC,C-type natriuretic peptide,22702,187,1.45 [1.11-1.90],0.0060472256268133
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NPR1,Atrial natriuretic peptide receptor 1,19204,165,0.80 [0.53-1.20],0.2786544524948843
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NPTN,Neuroplastin,22228,185,0.92 [0.78-1.10],0.3703667795914381
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NPTX1,Neuronal pentraxin-1,22752,190,1.08 [0.78-1.50],0.6384701580850142
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NPTX2,Neuronal pentraxin-2,19801,169,1.00 [0.64-1.58],0.9876664317858396
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NPTXR,Neuronal pentraxin receptor,22739,185,0.93 [0.64-1.36],0.7129735141486453
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NPY,Pro-neuropeptide Y,22943,189,1.27 [1.04-1.55],0.0191604145880315
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NRCAM,Neuronal cell adhesion molecule,22739,185,1.44 [0.93-2.23],0.1019995611486953
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NRGN,Neurogranin,19809,169,0.87 [0.74-1.02],0.0822294821913671
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NRN1,Neuritin,19775,169,1.23 [0.88-1.73],0.2290287019114184
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NRP1,Neuropilin-1,22851,192,1.05 [0.68-1.65],0.8167110789349005
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NRP2,Neuropilin-2,22752,190,1.14 [0.73-1.77],0.5712249872313734
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NRTN,Neurturin,22309,181,0.88 [0.67-1.16],0.370389915038769
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NRXN3,Neurexin-3,19251,160,1.32 [0.92-1.89],0.1278043083820338
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NSFL1C,NSFL1 cofactor p47,22944,191,1.00 [0.82-1.21],0.9836490488568996
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",19806,170,0.89 [0.73-1.09],0.2538543344722105
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NT5C1A,Cytosolic 5'-nucleotidase 1A,19765,168,1.51 [1.10-2.08],0.0108136698542577
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NT5C3A,Cytosolic 5'-nucleotidase 3A,22671,186,0.88 [0.76-1.01],0.0761308129535492
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NT5E,5'-nucleotidase,22813,190,1.20 [0.97-1.47],0.0934046816462012
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NTF3,Neurotrophin-3,22702,187,0.77 [0.54-1.11],0.1673818563127358
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NTF4,Neurotrophin-4,22228,185,1.20 [0.92-1.56],0.1812204959780552
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NTRK2,BDNF/NT-3 growth factors receptor,22739,185,1.27 [0.77-2.11],0.3529732410914954
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NTRK3,NT-3 growth factor receptor,22944,191,1.22 [0.68-2.18],0.4979652344138701
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NTproBNP,N-terminal prohormone of brain natriuretic peptide,22739,185,1.07 [0.94-1.21],0.3086733434518672
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NUB1,NEDD8 ultimate buster 1,22702,187,0.86 [0.73-1.01],0.0636873970676145
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,19698,167,1.06 [0.92-1.23],0.3978186144524634
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NUCB2,Nucleobindin-2,22902,189,0.94 [0.66-1.33],0.7130428983233523
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NUDC,Nuclear migration protein nudC,22992,190,0.90 [0.74-1.11],0.3216829392896438
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,19304,165,1.05 [0.59-1.86],0.8666750232146453
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,19204,165,0.72 [0.51-1.02],0.0645678072551545
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NUDT16,U8 snoRNA-decapping enzyme,19668,167,0.86 [0.72-1.02],0.0782502100935538
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],22638,187,0.83 [0.66-1.06],0.1355736673267135
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NUDT5,ADP-sugar pyrophosphatase,22752,190,0.77 [0.60-1.00],0.0513270344511046
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NUMB,Protein numb homolog,19252,163,0.97 [0.80-1.16],0.7032525890244303
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NUP50,Nuclear pore complex protein Nup50,19204,165,1.04 [0.68-1.59],0.8427687688400474
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NXPE4,NXPE family member 4,19204,165,0.70 [0.42-1.16],0.1659495296618892
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NXPH1,Neurexophilin-1,22176,182,0.90 [0.63-1.29],0.5685521432749163
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NXPH3,Neurexophilin-3,19252,163,1.20 [0.72-1.99],0.4794949736678856
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OBP2B,Odorant-binding protein 2b,22523,189,1.14 [0.93-1.39],0.2092739473744767
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OCLN,Occludin,19775,169,0.97 [0.69-1.36],0.8529041748326049
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ODAM,Odontogenic ameloblast-associated protein,22146,182,1.03 [0.82-1.29],0.8015046421061239
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OFD1,Oral-facial-digital syndrome 1 protein,19422,163,1.19 [1.00-1.43],0.056597298540163
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OGA,Protein O-GlcNAcase,19705,168,0.93 [0.75-1.14],0.4736717305840753
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OGFR,Opioid growth factor receptor,22638,187,0.99 [0.66-1.48],0.967483451742314
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OGN,Mimecan,22752,190,1.17 [0.86-1.59],0.3262964847063871
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,19422,163,1.15 [0.93-1.41],0.1899295490095086
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OLFM4,Olfactomedin-4,18658,156,0.93 [0.82-1.06],0.2752971630240876
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OLR1,Oxidized low-density lipoprotein receptor 1,22519,183,0.98 [0.78-1.22],0.8356864211734878
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OMD,Osteomodulin,22848,191,0.88 [0.66-1.17],0.3686367930967379
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OMG,Oligodendrocyte-myelin glycoprotein,22638,187,0.89 [0.73-1.09],0.2588024113609848
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OMP,Olfactory marker protein,19195,164,1.01 [0.75-1.35],0.960962005825916
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OPHN1,Oligophrenin-1,19765,168,0.96 [0.84-1.10],0.5758334037463089
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OPLAH,5-oxoprolinase,19304,165,0.95 [0.76-1.19],0.650543856639874
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OPTC,Opticin,22638,187,0.83 [0.61-1.13],0.2386599794583725
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ORM1,Alpha-1-acid glycoprotein 1,19766,169,1.07 [0.52-2.23],0.8485977492725824
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OSBPL2,Oxysterol-binding protein-related protein 2,19765,168,1.05 [0.74-1.49],0.774636163390674
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OSCAR,Osteoclast-associated immunoglobulin-like receptor,22780,190,1.08 [0.73-1.58],0.7130782443417248
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OSM,Oncostatin-M,22598,186,1.01 [0.84-1.21],0.9224082389245368
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OSMR,Oncostatin-M-specific receptor subunit beta,22851,192,1.05 [0.57-1.92],0.8834615271439965
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OSTN,Osteocrin,19251,160,1.13 [0.82-1.56],0.4593789715615265
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OTOA,Otoancorin,19195,164,0.86 [0.63-1.16],0.3269805403586198
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OTUD6B,Deubiquitinase OTUD6B,19705,168,0.87 [0.68-1.12],0.2810604145839681
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OTUD7B,OTU domain-containing protein 7B,19775,169,1.02 [0.81-1.29],0.8775359425671009
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",19304,165,0.86 [0.69-1.08],0.2070268508191033
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OXT,Oxytocin-neurophysin 1,22944,191,1.04 [0.94-1.14],0.452917916200267
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",P4HB,Protein disulfide-isomerase,22627,188,0.79 [0.56-1.11],0.1698601605549062
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PACS2,Phosphofurin acidic cluster sorting protein 2,19204,165,0.93 [0.72-1.19],0.5501759693577961
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PADI2,Protein-arginine deiminase type-2,22309,181,0.91 [0.71-1.18],0.4804747424203918
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PADI4,Protein-arginine deiminase type-4,22146,182,1.01 [0.85-1.20],0.9241641271478952
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PAEP,Glycodelin,22595,190,1.24 [1.13-1.36],7.38196764265492e-06
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,19775,169,1.09 [0.98-1.22],0.1157311221509691
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",19422,163,0.92 [0.67-1.25],0.5891630489094846
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,22335,183,0.82 [0.64-1.05],0.1209289869414395
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PAGR1,PAXIP1-associated glutamate-rich protein 1,19304,165,0.89 [0.63-1.27],0.5267380224846014
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,19069,162,1.07 [0.81-1.42],0.6381310574229822
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PAK4,Serine/threonine-protein kinase PAK 4,22176,182,0.91 [0.72-1.13],0.3909373080517127
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PALLD,Palladin,19252,163,1.16 [0.84-1.60],0.3804126460596476
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PALM,Paralemmin-1,19602,168,1.59 [1.01-2.52],0.0472569802368541
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PALM2,Paralemmin-2,19765,168,1.45 [1.01-2.08],0.0426522484666301
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PALM3,Paralemmin-3,19204,165,1.06 [0.88-1.28],0.51534342352182
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PAM,Peptidyl-glycine alpha-amidating monooxygenase,22884,189,1.12 [0.70-1.80],0.6320792154631901
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PAMR1,Inactive serine protease PAMR1,22752,190,1.04 [0.65-1.65],0.8699968180982658
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PAPPA,Pappalysin-1,22309,181,1.02 [0.77-1.36],0.8835850387144731
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PARD3,Partitioning defective 3 homolog,19422,163,1.06 [0.87-1.29],0.5838965344429948
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PARK7,Parkinson disease protein 7,22752,190,0.87 [0.68-1.11],0.2548817543668021
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PARP1,Poly [ADP-ribose] polymerase 1,22702,187,0.85 [0.65-1.11],0.2227584616753085
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PAXX,Protein PAXX,19390,164,0.89 [0.64-1.25],0.5022138432504353
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PBK,Lymphokine-activated killer T-cell-originated protein kinase,19107,162,1.35 [0.83-2.19],0.2258253222673396
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PBLD,Phenazine biosynthesis-like domain-containing protein,22176,182,0.98 [0.76-1.27],0.8992389700702011
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,19705,168,0.93 [0.56-1.55],0.7886182386627909
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PCARE,Photoreceptor cilium actin regulator,19195,164,1.07 [0.92-1.26],0.3674866519396665
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,19351,164,0.92 [0.67-1.26],0.5902502240777705
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PCBP2,Poly(rC)-binding protein 2,19775,169,0.94 [0.77-1.16],0.584571743418284
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PCDH1,Protocadherin-1,22920,188,1.19 [0.68-2.11],0.539537023746163
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PCDH12,Protocadherin-12,19775,169,1.07 [0.60-1.88],0.825081104003907
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PCDH17,Protocadherin-17,22739,185,1.52 [1.07-2.17],0.0208855098961376
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PCDH7,Protocadherin-7,19705,168,0.93 [0.59-1.46],0.759573837767235
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PCDH9,Protocadherin-9,19705,168,0.91 [0.59-1.40],0.6693592581271168
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PCDHB15,Protocadherin beta-15,19698,167,1.14 [0.80-1.63],0.4722484507860163
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PCNA,Proliferating cell nuclear antigen,19107,162,1.11 [0.90-1.37],0.3142266133531761
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PCSK7,Proprotein convertase subtilisin/kexin type 7,19698,167,1.11 [0.82-1.50],0.4896390810167867
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PCSK9,Proprotein convertase subtilisin/kexin type 9,23014,190,1.22 [0.89-1.69],0.2221909163340875
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PCYT2,Ethanolamine-phosphate cytidylyltransferase,19705,168,0.87 [0.72-1.05],0.156723396879915
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDAP1,28 kDa heat- and acid-stable phosphoprotein,19806,170,0.85 [0.73-0.99],0.0393122395158733
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,22911,189,0.98 [0.73-1.32],0.9089337112377952
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDCD1LG2,Programmed cell death 1 ligand 2,22638,187,0.83 [0.54-1.25],0.3704942975532763
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDCD5,Programmed cell death protein 5,22944,191,1.00 [0.81-1.25],0.9813722692844636
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDCD6,Programmed cell death protein 6,22739,185,0.84 [0.72-0.97],0.0217521765468599
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDCL2,Phosducin-like protein 2,19107,162,0.92 [0.68-1.24],0.5834979910791611
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",19107,162,1.23 [1.00-1.51],0.0464505920005639
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",19204,165,0.79 [0.58-1.06],0.1192595484163058
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",19390,164,0.90 [0.78-1.03],0.1289117888490582
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDGFA,Platelet-derived growth factor subunit A,23014,190,0.97 [0.82-1.16],0.7745658208400783
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDGFB,Platelet-derived growth factor subunit B,22848,191,1.03 [0.89-1.20],0.6843699796131604
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDGFC,Platelet-derived growth factor C,22228,185,1.59 [1.11-2.27],0.0111612510085595
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDGFRA,Platelet-derived growth factor receptor alpha,22739,185,1.61 [1.04-2.48],0.0314128342527482
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDGFRB,Platelet-derived growth factor receptor beta,23014,190,1.18 [0.82-1.71],0.3686206539408418
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDIA2,Protein disulfide-isomerase A2,19107,162,0.83 [0.55-1.25],0.3676836730248262
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDIA3,Protein disulfide-isomerase A3,19390,164,0.66 [0.35-1.24],0.1977800734581157
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDIA4,Protein disulfide-isomerase A4,19801,169,0.83 [0.65-1.06],0.1419027101962606
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDIA5,Protein disulfide-isomerase A5,19107,162,1.04 [0.82-1.33],0.7322530629900127
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDLIM5,PDZ and LIM domain protein 5,19775,169,0.94 [0.83-1.06],0.3375083935166655
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDLIM7,PDZ and LIM domain protein 7,22848,191,0.96 [0.87-1.06],0.4074354521575591
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",22228,185,0.86 [0.65-1.15],0.311375179659303
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDRG1,p53 and DNA damage-regulated protein 1,19251,160,1.10 [0.86-1.41],0.4494958852620168
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,19107,162,0.96 [0.73-1.25],0.7609919713394244
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDZD2,PDZ domain-containing protein 2,19204,165,0.90 [0.69-1.17],0.4252279165663171
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,19252,163,0.93 [0.66-1.32],0.684192280552662
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PEAR1,Platelet endothelial aggregation receptor 1,23014,190,0.86 [0.49-1.53],0.6161312678301595
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PEBP1,Phosphatidylethanolamine-binding protein 1,22752,190,0.89 [0.71-1.11],0.2940220127759188
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PECAM1,Platelet endothelial cell adhesion molecule,22752,190,0.78 [0.51-1.20],0.2558197200892345
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PECR,Peroxisomal trans-2-enoyl-CoA reductase,19304,165,0.79 [0.45-1.38],0.4072111324288539
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PENK,Proenkephalin-A,19390,164,1.37 [0.88-2.13],0.1664365533317308
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PEPD,Xaa-Pro dipeptidase,19809,169,1.22 [0.69-2.15],0.4957556718043049
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PER3,Period circadian protein homolog 3,19252,163,1.03 [0.90-1.16],0.6959114073560144
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PF4,Platelet factor 4,19692,168,1.05 [0.90-1.22],0.5212966294898471
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PFDN2,Prefoldin subunit 2,22176,182,0.92 [0.72-1.17],0.4917841905306647
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PFDN4,Prefoldin subunit 4,19107,162,0.98 [0.74-1.30],0.9078970608867584
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PFDN6,Prefoldin subunit 6,19251,160,1.01 [0.80-1.26],0.950634626492144
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",22598,187,0.98 [0.83-1.16],0.831895329465094
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PGA4,Pepsin A-4,19809,169,0.99 [0.82-1.21],0.9366832448891478
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",19806,170,0.87 [0.66-1.14],0.313457513600591
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PGF,Placenta growth factor,22992,190,1.32 [0.82-2.14],0.2555026002475479
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PGLYRP1,Peptidoglycan recognition protein 1,22905,188,0.87 [0.64-1.19],0.3919143474915871
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,19573,166,1.66 [1.02-2.73],0.0431944677341036
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PGLYRP4,Peptidoglycan recognition protein 4,19204,165,1.00 [0.79-1.27],0.9803550336848752
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PGM2,Phosphoglucomutase-2,19251,160,0.96 [0.73-1.26],0.7572821961890317
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PGR,Progesterone receptor,19252,163,1.05 [0.92-1.21],0.4725895201624301
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PHACTR2,Phosphatase and actin regulator 2,19775,169,0.93 [0.81-1.05],0.2372163316969936
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PHLDB1,Pleckstrin homology-like domain family B member 1,19705,168,1.10 [0.83-1.45],0.5172184400831025
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PHLDB2,Pleckstrin homology-like domain family B member 2,19107,162,1.00 [0.85-1.17],0.9616163184690842
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,22595,190,1.37 [0.88-2.14],0.1641334139830111
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,19390,164,0.68 [0.48-0.96],0.030363274784093
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PI16,Peptidase inhibitor 16,19809,169,0.83 [0.46-1.47],0.5184512175944141
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PI3,Elafin,22442,186,1.18 [0.94-1.48],0.1606472724967942
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",19775,169,0.92 [0.76-1.12],0.4180199925506134
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PIGR,Polymeric immunoglobulin receptor,22460,185,1.49 [1.04-2.14],0.029399998709336
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,22702,187,0.91 [0.74-1.13],0.4037746789104089
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,22752,190,1.15 [0.71-1.86],0.5654272155958436
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,19252,163,0.86 [0.64-1.16],0.3284546367194427
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PILRA,Paired immunoglobulin-like type 2 receptor alpha,22752,190,0.76 [0.57-1.03],0.0783581231689542
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PILRB,Paired immunoglobulin-like type 2 receptor beta,22739,185,0.84 [0.67-1.04],0.1091689214150134
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,19390,164,0.90 [0.73-1.12],0.3435022980379101
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PITHD1,PITH domain-containing protein 1,19069,162,0.99 [0.82-1.20],0.9536652741963474
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PKD1,Polycystin-1,19806,170,1.01 [0.58-1.75],0.9826314980617415
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PKD2,Polycystin-2,19204,165,0.96 [0.74-1.25],0.774930436723795
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PKLR,Pyruvate kinase PKLR,22775,191,1.08 [0.90-1.30],0.3917227703557285
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PKN3,Serine/threonine-protein kinase N3,19422,163,0.94 [0.77-1.14],0.5257594251149188
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLA2G10,Group 10 secretory phospholipase A2,22595,190,1.01 [0.82-1.24],0.959892536795516
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLA2G15,Phospholipase A2 group XV,22813,190,1.01 [0.62-1.65],0.9653977785669158
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLA2G1B,Phospholipase A2,22976,190,0.95 [0.71-1.28],0.7326087831356554
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLA2G2A,"Phospholipase A2, membrane associated",22666,186,0.93 [0.74-1.18],0.5481593476494492
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLA2G4A,Cytosolic phospholipase A2,22848,191,0.89 [0.77-1.03],0.10969076005311
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLA2G7,Platelet-activating factor acetylhydrolase,22752,190,1.09 [0.73-1.61],0.686308450316077
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLAT,Tissue-type plasminogen activator,22945,189,1.17 [0.91-1.51],0.223942191618349
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLAU,Urokinase-type plasminogen activator,22752,190,1.31 [0.90-1.90],0.1570903456337548
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLAUR,Urokinase plasminogen activator surface receptor,22594,188,0.81 [0.49-1.34],0.4162769532583528
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLB1,"Phospholipase B1, membrane-associated",19765,168,1.18 [0.92-1.52],0.2017201852009658
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",19252,163,0.86 [0.60-1.23],0.4081328598576443
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",19765,168,0.93 [0.80-1.08],0.3300757842972535
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLEKHO1,Pleckstrin homology domain-containing family O member 1,19765,168,0.92 [0.74-1.14],0.4474011349069309
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLG,Plasminogen,19312,164,0.65 [0.33-1.27],0.2061823296481324
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLIN1,Perilipin-1,22176,182,1.05 [0.73-1.50],0.8020742179995703
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLIN3,Perilipin-3,22739,185,0.80 [0.58-1.10],0.1657595393343787
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLPBP,Pyridoxal phosphate homeostasis protein,22739,185,0.93 [0.77-1.13],0.4903334541867923
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLSCR3,Phospholipid scramblase 3,19733,166,0.95 [0.73-1.22],0.6727677251630941
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLTP,Phospholipid transfer protein,22926,189,1.00 [0.69-1.44],0.9810661575129266
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLXDC1,Plexin domain-containing protein 1,22228,185,0.93 [0.61-1.41],0.7191389167043785
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLXDC2,Plexin domain-containing protein 2,19765,168,1.48 [0.92-2.38],0.1024771518358022
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLXNA4,Plexin-A4,22702,187,0.86 [0.74-1.01],0.0580933759547408
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLXNB2,Plexin-B2,22912,189,0.80 [0.47-1.38],0.4261202264606826
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLXNB3,Plexin-B3,22672,184,0.92 [0.69-1.22],0.5540356005415805
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,22631,182,1.03 [0.95-1.10],0.5037362325804919
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PMCH,Pro-MCH,19204,165,0.89 [0.72-1.10],0.2806401470463204
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PMM2,Phosphomannomutase 2,19204,165,0.79 [0.61-1.03],0.0767892051402662
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PMS1,PMS1 protein homolog 1,19251,160,1.21 [0.92-1.58],0.1714058066906278
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PMVK,Phosphomevalonate kinase,22137,182,0.94 [0.84-1.05],0.2850794706216633
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PNLIP,Pancreatic triacylglycerol lipase,19809,169,1.17 [0.93-1.49],0.1798029480664019
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PNLIPRP1,Inactive pancreatic lipase-related protein 1,19765,168,0.97 [0.80-1.17],0.7291040921202316
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PNLIPRP2,Pancreatic lipase-related protein 2,22738,190,0.98 [0.94-1.02],0.3869208996541519
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PNMA1,Paraneoplastic antigen Ma1,19304,165,0.90 [0.68-1.19],0.4683707626978733
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PNMA2,Paraneoplastic antigen Ma2,19195,164,1.03 [0.73-1.44],0.8776628105554648
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",22309,181,0.93 [0.82-1.05],0.224973806029223
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PODXL,Podocalyxin,22638,187,0.84 [0.36-1.96],0.691761061903847
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PODXL2,Podocalyxin-like protein 2,22813,190,1.05 [0.66-1.68],0.8247247756523537
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",POF1B,Protein POF1B,19252,163,1.10 [0.80-1.51],0.5531442939343997
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",POLR2A,DNA-directed RNA polymerase II subunit RPB1,19252,163,0.89 [0.53-1.50],0.656729637163852
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",22638,187,0.91 [0.61-1.37],0.6618805978009303
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",POMC,Pro-opiomelanocortin,19304,165,1.28 [1.03-1.58],0.0263892804491139
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PON1,Serum paraoxonase/arylesterase 1,19809,169,0.73 [0.44-1.23],0.2373788664687781
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PON2,Serum paraoxonase/arylesterase 2,22335,183,1.58 [1.09-2.28],0.0162302749024107
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PON3,Serum paraoxonase/lactonase 3,22848,191,0.69 [0.52-0.93],0.0128894302128878
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",POSTN,Periostin,19801,169,1.02 [0.69-1.51],0.9135966776163276
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPBP,Platelet basic protein,19688,168,1.03 [0.87-1.23],0.718975687851927
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPCDC,Phosphopantothenoylcysteine decarboxylase,22944,191,0.95 [0.72-1.25],0.7094791367216963
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPIB,Peptidyl-prolyl cis-trans isomerase B,22750,188,0.88 [0.77-1.01],0.0726485961326673
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPIE,Peptidyl-prolyl cis-trans isomerase E,19422,163,1.13 [0.92-1.38],0.2355961335466487
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",19801,169,0.82 [0.63-1.05],0.1163006183704113
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPL,Periplakin,19252,163,1.22 [0.80-1.87],0.3541607517209406
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPM1A,Protein phosphatase 1A,22228,185,0.77 [0.49-1.21],0.2505339661182416
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPM1B,Protein phosphatase 1B,19252,163,0.96 [0.74-1.24],0.7377025302970716
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPM1F,Protein phosphatase 1F,19806,170,0.76 [0.57-1.01],0.056825122404176
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPME1,Protein phosphatase methylesterase 1,22638,187,1.02 [0.83-1.25],0.8722469817557694
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,19698,167,0.89 [0.74-1.06],0.1926561694298372
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,22813,190,0.92 [0.81-1.06],0.2487687410430529
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,19422,163,1.03 [0.84-1.25],0.7861550231158976
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,19775,169,0.83 [0.69-1.01],0.063640195941095
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,19775,169,0.88 [0.59-1.32],0.5282595507459777
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPP1R2,Protein phosphatase inhibitor 2,22739,185,0.89 [0.76-1.05],0.1832982102796516
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPP1R9B,Neurabin-2,22992,190,0.97 [0.85-1.11],0.6952348319325341
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,19705,168,0.95 [0.83-1.07],0.3867657059049375
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPP3R1,Calcineurin subunit B type 1,22595,190,0.79 [0.58-1.09],0.1510225284516265
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPT1,Palmitoyl-protein thioesterase 1,19251,160,1.07 [0.89-1.29],0.4742897358156549
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPY,Pancreatic prohormone,22731,190,1.13 [1.00-1.28],0.0450292689993851
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PQBP1,Polyglutamine-binding protein 1,22228,185,1.08 [0.86-1.34],0.5064730432802849
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRAME,Melanoma antigen preferentially expressed in tumors,19107,162,0.90 [0.49-1.64],0.7230908808740724
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRAP1,Proline-rich acidic protein 1,19801,169,1.61 [1.12-2.31],0.0104330819112764
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRC1,Protein regulator of cytokinesis 1,19698,167,1.24 [1.01-1.52],0.0431172593948366
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRCP,Lysosomal Pro-X carboxypeptidase,22882,190,0.90 [0.60-1.36],0.6145194378709578
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRDX1,Peroxiredoxin-1,22126,185,0.88 [0.75-1.03],0.100169499561537
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRDX2,Peroxiredoxin-2,19467,166,1.19 [0.95-1.48],0.1284977628521164
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",22309,181,0.87 [0.72-1.05],0.1516037953090624
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRDX5,"Peroxiredoxin-5, mitochondrial",22992,190,0.91 [0.75-1.09],0.2836395888657376
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRDX6,Peroxiredoxin-6,22943,189,0.97 [0.78-1.20],0.7666585888122794
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PREB,Prolactin regulatory element-binding protein,22309,181,1.10 [0.72-1.68],0.6718945637622198
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRELP,Prolargin,22738,190,0.97 [0.57-1.67],0.9228099388422624
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRG2,Bone marrow proteoglycan,19801,169,0.95 [0.72-1.26],0.72599211926562
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRG3,Proteoglycan 3,19801,169,0.95 [0.71-1.27],0.7353041997116001
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,22309,181,0.72 [0.55-0.94],0.0172705417311635
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,19251,160,1.43 [0.97-2.10],0.0676350832481706
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,22739,185,0.85 [0.73-0.99],0.0367528669652796
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,19729,168,0.98 [0.82-1.17],0.8232791943986922
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRKCQ,Protein kinase C theta type,22309,181,1.04 [0.78-1.39],0.7873503629884399
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRKD2,Serine/threonine-protein kinase D2,19204,165,1.11 [0.84-1.48],0.4620505693374387
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRKG1,cGMP-dependent protein kinase 1,19390,164,0.93 [0.83-1.05],0.2282817044781714
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,22228,185,0.91 [0.74-1.10],0.3291952010249254
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRL,Prolactin,22944,191,1.08 [0.91-1.27],0.3737786587300135
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRND,Prion-like protein doppel,19765,168,1.27 [0.98-1.64],0.0664278400887036
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PROC,Vitamin K-dependent protein C,22771,192,1.06 [0.63-1.78],0.828487488566105
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PROCR,Endothelial protein C receptor,19204,165,0.90 [0.58-1.39],0.6219251389520937
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PROK1,Prokineticin-1,22702,187,1.23 [1.02-1.48],0.0310314373026693
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PROS1,Vitamin K-dependent protein S,19834,169,0.69 [0.38-1.26],0.2282537047679961
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRR4,Proline-rich protein 4,19251,163,0.87 [0.70-1.09],0.2228636164370767
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRR5,Proline-rich protein 5,19252,163,1.03 [0.76-1.40],0.8388873772306278
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRRT3,Proline-rich transmembrane protein 3,19304,165,1.01 [0.68-1.49],0.9691504600914782
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRSS2,Trypsin-2,22808,192,1.07 [0.84-1.37],0.5976356347049965
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRSS22,Brain-specific serine protease 4,19252,163,1.45 [1.04-2.00],0.0270565852262726
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRSS27,Serine protease 27,22671,184,1.26 [0.92-1.73],0.1531223691757917
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRSS53,Serine protease 53,19765,168,1.14 [0.77-1.69],0.5218730456326164
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRSS8,Prostasin,22661,188,1.23 [0.90-1.66],0.1913983651693588
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,22176,182,0.93 [0.83-1.04],0.2016655531463173
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRTG,Protogenin,22943,189,1.10 [0.67-1.82],0.697968218891315
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRTN3,Myeloblastin,22150,182,0.77 [0.57-1.04],0.0853099317981159
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRUNE2,Protein prune homolog 2,19422,163,1.20 [0.77-1.89],0.4197843487381424
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSAP,Prosaposin,19609,167,0.94 [0.56-1.59],0.820131560642845
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSAPL1,Proactivator polypeptide-like 1,19705,168,1.20 [0.90-1.60],0.2105407671303472
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSCA,Prostate stem cell antigen,19705,168,1.01 [0.96-1.07],0.6701714977687907
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSG1,Pregnancy-specific beta-1-glycoprotein 1,22595,190,1.03 [0.92-1.15],0.5966328966839491
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSIP1,PC4 and SFRS1-interacting protein,22702,187,0.82 [0.65-1.03],0.0949649452645818
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSMA1,Proteasome subunit alpha type-1,22228,185,0.83 [0.61-1.13],0.2384576771837531
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSMC3,26S proteasome regulatory subunit 6A,19107,162,1.30 [0.81-2.09],0.2707859036849273
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSMD1,26S proteasome non-ATPase regulatory subunit 1,19775,169,0.88 [0.65-1.19],0.4050948258632528
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSMD5,26S proteasome non-ATPase regulatory subunit 5,19251,160,1.03 [0.79-1.34],0.8365064242960536
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSMD9,26S proteasome non-ATPase regulatory subunit 9,22638,187,1.14 [0.91-1.42],0.2572295762958096
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSME1,Proteasome activator complex subunit 1,22565,190,1.03 [0.74-1.45],0.8507579780608351
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSME2,Proteasome activator complex subunit 2,22483,190,1.12 [0.79-1.58],0.5305635524353723
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSMG3,Proteasome assembly chaperone 3,22702,187,1.14 [0.89-1.45],0.2877566328169111
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSMG4,Proteasome assembly chaperone 4,19252,163,1.05 [0.82-1.36],0.6882472793986998
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSPN,Persephin,22702,187,1.07 [0.95-1.22],0.2654631968044443
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSRC1,Proline/serine-rich coiled-coil protein 1,22228,185,0.88 [0.70-1.11],0.2855428419942757
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,18695,156,0.94 [0.82-1.08],0.3806278177839864
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",22176,182,0.92 [0.60-1.43],0.7231951351944063
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,22547,190,1.70 [1.15-2.50],0.0074052745316823
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTGES2,Prostaglandin E synthase 2,19098,159,0.77 [0.57-1.02],0.0707775900699136
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTGR1,Prostaglandin reductase 1,19806,170,1.11 [0.93-1.32],0.2486608713974501
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTH,Parathyroid hormone,19251,160,1.28 [1.08-1.53],0.0047581093418491
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,22702,187,1.20 [0.91-1.58],0.1860974847125943
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTK7,Inactive tyrosine-protein kinase 7,22176,182,1.25 [0.89-1.75],0.1981377234781903
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTN,Pleiotrophin,22335,183,0.95 [0.73-1.24],0.7270787991213196
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTP4A3,Protein tyrosine phosphatase type IVA 3,19252,163,0.99 [0.74-1.31],0.9390967527776676
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,22595,190,0.97 [0.82-1.14],0.7055970633832009
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,22809,191,0.88 [0.77-1.01],0.0659288813295478
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,19214,163,0.94 [0.62-1.44],0.7876980930508818
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTPRB,Receptor-type tyrosine-protein phosphatase beta,19806,170,0.85 [0.51-1.42],0.5429879574917429
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTPRC,Receptor-type tyrosine-protein phosphatase C,19801,169,0.95 [0.49-1.84],0.8847214924438794
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTPRF,Receptor-type tyrosine-protein phosphatase F,23014,190,0.94 [0.60-1.46],0.7794129160119324
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTPRH,Receptor-type tyrosine-protein phosphatase H,19705,168,1.61 [1.22-2.13],0.0008493879533427
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,19705,168,1.19 [0.64-2.20],0.5748885639408439
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTPRM,Receptor-type tyrosine-protein phosphatase mu,22665,187,0.91 [0.54-1.55],0.7338694180826355
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,22516,190,1.16 [0.78-1.72],0.4759923361707712
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTPRR,Receptor-type tyrosine-protein phosphatase R,19765,168,1.08 [0.72-1.63],0.7131669421009825
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTPRS,Receptor-type tyrosine-protein phosphatase S,23014,190,1.28 [0.75-2.17],0.3639417147364143
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,19806,170,0.69 [0.44-1.08],0.1067111545966194
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,19390,164,0.90 [0.71-1.16],0.4274947136801593
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTS,6-pyruvoyl tetrahydrobiopterin synthase,22085,181,1.05 [0.84-1.32],0.6397339200732066
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTTG1,Securin,19422,163,0.94 [0.65-1.36],0.7389417265519478
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTX3,Pentraxin-related protein PTX3,22702,187,0.82 [0.64-1.04],0.1078273947255175
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PVALB,Parvalbumin alpha,22829,187,0.94 [0.84-1.05],0.2847435131080538
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PVR,Poliovirus receptor,22944,191,1.10 [0.78-1.55],0.5896364069564899
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PXDNL,Peroxidasin-like protein,19698,167,0.88 [0.65-1.19],0.4097007843513867
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PXN,Paxillin,22176,182,1.11 [0.87-1.41],0.4062722851737309
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PYDC1,Pyrin domain-containing protein 1,19304,165,1.19 [0.87-1.65],0.2811549320391041
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PYY,Peptide YY,19204,165,1.12 [0.96-1.29],0.1442391768173363
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PZP,Pregnancy zone protein,19834,169,0.87 [0.69-1.11],0.2618320003927295
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",QDPR,Dihydropteridine reductase,22639,184,0.85 [0.63-1.15],0.2882201751963147
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",QPCT,Glutaminyl-peptide cyclotransferase,22784,189,0.79 [0.49-1.28],0.334122141529005
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",QSOX1,Sulfhydryl oxidase 1,19428,167,1.30 [1.03-1.64],0.0250609310069204
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAB10,Ras-related protein Rab-10,19806,170,0.79 [0.59-1.04],0.0929068024862636
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAB11FIP3,Rab11 family-interacting protein 3,19806,170,0.94 [0.83-1.08],0.4081974175772604
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAB27B,Ras-related protein Rab-27B,19806,170,0.89 [0.75-1.06],0.2065512714287163
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAB2B,Ras-related protein Rab-2B,19698,167,0.91 [0.71-1.16],0.4469424439384398
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAB33A,Ras-related protein Rab-33A,19204,165,0.93 [0.74-1.17],0.5493720385201701
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAB37,Ras-related protein Rab-37,22309,181,0.88 [0.74-1.05],0.1687013718809824
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAB39B,Ras-related protein Rab-39B,19204,165,0.93 [0.77-1.12],0.4354001142062828
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,19195,164,0.89 [0.66-1.19],0.4263223425632763
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAB44,Ras-related protein Rab-44,19698,167,1.25 [0.97-1.61],0.0836742792941555
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAB6A,Ras-related protein Rab-6A,22702,187,0.97 [0.74-1.27],0.8072992542362037
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAB6B,Ras-related protein Rab-6B,22176,182,0.81 [0.60-1.09],0.1596805715617495
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RABEP1,Rab GTPase-binding effector protein 1,19390,164,0.92 [0.75-1.11],0.3723776690666095
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RABEPK,Rab9 effector protein with kelch motifs,22228,185,0.91 [0.72-1.16],0.4532130786295215
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RABGAP1L,Rab GTPase-activating protein 1-like,22309,181,0.94 [0.76-1.17],0.5947907059204287
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAC3,Ras-related C3 botulinum toxin substrate 3,19251,160,1.04 [0.85-1.28],0.6906416151768975
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAD23B,UV excision repair protein RAD23 homolog B,22228,185,0.81 [0.61-1.08],0.1580427467388235
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAD51,DNA repair protein RAD51 homolog 1,19422,163,0.94 [0.70-1.26],0.6911520285208038
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RALB,Ras-related protein Ral-B,19252,163,1.25 [0.77-2.05],0.3673883407220407
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RALY,RNA-binding protein Raly,19698,167,0.81 [0.58-1.14],0.2242084224220213
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RANBP1,Ran-specific GTPase-activating protein,19304,165,1.04 [0.79-1.37],0.792786792550466
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RANBP2,E3 SUMO-protein ligase RanBP2,19195,164,1.08 [0.69-1.70],0.7292056628408541
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RANGAP1,Ran GTPase-activating protein 1,22228,185,0.70 [0.51-0.96],0.0295135303497122
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAP1A,Ras-related protein Rap-1A,19252,163,0.81 [0.63-1.05],0.1102678136430263
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAPGEF2,Rap guanine nucleotide exchange factor 2,19422,163,0.81 [0.60-1.10],0.1803496774952916
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RARRES1,Retinoic acid receptor responder protein 1,22228,185,0.89 [0.59-1.34],0.5728659878387903
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RARRES2,Retinoic acid receptor responder protein 2,22851,192,0.92 [0.70-1.22],0.5734074962401867
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RASA1,Ras GTPase-activating protein 1,22176,182,1.23 [0.86-1.76],0.2666256133167364
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,19107,162,0.93 [0.65-1.32],0.6719652705544621
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RASSF2,Ras association domain-containing protein 2,22228,185,1.07 [0.87-1.33],0.5036018712065904
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RBFOX3,RNA binding protein fox-1 homolog 3,19775,169,1.32 [0.93-1.86],0.1170717915246191
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RBKS,Ribokinase,22201,185,1.00 [0.78-1.29],0.9905632111247296
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RBM17,Splicing factor 45,19775,169,0.98 [0.80-1.19],0.8152026592158158
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RBM19,Probable RNA-binding protein 19,19204,165,0.95 [0.69-1.31],0.7540798924134784
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RBM25,RNA-binding protein 25,19107,162,0.91 [0.65-1.27],0.5811821620685207
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RBP1,Retinol-binding protein 1,19251,160,1.18 [0.99-1.41],0.0592430794731035
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RBP2,Retinol-binding protein 2,22638,187,0.91 [0.77-1.09],0.3009383773249283
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RBP5,Retinol-binding protein 5,22638,187,1.26 [1.02-1.56],0.0308321798854682
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RBP7,Retinoid-binding protein 7,19705,168,1.08 [0.86-1.37],0.5023051093714991
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RBPMS,RNA-binding protein with multiple splicing,19252,163,1.26 [1.06-1.49],0.0086173787645822
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RBPMS2,RNA-binding protein with multiple splicing 2,19304,165,0.96 [0.83-1.11],0.5684319781576845
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RCC1,Regulator of chromosome condensation,19698,167,1.11 [0.86-1.44],0.4140607510910687
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RCOR1,REST corepressor 1,22335,183,0.79 [0.55-1.15],0.2177244349850207
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,19304,165,1.21 [0.57-2.54],0.6204912259385407
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",REEP4,Receptor expression-enhancing protein 4,19775,169,1.08 [0.86-1.36],0.5098682211425196
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",REG1A,Lithostathine-1-alpha,22588,192,0.84 [0.64-1.10],0.2073485867734815
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",REG1B,Lithostathine-1-beta,23014,190,0.85 [0.67-1.08],0.1847319210874479
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",REG3A,Regenerating islet-derived protein 3-alpha,23014,190,0.93 [0.75-1.14],0.4689284310918379
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",REG3G,Regenerating islet-derived protein 3-gamma,19698,167,1.01 [0.70-1.45],0.977053530205828
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",REG4,Regenerating islet-derived protein 4,22780,190,0.89 [0.69-1.16],0.3997182581267915
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RELB,Transcription factor RelB,19252,163,1.02 [0.77-1.36],0.8726114759193362
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RELT,Tumor necrosis factor receptor superfamily member 19L,22752,190,1.25 [0.79-1.99],0.3387551943270652
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",REN,Renin,22739,185,1.15 [0.98-1.34],0.0824648879726192
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",REPS1,RalBP1-associated Eps domain-containing protein 1,19252,163,0.85 [0.57-1.28],0.4360519237334525
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",REST,RE1-silencing transcription factor,19107,162,0.79 [0.50-1.25],0.3167079324412114
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,22638,187,1.22 [0.89-1.66],0.2158627098981314
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RETN,Resistin,22673,186,0.77 [0.56-1.06],0.1079998362694775
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",REXO2,"Oligoribonuclease, mitochondrial",19204,165,1.06 [0.79-1.41],0.7048889182762423
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RFC4,Replication factor C subunit 4,19698,167,1.29 [0.66-2.52],0.4491984552559345
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RGCC,Regulator of cell cycle RGCC,19775,169,0.96 [0.79-1.17],0.6878068160340738
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,19422,163,1.11 [0.90-1.37],0.3381713677827873
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RGMA,Repulsive guidance molecule A,22944,191,1.28 [0.85-1.94],0.2364150485149389
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RGMB,RGM domain family member B,22944,191,1.03 [0.64-1.69],0.8901666141040511
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RGS10,Regulator of G-protein signaling 10,19775,169,0.87 [0.67-1.12],0.2834229301995463
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RGS8,Regulator of G-protein signaling 8,22309,181,1.10 [0.92-1.32],0.3006301773312358
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RHOC,Rho-related GTP-binding protein RhoC,22438,189,0.91 [0.82-1.01],0.084892737443485
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RICTOR,Rapamycin-insensitive companion of mTOR,19252,163,1.10 [0.84-1.46],0.4892756166498676
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,19390,164,1.02 [0.76-1.37],0.9002331392541698
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RILP,Rab-interacting lysosomal protein,22870,188,1.03 [0.83-1.27],0.795833445489724
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RILPL2,RILP-like protein 2,19806,170,0.89 [0.77-1.04],0.1351770903726482
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,19204,165,1.11 [0.92-1.34],0.2536410190778734
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RLN1,Prorelaxin H1,19775,169,1.17 [0.99-1.37],0.0578633915520171
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RLN2,Prorelaxin H2,19354,164,1.11 [1.00-1.25],0.059847783370019
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RNASE1,Ribonuclease pancreatic,19809,169,1.65 [1.03-2.64],0.0381644050144089
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RNASE10,Inactive ribonuclease-like protein 10,19304,165,1.01 [0.75-1.37],0.9269642147957544
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RNASE3,Eosinophil cationic protein,22636,184,0.97 [0.86-1.10],0.6368606821185571
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RNASE4,Ribonuclease 4,19136,162,1.31 [0.76-2.24],0.3315268585026314
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RNASE6,Ribonuclease K6,19652,167,1.03 [0.63-1.69],0.8959963765958251
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RNASEH2A,Ribonuclease H2 subunit A,19775,169,1.11 [0.85-1.46],0.4337901223582079
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RNASET2,Ribonuclease T2,22914,190,0.90 [0.55-1.47],0.6709222215993502
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RNF149,E3 ubiquitin-protein ligase RNF149,19304,165,0.93 [0.57-1.50],0.7556083639574576
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RNF168,E3 ubiquitin-protein ligase RNF168,19252,163,0.78 [0.52-1.18],0.2373507273301012
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RNF31,E3 ubiquitin-protein ligase RNF31,19252,163,0.97 [0.63-1.47],0.8745418412966041
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RNF4,E3 ubiquitin-protein ligase RNF4,19422,163,1.13 [0.92-1.39],0.2293386530413328
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RNF41,E3 ubiquitin-protein ligase NRDP1,22228,185,1.01 [0.83-1.22],0.9407530838488244
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RNF43,E3 ubiquitin-protein ligase RNF43,19422,163,0.87 [0.65-1.16],0.3514585356348582
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RNF5,E3 ubiquitin-protein ligase RNF5,19304,165,0.90 [0.73-1.10],0.2875450612775146
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,22780,190,1.20 [0.73-1.97],0.4683799888344426
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ROBO2,Roundabout homolog 2,22944,191,1.49 [0.87-2.57],0.1475781233055763
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ROBO4,Roundabout homolog 4,19304,165,0.82 [0.35-1.91],0.6430873828632238
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,22739,185,1.28 [0.85-1.93],0.2429562196397336
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RP2,Protein XRP2,22638,187,0.96 [0.70-1.31],0.792232447772502
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RPA2,Replication protein A 32 kDa subunit,19252,163,1.05 [0.66-1.67],0.8419923293611434
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RPE,Ribulose-phosphate 3-epimerase,19422,163,0.96 [0.78-1.20],0.7424904056444384
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RPGR,X-linked retinitis pigmentosa GTPase regulator,19251,160,1.01 [0.70-1.45],0.9637254130731786
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RPL14,60S ribosomal protein L14,19304,165,1.02 [0.71-1.47],0.8965742464977864
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RPS10,40S ribosomal protein S10,19204,165,0.75 [0.50-1.13],0.1702126345981222
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RRAS,Ras-related protein R-Ras,19251,160,0.94 [0.84-1.06],0.3246333429509495
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RRM2,Ribonucleoside-diphosphate reductase subunit M2,22228,185,0.89 [0.68-1.18],0.4273227843184755
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,22228,185,0.95 [0.78-1.15],0.5660227079913884
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RRP15,RRP15-like protein,19195,164,0.91 [0.77-1.07],0.2350461796366346
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RSPO1,R-spondin-1,22595,190,1.69 [1.18-2.42],0.0041154890254705
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RSPO3,R-spondin-3,22943,189,1.27 [0.81-1.99],0.2952527947627514
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RTBDN,Retbindin,22638,187,1.09 [0.69-1.72],0.7079106219326339
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RTKN2,Rhotekin-2,19204,165,1.15 [0.91-1.45],0.2340542748141374
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",19775,169,0.89 [0.76-1.05],0.1716185430760829
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RTN4R,Reticulon-4 receptor,22943,189,1.57 [1.15-2.14],0.0041862379612752
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RUVBL1,RuvB-like 1,22228,185,1.00 [0.89-1.13],0.960020889656767
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RWDD1,RWD domain-containing protein 1,22944,191,0.89 [0.73-1.08],0.2331963928133653
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RYR1,Ryanodine receptor 1,19204,165,0.88 [0.55-1.40],0.5793600855499501
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",S100A11,Protein S100-A11,22559,185,0.95 [0.72-1.27],0.7423985711185304
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",S100A12,Protein S100-A12,22434,185,1.01 [0.85-1.20],0.8970383485235326
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",S100A13,Protein S100-A13,19252,163,1.32 [0.89-1.94],0.163708129842946
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",S100A14,Protein S100-A14,19775,169,1.15 [0.89-1.50],0.2812129226014813
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",S100A16,Protein S100-A16,22146,182,1.02 [0.83-1.26],0.834323377433941
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",S100A3,Protein S100-A3,19698,167,1.09 [0.82-1.45],0.540562610059963
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",S100A4,Protein S100-A4,22813,190,1.00 [0.80-1.26],0.9800724532895034
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",S100G,Protein S100-G,19775,169,1.24 [0.91-1.69],0.1740222029901655
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",S100P,Protein S100-P,22335,183,0.94 [0.73-1.21],0.6338981158207821
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SAA4,Serum amyloid A-4 protein,19834,169,1.29 [0.93-1.78],0.128329469140247
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SAFB2,Scaffold attachment factor B2,19775,169,0.95 [0.57-1.59],0.8480600020856723
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SAG,S-arrestin,19195,164,1.06 [0.80-1.39],0.7004437306015042
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SAMD9L,Sterile alpha motif domain-containing protein 9-like,22702,187,0.86 [0.72-1.04],0.1173499835766345
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SAP18,Histone deacetylase complex subunit SAP18,19422,163,1.07 [0.89-1.29],0.4891215888449528
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SARG,Specifically androgen-regulated gene protein,19729,168,0.94 [0.82-1.07],0.3561491551205733
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SART1,U4/U6.U5 tri-snRNP-associated protein 1,19204,165,0.86 [0.55-1.35],0.5204506414308514
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SAT1,Diamine acetyltransferase 1,19204,165,1.16 [0.90-1.49],0.2574255688834895
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SAT2,Thialysine N-epsilon-acetyltransferase,19422,163,0.97 [0.77-1.21],0.7606842498247077
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SATB1,DNA-binding protein SATB1,19775,169,1.12 [0.71-1.75],0.6312673023239426
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SBSN,Suprabasin,19763,169,0.73 [0.47-1.12],0.1486387209231693
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCAMP3,Secretory carrier-associated membrane protein 3,22638,187,0.97 [0.83-1.13],0.7089004476571619
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCARA5,Scavenger receptor class A member 5,22944,191,1.16 [0.75-1.78],0.5084471813867488
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCARB1,Scavenger receptor class B member 1,22176,182,1.13 [0.93-1.37],0.2232175467478856
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,22168,185,1.49 [0.99-2.23],0.0535056071527279
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCARF1,Scavenger receptor class F member 1,23014,190,0.84 [0.62-1.15],0.2759644148413978
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCARF2,Scavenger receptor class F member 2,22944,191,1.13 [0.73-1.74],0.5822804871034934
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCG2,Secretogranin-2,22829,188,1.23 [0.83-1.82],0.3020810792486496
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCG3,Secretogranin-3,22780,190,1.06 [0.73-1.55],0.7541100501122081
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCGB1A1,Uteroglobin,22774,190,1.12 [0.88-1.41],0.3505694451732198
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCGB2A2,Mammaglobin-A,19204,165,1.27 [0.85-1.89],0.2381746679704596
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCGB3A1,Secretoglobin family 3A member 1,19390,164,0.91 [0.50-1.67],0.7677231904622074
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCGB3A2,Secretoglobin family 3A member 2,22809,191,0.92 [0.79-1.06],0.2446374724274771
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCGN,Secretagogin,22309,181,0.77 [0.57-1.05],0.1017270514091976
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCIN,Adseverin,19195,164,0.87 [0.69-1.08],0.2119760444113106
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCLY,Selenocysteine lyase,22870,188,1.01 [0.78-1.32],0.9385999597718476
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCN2A,Sodium channel protein type 2 subunit alpha,19195,164,1.06 [0.80-1.41],0.6749135462925775
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCN2B,Sodium channel subunit beta-2,19251,160,1.15 [0.70-1.89],0.5703982126865729
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCN3A,Sodium channel protein type 3 subunit alpha,19251,160,1.04 [0.71-1.53],0.841243117248618
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCN3B,Sodium channel subunit beta-3,19195,164,1.31 [1.03-1.65],0.0248983159255939
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCN4B,Sodium channel subunit beta-4,19304,165,1.30 [0.92-1.84],0.1326179740034073
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCP2,Non-specific lipid-transfer protein,22228,185,0.88 [0.73-1.06],0.1875578387674202
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCPEP1,Retinoid-inducible serine carboxypeptidase,19229,165,0.99 [0.73-1.34],0.9437109153334212
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCRG1,Scrapie-responsive protein 1,19806,170,0.82 [0.48-1.39],0.4598333999000452
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCRIB,Protein scribble homolog,19304,165,1.12 [0.97-1.29],0.1224629253395409
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCRN1,Secernin-1,22702,187,0.77 [0.61-0.98],0.0359054616422286
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCT,Secretin,19251,160,0.92 [0.66-1.28],0.6294528692007846
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SDC1,Syndecan-1,22739,185,1.19 [0.86-1.65],0.2850470488498726
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SDC4,Syndecan-4,22739,185,0.85 [0.64-1.13],0.2673012859844612
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SDCCAG8,Serologically defined colon cancer antigen 8,19698,167,0.96 [0.84-1.10],0.5529290145279595
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SDHB,Succinate dehydrogenase,19705,168,0.85 [0.67-1.07],0.1575764786204152
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SDK2,Protein sidekick-2,19390,164,1.32 [0.91-1.91],0.1394546877794434
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SEC31A,Protein transport protein Sec31A,19304,165,0.82 [0.68-1.00],0.0488320354029826
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SEL1L,Protein sel-1 homolog 1,19304,165,0.93 [0.56-1.52],0.7596911910174833
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SELE,E-selectin,23014,190,0.85 [0.66-1.09],0.1968856526988373
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SELENOP,Selenoprotein P,19834,169,1.09 [0.57-2.08],0.7963667718608097
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SELL,L-selectin,19834,169,1.04 [0.55-2.00],0.8961031172134463
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SELP,P-selectin,22808,192,0.94 [0.75-1.17],0.55420100054586
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SELPLG,P-selectin glycoprotein ligand 1,22702,187,0.94 [0.60-1.49],0.8033869439422895
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SEMA3F,Semaphorin-3F,22739,185,1.64 [1.00-2.69],0.048097753962329
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SEMA3G,Semaphorin-3G,19390,164,0.67 [0.46-0.97],0.0323754213563044
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SEMA4C,Semaphorin-4C,22638,187,0.80 [0.49-1.32],0.3906554695057811
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SEMA4D,Semaphorin-4D,22944,191,0.71 [0.46-1.08],0.112067970377964
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SEMA6C,Semaphorin-6C,19252,163,1.19 [0.70-2.02],0.5308974313616572
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,22945,189,1.17 [0.73-1.86],0.5228286005928204
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SEPTIN3,Neuronal-specific septin-3,19775,169,1.18 [0.98-1.42],0.0721668313978236
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SEPTIN7,Septin-7,19422,163,0.90 [0.66-1.23],0.5080043890982229
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SEPTIN8,Septin-8,19724,168,1.34 [0.88-2.06],0.1751540049687494
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SEPTIN9,Septin-9,22638,187,0.77 [0.48-1.25],0.2872895860906153
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINA1,Alpha-1-antitrypsin,19441,163,0.68 [0.10-4.59],0.6906424723473586
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINA11,Serpin A11,23014,190,0.69 [0.51-0.95],0.0205586322433598
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINA12,Serpin A12,22092,181,1.00 [0.89-1.13],0.9639204572170972
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINA3,Alpha-1-antichymotrypsin,19753,168,1.24 [0.46-3.33],0.6697049381555664
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINA4,Kallistatin,19454,166,2.35 [1.27-4.35],0.0063288723153844
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINA5,Plasma serine protease inhibitor,19527,166,1.48 [1.00-2.19],0.0517378077418364
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINA6,Corticosteroid-binding globulin,19834,169,0.52 [0.21-1.28],0.1574086201542102
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINA7,Thyroxine-binding globulin,19834,169,1.00 [0.46-2.19],0.9987181936334292
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINA9,Serpin A9,22505,185,0.89 [0.74-1.07],0.1996435189612026
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINB1,Leukocyte elastase inhibitor,22680,189,0.89 [0.77-1.03],0.1097394060855677
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINB5,Serpin B5,22335,183,0.98 [0.75-1.27],0.8663413558922849
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINB6,Serpin B6,22871,189,0.83 [0.66-1.03],0.0888400859881491
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINB8,Serpin B8,22992,190,0.95 [0.76-1.20],0.6730267999266575
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINB9,Serpin B9,22595,190,0.85 [0.58-1.24],0.3951520627922014
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINC1,Antithrombin-III,19790,169,0.83 [0.31-2.24],0.7184416149659107
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPIND1,Heparin cofactor 2,19790,169,1.09 [0.64-1.87],0.755285145111484
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINE1,Plasminogen activator inhibitor 1,23014,190,1.04 [0.86-1.26],0.6707569390761821
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINE2,Glia-derived nexin,19806,170,1.00 [0.80-1.25],0.9888340830645892
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINF1,Pigment epithelium-derived factor,19529,166,1.75 [1.03-2.99],0.0386360984912266
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINF2,Alpha-2-antiplasmin,19452,165,0.78 [0.26-2.35],0.6637365823057562
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPING1,Plasma protease C1 inhibitor,19790,169,0.60 [0.27-1.33],0.2122506482597794
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINH1,Serpin H1,19422,163,0.96 [0.86-1.08],0.5311732337963855
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINI1,Neuroserpin,19347,164,0.59 [0.36-0.98],0.0410502620373301
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINI2,Serpin I2,19705,168,1.08 [0.84-1.39],0.5604180644227192
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,22176,182,0.90 [0.73-1.11],0.3161632536570386
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SETMAR,Histone-lysine N-methyltransferase SETMAR,22531,188,1.13 [0.74-1.73],0.5745997760952762
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SEZ6,Seizure protein 6 homolog,19251,160,0.77 [0.46-1.29],0.3234642953963131
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SEZ6L,Seizure 6-like protein,22813,190,1.02 [0.64-1.64],0.9310286427706004
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SEZ6L2,Seizure 6-like protein 2,22638,187,1.24 [0.72-2.11],0.4388051658784656
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SF3B4,Splicing factor 3B subunit 4,22638,187,0.96 [0.81-1.15],0.6858843988845894
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SFRP1,Secreted frizzled-related protein 1,22528,189,1.21 [0.91-1.62],0.1943200079514878
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SFRP4,Secreted frizzled-related protein 4,19390,164,1.80 [1.26-2.58],0.0012608107787528
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SFTPA1,Pulmonary surfactant-associated protein A1,22228,185,1.10 [0.90-1.36],0.3553304644131266
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SFTPA2,Pulmonary surfactant-associated protein A2,22228,185,1.14 [0.89-1.47],0.306870756775045
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SFTPD,Pulmonary surfactant-associated protein D,22739,185,1.04 [0.86-1.27],0.6708652242621643
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SGSH,N-sulphoglucosamine sulphohydrolase,19452,168,0.98 [0.75-1.28],0.8901327355829565
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SH2B3,SH2B adapter protein 3,22228,185,0.94 [0.82-1.07],0.3474781914439301
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SH2D1A,SH2 domain-containing protein 1A,22702,187,0.76 [0.58-0.99],0.0423404720788733
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,19195,164,0.89 [0.68-1.17],0.4149164062225917
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SH3BP1,SH3 domain-binding protein 1,19705,168,0.96 [0.71-1.31],0.8019254853226947
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SH3GL3,Endophilin-A3,19316,162,0.93 [0.78-1.11],0.4163123705216872
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SH3GLB2,Endophilin-B2,19765,168,0.95 [0.76-1.18],0.6345812074656592
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SHBG,Sex hormone-binding globulin,19809,169,0.59 [0.46-0.75],1.3499308484958451e-05
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SHC1,SHC-transforming protein 1,19107,162,1.01 [0.88-1.15],0.9331254812341592
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SHD,SH2 domain-containing adapter protein D,19165,165,1.02 [0.86-1.20],0.8560649283969712
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SHH,Sonic hedgehog protein,19252,163,0.95 [0.67-1.34],0.7575008987278409
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SHISA5,Protein shisa-5,19801,169,1.56 [0.96-2.56],0.0752380982218209
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SHMT1,"Serine hydroxymethyltransferase, cytosolic",22809,191,0.94 [0.81-1.09],0.4080254225745028
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SHPK,Sedoheptulokinase,19422,163,0.65 [0.42-1.01],0.0529203244503197
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIAE,Sialate O-acetylesterase,22777,190,0.86 [0.66-1.14],0.3047557458967578
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,22848,191,1.11 [0.82-1.49],0.4943397501336021
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,22702,187,1.59 [1.08-2.33],0.0178476051459419
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIGLEC15,Sialic acid-binding Ig-like lectin 15,22176,182,1.07 [0.92-1.24],0.3888275059419328
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIGLEC5,Sialic acid-binding Ig-like lectin 5,22752,190,1.01 [0.91-1.13],0.8014407898227252
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIGLEC6,Sialic acid-binding Ig-like lectin 6,22943,189,0.97 [0.66-1.44],0.877348940923258
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIGLEC7,Sialic acid-binding Ig-like lectin 7,22739,185,0.96 [0.60-1.53],0.8520958420811302
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIGLEC8,Sialic acid-binding Ig-like lectin 8,19304,165,1.47 [1.06-2.04],0.0211837286747065
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIGLEC9,Sialic acid-binding Ig-like lectin 9,22910,189,0.84 [0.55-1.30],0.4363106325114043
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIL1,Nucleotide exchange factor SIL1,19304,165,0.70 [0.39-1.26],0.234379653439127
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,22793,188,1.10 [0.87-1.39],0.4102706722826006
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIRPB1,Signal-regulatory protein beta-1,22704,190,0.93 [0.70-1.24],0.6397360894194676
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIRT1,NAD-dependent protein deacetylase sirtuin-1,19252,163,0.97 [0.80-1.17],0.7288316926916163
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIRT2,NAD-dependent protein deacetylase sirtuin-2,22638,187,0.91 [0.79-1.05],0.1992694766282341
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",22176,182,0.72 [0.54-0.95],0.0214451145211866
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIT1,Signaling threshold-regulating transmembrane adapter 1,22309,181,0.90 [0.71-1.15],0.4091839581392117
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SKAP1,Src kinase-associated phosphoprotein 1,22547,190,0.90 [0.76-1.07],0.2428430883109842
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SKAP2,Src kinase-associated phosphoprotein 2,22848,191,0.92 [0.81-1.03],0.1581189376692684
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SKIV2L,Helicase SKI2W,19204,165,0.89 [0.60-1.31],0.5533725348546217
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLA2,Src-like-adapter 2,19775,169,0.91 [0.79-1.05],0.1883589066539653
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLAMF1,Signaling lymphocytic activation molecule,22309,181,0.89 [0.72-1.10],0.2953203854043114
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLAMF6,SLAM family member 6,22228,185,0.94 [0.66-1.33],0.7136549566001229
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLAMF7,SLAM family member 7,22702,187,0.75 [0.59-0.94],0.0124273540561421
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLAMF8,SLAM family member 8,22228,185,1.06 [0.83-1.36],0.6139022307658248
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLC12A2,Solute carrier family 12 member 2,19204,165,1.04 [0.62-1.75],0.8759005693642594
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLC13A1,Solute carrier family 13 member 1,19698,167,0.83 [0.61-1.12],0.2287706279408875
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLC16A1,Monocarboxylate transporter 1,22176,182,1.18 [0.97-1.43],0.0988111165114537
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLC1A4,Neutral amino acid transporter A,19251,160,1.02 [0.77-1.36],0.8796625097171605
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLC27A4,Long-chain fatty acid transport protein 4,22176,182,0.95 [0.77-1.17],0.6096968928936507
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLC28A1,Sodium/nucleoside cotransporter 1,19107,162,1.12 [0.89-1.41],0.3384932157925691
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLC34A3,Sodium-dependent phosphate transport protein 2C,19107,162,1.13 [0.86-1.49],0.3715022526064684
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLC39A14,Zinc transporter ZIP14,22176,182,0.77 [0.50-1.17],0.2160400537621712
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLC39A5,Zinc transporter ZIP5,22702,187,1.29 [1.08-1.54],0.0058286100085551
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLC44A4,Choline transporter-like protein 4,19251,160,1.01 [0.82-1.25],0.9192166703853584
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLC4A1,Band 3 anion transport protein,19801,169,1.02 [0.75-1.40],0.8799964966685632
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLC51B,Organic solute transporter subunit beta,19204,165,0.91 [0.75-1.11],0.3660395042104524
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,19390,164,0.83 [0.69-1.00],0.0449442931380638
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,19705,168,1.10 [0.85-1.41],0.4664455882782949
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",19107,162,1.01 [0.78-1.30],0.952240593536031
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLIT2,Slit homolog 2 protein,22176,182,1.14 [0.90-1.45],0.2913615143210611
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLITRK1,SLIT and NTRK-like protein 1,19252,163,1.08 [0.67-1.73],0.7478437319445147
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLITRK2,SLIT and NTRK-like protein 2,22943,189,1.74 [1.24-2.44],0.0013849355003065
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLITRK6,SLIT and NTRK-like protein 6,22335,183,0.87 [0.59-1.27],0.4638378745404965
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLK,STE20-like serine/threonine-protein kinase,19422,163,1.13 [0.97-1.32],0.1275956519720923
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLMAP,Sarcolemmal membrane-associated protein,19705,168,0.99 [0.83-1.18],0.887335577354589
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLURP1,Secreted Ly-6/uPAR-related protein 1,19646,168,1.12 [0.79-1.58],0.5426716023270374
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SMAD1,Mothers against decapentaplegic homolog 1,22228,185,0.99 [0.84-1.16],0.8963455090793178
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SMAD2,Mothers against decapentaplegic homolog 2,19698,167,0.95 [0.76-1.18],0.6454013502553027
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SMAD3,Mothers against decapentaplegic homolog 3,19698,167,0.84 [0.62-1.13],0.2462374456874418
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SMAD5,Mothers against decapentaplegic homolog 5,22638,187,1.32 [0.68-2.55],0.4140848484719992
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SMARCA2,Probable global transcription activator SNF2L2,22176,182,0.85 [0.70-1.04],0.1082392499843911
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SMC3,Structural maintenance of chromosomes protein 3,19107,162,1.06 [0.81-1.37],0.6773220598396599
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SMNDC1,Survival of motor neuron-related-splicing factor 30,19705,168,0.91 [0.70-1.18],0.4663443327779749
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SMOC1,SPARC-related modular calcium-binding protein 1,22943,189,1.25 [0.85-1.84],0.263478235103551
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SMOC2,SPARC-related modular calcium-binding protein 2,22848,191,1.52 [1.11-2.09],0.0099370289354281
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SMPD1,Sphingomyelin phosphodiesterase,22829,189,0.92 [0.70-1.21],0.5554040225748134
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SMPD3,Sphingomyelin phosphodiesterase 3,19252,163,0.84 [0.62-1.16],0.2928912846808274
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,22814,191,1.09 [0.89-1.33],0.4146745054383471
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,19698,167,0.99 [0.82-1.20],0.9169066533870448
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SMS,Spermine synthase,19195,164,1.02 [0.81-1.29],0.8338859473985087
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SMTN,Smoothelin,19733,168,1.01 [0.86-1.18],0.915094584183552
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SNAP23,Synaptosomal-associated protein 23,22739,185,0.92 [0.79-1.06],0.2439657778720649
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SNAP25,Synaptosomal-associated protein 25,19195,164,0.84 [0.61-1.16],0.3002644192088136
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SNAP29,Synaptosomal-associated protein 29,22813,190,0.93 [0.80-1.07],0.2824055921826648
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SNAPIN,SNARE-associated protein Snapin,19775,169,0.96 [0.74-1.24],0.7297086205618851
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SNCA,Alpha-synuclein,19390,164,0.98 [0.86-1.12],0.8123624606817297
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SNCG,Gamma-synuclein,22595,190,1.08 [0.89-1.30],0.4438718525599915
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",19304,165,1.25 [0.83-1.88],0.2808095514162437
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SNRPB2,U2 small nuclear ribonucleoprotein B'',19765,168,0.95 [0.67-1.35],0.7758941968406734
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SNU13,NHP2-like protein 1,19204,165,1.16 [0.94-1.42],0.1562571885235438
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SNX15,Sorting nexin-15,19390,164,0.85 [0.64-1.12],0.2521806619964104
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SNX18,Sorting nexin-18,19705,168,0.97 [0.69-1.36],0.8748296686872522
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SNX2,Sorting nexin-2,19698,167,1.07 [0.89-1.28],0.4612624023655562
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SNX5,Sorting nexin-5,19304,165,1.10 [0.67-1.79],0.7036328953391271
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SNX9,Sorting nexin-9,22739,185,0.88 [0.72-1.07],0.1937954978804399
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SOD1,Superoxide dismutase [Cu-Zn],22261,188,0.94 [0.72-1.22],0.6358360584303699
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SOD2,"Superoxide dismutase [Mn], mitochondrial",22752,190,0.67 [0.47-0.95],0.0252392265246169
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SOD3,Extracellular superoxide dismutase,19809,169,1.13 [0.91-1.40],0.2632204697840714
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SORBS1,Sorbin and SH3 domain-containing protein 1,19775,169,1.33 [1.01-1.75],0.0421198114968216
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SORCS2,VPS10 domain-containing receptor SorCS2,22228,185,1.47 [1.03-2.11],0.0352573652194376
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SORD,Sorbitol dehydrogenase,22833,188,0.96 [0.79-1.15],0.6508089972438569
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SORT1,Sortilin,22705,185,1.04 [0.73-1.47],0.8477582415280678
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SOST,Sclerostin,22705,185,1.21 [0.86-1.69],0.269941548810874
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,19251,160,0.93 [0.68-1.29],0.6650582215304661
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SOX2,Transcription factor SOX-2,19748,169,1.19 [0.64-2.22],0.5789749449960797
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SOX9,Transcription factor SOX-9,19251,160,1.26 [0.71-2.21],0.4286482639970574
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,19775,169,1.16 [0.72-1.86],0.5406547058819727
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPAG1,Sperm-associated antigen 1,19775,169,1.10 [0.87-1.39],0.4314120803899876
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPARC,SPARC,22813,190,0.95 [0.79-1.13],0.5429155896349469
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPARCL1,SPARC-like protein 1,22734,191,1.22 [0.78-1.90],0.3892774104401731
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPART,Spartin,19390,164,0.90 [0.74-1.10],0.3200557952943509
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPESP1,Sperm equatorial segment protein 1,19806,170,1.07 [0.64-1.78],0.8065296552202614
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPINK1,Serine protease inhibitor Kazal-type 1,22752,190,1.08 [0.82-1.43],0.5802819639635239
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPINK2,Serine protease inhibitor Kazal-type 2,19390,164,0.86 [0.58-1.28],0.4619646791284326
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPINK4,Serine protease inhibitor Kazal-type 4,22702,187,0.99 [0.81-1.21],0.9295704416394772
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPINK5,Serine protease inhibitor Kazal-type 5,22752,190,1.45 [0.98-2.14],0.0610314613029988
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPINK6,Serine protease inhibitor Kazal-type 6,22943,189,0.96 [0.75-1.21],0.7179625691696623
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPINK8,Serine protease inhibitor Kazal-type 8,19204,165,0.78 [0.49-1.23],0.2802080973172864
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,22688,190,1.40 [0.85-2.31],0.1900754145949985
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPINT2,Kunitz-type protease inhibitor 2,22848,191,0.96 [0.71-1.30],0.7781428211526634
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPINT3,Kunitz-type protease inhibitor 3,19705,168,0.98 [0.87-1.10],0.7185739689757868
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPOCK1,Testican-1,22595,190,1.35 [0.82-2.22],0.2425211621232859
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPON1,Spondin-1,22780,190,1.09 [0.73-1.62],0.6710299135908118
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPON2,Spondin-2,22639,185,0.92 [0.63-1.34],0.6675559996630516
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPP1,Osteopontin,22974,189,0.82 [0.63-1.08],0.1566836804721447
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",19252,163,1.03 [0.73-1.47],0.86075265481548
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPRING1,SREBP regulating gene protein,19107,162,1.18 [0.95-1.46],0.1255248137431075
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPRR1B,Cornifin-B,19422,163,1.11 [0.95-1.30],0.1786795990606157
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPRR3,Small proline-rich protein 3,19765,168,1.09 [0.89-1.33],0.395151962927954
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPRY2,Protein sprouty homolog 2,22309,181,0.95 [0.82-1.09],0.4431169514045661
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",19195,164,1.22 [0.81-1.85],0.3452094219089887
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPTLC1,Serine palmitoyltransferase 1,19765,168,0.81 [0.52-1.27],0.3594048744893944
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SRC,Proto-oncogene tyrosine-protein kinase Src,22773,190,0.92 [0.83-1.02],0.1278092406678715
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SRP14,Signal recognition particle 14 kDa protein,22638,187,0.96 [0.77-1.18],0.6736318775493799
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SRPK2,SRSF protein kinase 2,22702,187,0.90 [0.76-1.06],0.192793933166584
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SRPX,Sushi repeat-containing protein SRPX,19806,170,0.80 [0.51-1.24],0.3099308999102962
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SSB,Lupus La protein,22176,182,1.23 [1.03-1.47],0.0217006684733879
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",19252,163,1.07 [0.71-1.61],0.7507078038701805
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,22705,185,1.16 [1.04-1.30],0.009021772427472
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,22808,192,1.15 [0.85-1.56],0.3554254723575963
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SSH3,Protein phosphatase Slingshot homolog 3,19107,162,0.90 [0.53-1.53],0.6924865651080022
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SSNA1,Sjoegren syndrome nuclear autoantigen 1,19705,168,0.95 [0.72-1.26],0.7208213959681267
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ST13,Hsc70-interacting protein,19390,164,0.89 [0.69-1.16],0.4065369533940974
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",22638,187,0.79 [0.56-1.10],0.1664944434218075
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",23014,190,0.73 [0.46-1.15],0.1707343114973964
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",19252,163,1.00 [0.72-1.38],0.9847651474033958
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STAB2,Stabilin-2,19801,169,0.98 [0.59-1.64],0.951034771466366
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STAM,Signal transducing adapter molecule 1,19698,167,1.06 [0.72-1.55],0.7813242110432526
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STAMBP,STAM-binding protein,22547,190,0.94 [0.77-1.15],0.5758368583076148
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STAT2,Signal transducer and activator of transcription 2,19252,163,0.89 [0.73-1.09],0.2672562570855891
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STAT5B,Signal transducer and activator of transcription 5B,22638,187,0.95 [0.86-1.04],0.2643291755635911
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,19107,162,1.19 [0.98-1.44],0.0847019916139945
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,22944,191,1.11 [0.82-1.51],0.4914894086068747
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STC2,Stanniocalcin-2,22719,190,2.37 [1.41-4.00],0.0012100485439787
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STEAP4,Metalloreductase STEAP4,19195,164,1.00 [0.82-1.22],0.9852074677053222
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STIP1,Stress-induced-phosphoprotein 1,22722,190,0.91 [0.74-1.10],0.3298756430704773
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STK11,Serine/threonine-protein kinase STK11,22335,183,0.95 [0.79-1.13],0.5486192858973125
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STK24,Serine/threonine-protein kinase 24,22176,182,0.83 [0.67-1.03],0.0950279853391373
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STK4,Serine/threonine-protein kinase 4,22739,185,0.89 [0.77-1.04],0.1411124353980707
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STOML2,"Stomatin-like protein 2, mitochondrial",19107,162,1.07 [0.92-1.25],0.3892318662970813
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STX16,Syntaxin-16,22228,185,0.98 [0.78-1.23],0.8754246281756624
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STX1B,Syntaxin-1B,19251,160,0.80 [0.53-1.23],0.31277221489912
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STX3,Syntaxin-3,19765,168,0.91 [0.61-1.35],0.6395162051923431
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STX4,Syntaxin-4,22638,187,0.99 [0.79-1.24],0.9157387095752194
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STX5,Syntaxin-5,19252,163,0.79 [0.52-1.20],0.2746287536389866
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STX6,Syntaxin-6,22228,185,0.97 [0.79-1.18],0.7549857237476852
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STX7,Syntaxin-7,19252,163,1.52 [1.13-2.06],0.0057768527557221
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STX8,Syntaxin-8,22702,187,0.98 [0.75-1.28],0.896632747140609
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STXBP1,Syntaxin-binding protein 1,19775,169,0.93 [0.77-1.12],0.4194660359401442
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STXBP3,Syntaxin-binding protein 3,22228,185,0.80 [0.58-1.10],0.1741564437713669
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SUGP1,SURP and G-patch domain-containing protein 1,19705,168,0.79 [0.54-1.17],0.2409481995753095
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SUGT1,Protein SGT1 homolog,22228,185,0.92 [0.78-1.08],0.3168763259825629
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SULT1A1,Sulfotransferase 1A1,22944,191,0.92 [0.83-1.01],0.0803457539573476
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SULT2A1,Bile salt sulfotransferase,22702,187,0.84 [0.65-1.08],0.1746738003312772
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SUMF1,Formylglycine-generating enzyme,19252,163,1.00 [0.82-1.23],0.9683847646463086
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,22944,191,0.98 [0.77-1.24],0.8415087293093908
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SUOX,"Sulfite oxidase, mitochondrial",19775,169,1.04 [0.83-1.30],0.7502572672915054
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SUSD1,Sushi domain-containing protein 1,22335,183,0.91 [0.69-1.19],0.4790183147805954
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SUSD2,Sushi domain-containing protein 2,22752,190,0.96 [0.61-1.51],0.8600547318685249
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SUSD4,Sushi domain-containing protein 4,19698,167,0.73 [0.51-1.05],0.0870918816688434
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SUSD5,Sushi domain-containing protein 5,19273,163,0.85 [0.55-1.32],0.4672460665366382
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SV2A,Synaptic vesicle glycoprotein 2A,19251,160,1.15 [0.91-1.43],0.2388534623955406
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SWAP70,Switch-associated protein 70,19705,168,0.87 [0.56-1.34],0.5230155725447705
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SYAP1,Synapse-associated protein 1,19390,164,0.90 [0.68-1.18],0.4309662208495497
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,19195,164,0.98 [0.76-1.28],0.8943780350360242
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SYT1,Synaptotagmin-1,19765,168,0.95 [0.63-1.41],0.7822789336299035
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SYTL4,Synaptotagmin-like protein 4,19806,170,0.96 [0.78-1.17],0.6673303167506315
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,19422,163,0.95 [0.82-1.09],0.4534494406158988
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TACC3,Transforming acidic coiled-coil-containing protein 3,22638,187,0.94 [0.85-1.05],0.3071541969829182
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TACSTD2,Tumor-associated calcium signal transducer 2,20197,167,0.68 [0.42-1.09],0.1111382559761381
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TADA3,Transcriptional adapter 3,19698,167,1.11 [0.76-1.61],0.5971734523464751
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TAFA5,Chemokine-like protein TAFA-5,22638,187,1.70 [1.20-2.40],0.0026068151191502
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TAGLN3,Transgelin-3,19107,162,1.12 [0.89-1.40],0.3261603477119199
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TALDO1,Transaldolase,19716,167,0.85 [0.60-1.19],0.3372989596113304
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TANK,TRAF family member-associated NF-kappa-B activator,22309,181,0.98 [0.81-1.19],0.8267107567820273
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TAP1,Antigen peptide transporter 1,19422,163,0.86 [0.64-1.14],0.2915244018111061
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TARBP2,RISC-loading complex subunit TARBP2,22176,182,0.98 [0.83-1.16],0.8475705852546056
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",19251,160,1.16 [0.98-1.37],0.0853897038484658
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",19698,167,1.12 [0.76-1.65],0.5596262767829183
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TAX1BP1,Tax1-binding protein 1,19765,168,0.97 [0.77-1.23],0.8109674711891915
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TBC1D17,TBC1 domain family member 17,22176,182,1.10 [0.84-1.45],0.4709948816224267
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TBC1D23,TBC1 domain family member 23,22638,187,0.92 [0.80-1.07],0.2915653259016725
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TBC1D5,TBC1 domain family member 5,22702,187,0.99 [0.84-1.17],0.8897157543873504
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TBCA,Tubulin-specific chaperone A,19390,164,0.89 [0.74-1.06],0.1778734259124871
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TBCB,Tubulin-folding cofactor B,22595,190,0.92 [0.81-1.04],0.1768389123943358
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TBCC,Tubulin-specific chaperone C,22595,190,0.89 [0.76-1.05],0.1613829308348373
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TBL1X,F-box-like/WD repeat-containing protein TBL1X,22228,185,0.89 [0.77-1.04],0.1570634081270501
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TBR1,T-box brain protein 1,19251,160,0.75 [0.51-1.11],0.150938750569667
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TCL1A,T-cell leukemia/lymphoma protein 1A,22555,189,0.94 [0.82-1.08],0.4139830827650042
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TCL1B,T-cell leukemia/lymphoma protein 1B,22335,183,1.03 [0.88-1.20],0.7086507262222346
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TCN1,Transcobalamin-1,19393,163,1.13 [0.73-1.74],0.5864288947839764
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TCN2,Transcobalamin-2,22974,189,0.67 [0.43-1.03],0.0706016554406853
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TCOF1,Treacle protein,19806,170,0.97 [0.60-1.57],0.8943851769189565
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TCP11,T-complex protein 11 homolog,19422,163,1.23 [1.01-1.49],0.0403439883093306
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TCTN3,Tectonic-3,19806,170,1.01 [0.62-1.66],0.9600387291026108
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TDGF1,Teratocarcinoma-derived growth factor 1,22176,182,0.95 [0.86-1.04],0.2663140677088623
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TDO2,"Tryptophan 2,3-dioxygenase",19251,160,0.98 [0.66-1.44],0.8986336359797917
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TDP1,Tyrosyl-DNA phosphodiesterase 1,19698,167,1.10 [0.91-1.34],0.312559409669038
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TDRKH,Tudor and KH domain-containing protein,22176,182,0.94 [0.80-1.10],0.4338414589816167
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TEF,Thyrotroph embryonic factor,19204,165,1.17 [0.85-1.62],0.3298768139804551
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TEK,Angiopoietin-1 receptor,22813,190,1.67 [0.94-2.99],0.082444801735802
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TERF1,Telomeric repeat-binding factor 1,19252,163,1.05 [0.64-1.73],0.8541428416068317
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TET2,Methylcytosine dioxygenase TET2,19385,162,1.05 [0.91-1.21],0.5325495912865728
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TEX101,Testis-expressed protein 101,19251,160,0.90 [0.60-1.33],0.5832308630647832
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TEX33,Testis-expressed protein 33,19422,163,1.24 [0.92-1.67],0.1558689206916292
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TF,Serotransferrin,19834,169,1.43 [0.73-2.79],0.2962066885663138
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TFAP2A,Transcription factor AP-2-alpha,19195,164,1.11 [0.88-1.39],0.3924998049551353
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TFF1,Trefoil factor 1,22639,187,0.97 [0.82-1.15],0.743397293696233
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TFF2,Trefoil factor 2,22809,191,0.99 [0.78-1.24],0.9023912480474224
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TFF3,Trefoil factor 3,22702,190,0.90 [0.68-1.21],0.4890482270629043
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TFPI,Tissue factor pathway inhibitor,22662,191,1.21 [0.81-1.81],0.3457132754196259
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TFPI2,Tissue factor pathway inhibitor 2,22740,189,0.66 [0.45-0.97],0.0362896761196373
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TFRC,Transferrin receptor protein 1,22820,192,1.62 [1.20-2.20],0.0018851375815984
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TG,Thyroglobulin,19698,167,1.03 [0.92-1.16],0.6029928531741084
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TGFA,Protransforming growth factor alpha,22702,187,1.06 [0.81-1.39],0.6542628895625144
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TGFB1,Transforming growth factor beta-1 proprotein,22951,189,0.98 [0.70-1.37],0.8953449447302473
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TGFB2,Transforming growth factor beta-2 proprotein,19698,167,1.08 [0.83-1.40],0.58541070561992
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TGFBI,Transforming growth factor-beta-induced protein ig-h3,22585,191,1.04 [0.66-1.66],0.8560184116697895
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TGFBR1,TGF-beta receptor type-1,19252,163,1.21 [0.62-2.35],0.5807861682836222
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TGFBR2,TGF-beta receptor type-2,22813,190,1.12 [0.76-1.67],0.5652202821371215
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TGFBR3,Transforming growth factor beta receptor type 3,23014,190,1.05 [0.71-1.56],0.7972649566013538
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TGM2,Protein-glutamine gamma-glutamyltransferase 2,22709,185,1.01 [0.86-1.20],0.8707114717627262
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TGOLN2,Trans-Golgi network integral membrane protein 2,19809,169,1.29 [0.74-2.24],0.3688454163890382
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",THAP12,52 kDa repressor of the inhibitor of the protein kinase,19069,162,0.93 [0.78-1.12],0.4369389436350234
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,22739,185,1.02 [0.64-1.64],0.9268390274360124
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",THBS2,Thrombospondin-2,22752,190,1.16 [0.83-1.61],0.3770629748673102
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",THBS4,Thrombospondin-4,22731,192,1.44 [1.09-1.90],0.010159965989666
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",THOP1,Thimet oligopeptidase,22634,183,1.35 [0.90-2.03],0.1512990505933167
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",THPO,Thrombopoietin,22335,183,0.91 [0.65-1.29],0.6017707258750857
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",THRAP3,Thyroid hormone receptor-associated protein 3,19204,165,1.06 [0.94-1.19],0.333759261918106
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",THSD1,Thrombospondin type-1 domain-containing protein 1,19105,160,0.99 [0.63-1.55],0.9709899184590416
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",THTPA,Thiamine-triphosphatase,19670,166,0.89 [0.75-1.06],0.1832701624302339
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",THY1,Thy-1 membrane glycoprotein,22944,191,1.59 [1.02-2.46],0.0386492734278223
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TIA1,Nucleolysin TIA-1 isoform p40,22093,182,0.92 [0.83-1.03],0.1547986309119854
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TIE1,Tyrosine-protein kinase receptor Tie-1,23014,190,0.93 [0.70-1.26],0.6557000858995572
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",22128,182,1.05 [0.79-1.39],0.7481452276818471
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,19422,163,1.32 [0.93-1.87],0.1197521553206684
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,22808,192,0.96 [0.72-1.28],0.7773214365738396
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,19806,170,0.74 [0.50-1.09],0.1276465693573948
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,19765,168,0.93 [0.78-1.10],0.3823816773941066
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TIMP1,Metalloproteinase inhibitor 1,22468,187,1.03 [0.65-1.62],0.9102042037507037
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TIMP2,Metalloproteinase inhibitor 2,19806,170,1.34 [0.91-1.98],0.1354192727198734
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TIMP3,Metalloproteinase inhibitor 3,22848,191,0.99 [0.90-1.09],0.8052177705229271
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TIMP4,Metalloproteinase inhibitor 4,22752,190,0.60 [0.43-0.84],0.0027768255629136
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TINAGL1,Tubulointerstitial nephritis antigen-like,22664,185,1.00 [0.56-1.79],0.9967007899263792
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TJAP1,Tight junction-associated protein 1,22813,190,0.94 [0.80-1.10],0.415815707934112
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TJP3,Tight junction protein ZO-3,19195,164,0.89 [0.61-1.28],0.5245149060256008
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TK1,"Thymidine kinase, cytosolic",19422,163,1.17 [0.86-1.58],0.3152203297376115
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TLR1,Toll-like receptor 1,19252,163,1.64 [0.98-2.73],0.0574146031523718
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TLR2,Toll-like receptor 2,19422,163,1.88 [0.99-3.54],0.0520801319403293
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TLR3,Toll-like receptor 3,22992,190,0.99 [0.80-1.21],0.9116347758843152
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TLR4,Toll-like receptor 4,19252,163,1.19 [0.71-2.02],0.5072609908207464
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,19251,160,0.88 [0.65-1.18],0.3857916487357776
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TMED1,Transmembrane emp24 domain-containing protein 1,19422,163,1.11 [0.86-1.43],0.436564205344407
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TMED10,Transmembrane emp24 domain-containing protein 10,19204,165,0.79 [0.54-1.15],0.2173300038535087
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TMED4,Transmembrane emp24 domain-containing protein 4,19204,165,0.92 [0.69-1.22],0.5559049844043873
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TMED8,Protein TMED8,19705,168,0.91 [0.79-1.05],0.195612661868698
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TMEM106A,Transmembrane protein 106A,19698,167,0.93 [0.75-1.15],0.4876180980003255
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TMEM132A,Transmembrane protein 132A,19304,165,1.02 [0.80-1.29],0.8883850018501748
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TMEM25,Transmembrane protein 25,19775,169,1.20 [0.91-1.58],0.1965811394509049
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TMOD4,Tropomodulin-4,19107,162,1.03 [0.71-1.48],0.8781308418461137
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TMPRSS11B,Transmembrane protease serine 11B,19195,164,0.98 [0.81-1.19],0.8376730978868222
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TMPRSS11D,Transmembrane protease serine 11D,19724,168,0.92 [0.63-1.34],0.6584673357229639
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TMPRSS15,Enteropeptidase,22638,187,1.00 [0.87-1.15],0.9876816764245556
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TMPRSS5,Transmembrane protease serine 5,22484,187,0.93 [0.66-1.30],0.6708033354266162
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TMSB10,Thymosin beta-10,22752,190,0.87 [0.72-1.03],0.1126525814331565
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNC,Tenascin,22808,192,0.98 [0.75-1.27],0.8584841113875928
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNF,Tumor necrosis factor,22294,183,1.00 [0.71-1.41],0.9954939373117472
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,19705,168,0.83 [0.59-1.15],0.2595121345241939
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,22309,181,0.80 [0.55-1.16],0.2342555120131871
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,19390,164,0.78 [0.61-1.00],0.0533350858200962
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,22595,190,0.96 [0.64-1.43],0.8402137609005149
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,22595,190,1.30 [1.09-1.56],0.0044938052338895
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,22775,188,0.92 [0.71-1.19],0.5213010868771139
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,22992,190,1.11 [0.80-1.55],0.5252779262368441
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,22738,190,0.55 [0.35-0.86],0.0093634213671296
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,22813,190,1.12 [0.77-1.62],0.5495144299885978
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,22780,190,1.06 [0.70-1.61],0.7726564884672367
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,22309,181,1.05 [0.76-1.46],0.7687780630752332
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,22780,190,0.78 [0.50-1.21],0.2697814991141442
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,19390,164,0.74 [0.51-1.08],0.1209160633606182
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,22943,189,1.21 [0.81-1.81],0.3601028023641508
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,22752,190,1.00 [0.64-1.56],0.9875103436756476
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,22752,190,0.89 [0.61-1.30],0.5415088595456887
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,22944,191,1.09 [0.68-1.73],0.7259710074584269
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,22951,189,1.17 [0.84-1.63],0.362356929473451
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,22595,190,1.18 [0.94-1.47],0.1569806187882717
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,22944,191,0.83 [0.62-1.11],0.19849691593754
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,22595,190,1.04 [0.75-1.45],0.8102918380614585
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFSF10,Tumor necrosis factor ligand superfamily member 10,22992,190,0.84 [0.51-1.38],0.5021003643806934
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFSF11,Tumor necrosis factor ligand superfamily member 11,22702,187,1.31 [1.06-1.62],0.0122522905886851
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFSF12,Tumor necrosis factor ligand superfamily member 12,22992,190,0.91 [0.58-1.40],0.6587539912825334
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFSF13,Tumor necrosis factor ligand superfamily member 13,22848,191,0.95 [0.59-1.54],0.8425734181059756
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,22974,189,1.06 [0.66-1.71],0.8148746532909632
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFSF14,Tumor necrosis factor ligand superfamily member 14,22595,190,1.03 [0.82-1.29],0.784286951708058
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,19801,169,1.22 [0.82-1.81],0.3310011807917892
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNIP1,TNFAIP3-interacting protein 1,19765,168,0.95 [0.81-1.13],0.5627593823611023
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNN,Tenascin-N,19801,169,1.00 [0.72-1.40],0.9778550686010412
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNNI3,"Troponin I, cardiac muscle",22335,183,1.12 [0.95-1.33],0.1847957464844712
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNPO1,Transportin-1,19422,163,1.27 [0.85-1.89],0.2442588889471136
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNR,Tenascin-R,22595,190,1.07 [0.79-1.45],0.6688992385143899
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNXB,Tenascin-X,22752,190,0.83 [0.50-1.36],0.4527571233881152
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,19806,170,0.94 [0.78-1.14],0.5276656181272721
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TOP1,DNA topoisomerase 1,19705,168,1.05 [0.92-1.21],0.4586200319313929
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TOP1MT,"DNA topoisomerase I, mitochondrial",19107,162,0.97 [0.71-1.33],0.8661098469019337
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TOP2B,DNA topoisomerase 2-beta,19252,163,1.00 [0.82-1.21],0.9650200829624216
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TOR1AIP1,Torsin-1A-interacting protein 1,19304,165,1.03 [0.78-1.36],0.8344476255235123
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TP53,Cellular tumor antigen p53,22228,185,1.08 [0.80-1.47],0.6188114072764195
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TP53BP1,TP53-binding protein 1,19252,163,1.01 [0.85-1.20],0.8951404142565138
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TP53I3,Quinone oxidoreductase PIG3,18963,159,0.86 [0.64-1.15],0.2989862538478482
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TP53INP1,Tumor protein p53-inducible nuclear protein 1,22335,183,1.35 [1.00-1.82],0.0521174260764472
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TP73,Tumor protein p73,19251,160,1.21 [0.78-1.86],0.3956913307237105
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TPBGL,Trophoblast glycoprotein-like,19251,160,1.05 [0.74-1.48],0.7902705938272685
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TPD52L2,Tumor protein D54,19390,164,0.92 [0.80-1.05],0.2174300619181375
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TPK1,Thiamin pyrophosphokinase 1,19806,170,0.60 [0.35-1.03],0.0650925677948022
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TPM3,Tropomyosin alpha-3 chain,19204,165,0.89 [0.61-1.29],0.5300542057203793
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TPMT,Thiopurine S-methyltransferase,22228,185,0.96 [0.81-1.15],0.6929585913478539
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TPP1,Tripeptidyl-peptidase 1,22593,188,1.08 [0.81-1.44],0.5873403956916354
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TPPP2,Tubulin polymerization-promoting protein family member 2,19422,163,1.11 [0.94-1.31],0.2112811087686819
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TPPP3,Tubulin polymerization-promoting protein family member 3,22176,182,0.84 [0.58-1.20],0.3329324275897394
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TPR,Nucleoprotein TPR,19204,165,0.91 [0.66-1.25],0.5471663253081588
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TPRKB,EKC/KEOPS complex subunit TPRKB,19107,162,1.08 [0.87-1.34],0.4658147274498965
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TPSAB1,Tryptase alpha/beta-1,22954,189,0.79 [0.62-1.01],0.0551574201802492
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TPSD1,Tryptase delta,19775,169,1.10 [0.77-1.58],0.5920204901625347
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TPSG1,Tryptase gamma,19252,163,0.98 [0.56-1.73],0.9554696292275086
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TPT1,Translationally-controlled tumor protein,22309,181,1.03 [0.84-1.25],0.8009642122586743
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TRAF2,TNF receptor-associated factor 2,22702,187,0.99 [0.83-1.19],0.942027669038604
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TRAF3,"TNF receptor-associated factor 3, Isoform 2",19252,163,0.88 [0.58-1.36],0.5764908864901606
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,19204,165,0.92 [0.66-1.29],0.6408551634315715
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,19422,163,0.85 [0.70-1.03],0.0995160710870566
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TREH,Trehalase,19801,169,1.09 [0.89-1.33],0.3961993796214211
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TREM2,Triggering receptor expressed on myeloid cells 2,22738,190,0.83 [0.65-1.07],0.1447959905689321
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TREML1,Trem-like transcript 1 protein,19809,169,0.81 [0.61-1.08],0.1532961354893795
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TREML2,Trem-like transcript 2 protein,22752,190,0.78 [0.52-1.17],0.2274670100103564
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TRIAP1,TP53-regulated inhibitor of apoptosis 1,22943,189,0.83 [0.68-1.03],0.0904267556520854
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TRIM21,E3 ubiquitin-protein ligase TRIM21,22702,187,1.00 [0.85-1.17],0.9704514247282792
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TRIM24,Transcription intermediary factor 1-alpha,19379,163,0.97 [0.77-1.22],0.7902802836880529
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,19705,168,0.91 [0.80-1.05],0.19718541844684
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TRIM26,Tripartite motif-containing protein 26,19107,162,0.80 [0.60-1.08],0.1519667689845545
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TRIM40,E3 ubiquitin ligase TRIM40,19251,160,1.02 [0.83-1.27],0.8219394326358049
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TRIM5,Tripartite motif-containing protein 5,22702,187,0.98 [0.84-1.14],0.7820783692855144
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TRIM58,E3 ubiquitin-protein ligase TRIM58,19698,167,0.98 [0.82-1.16],0.7954818591110648
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TRPV3,Transient receptor potential cation channel subfamily V member 3,19204,165,0.72 [0.51-1.03],0.0710489220816978
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TSC1,Hamartin,19252,163,1.04 [0.85-1.27],0.7014766856658067
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TSC22D1,TSC22 domain family protein 1,19775,169,0.91 [0.72-1.14],0.3968676201739203
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TSHB,Thyrotropin subunit beta,22739,185,1.07 [0.92-1.25],0.3771352740117187
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TSLP,Thymic stromal lymphopoietin,22335,183,1.08 [0.89-1.31],0.4118946678958439
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TSNAX,Translin-associated protein X,19204,165,0.79 [0.54-1.17],0.2446845310539929
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TSPAN1,Tetraspanin-1,22335,183,1.57 [1.08-2.28],0.0171858245698765
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TSPAN15,Tetraspanin-15,19204,165,1.09 [0.84-1.42],0.5080636485573028
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TSPAN7,Tetraspanin-7,19195,164,0.91 [0.76-1.09],0.2842585662240401
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TSPAN8,Tetraspanin-8,19705,168,0.90 [0.78-1.04],0.169916223668481
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TSPYL1,Testis-specific Y-encoded-like protein 1,19252,163,0.71 [0.48-1.06],0.0919529650709825
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TST,Thiosulfate sulfurtransferase,22138,182,0.87 [0.72-1.04],0.1185432969362407
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TTF2,Transcription termination factor 2,19251,160,0.96 [0.70-1.31],0.797811870820337
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TTN,Titin,19204,165,1.16 [0.96-1.41],0.1323525586099488
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TTR,Transthyretin,19606,166,1.00 [0.56-1.79],0.999772095338332
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TUBB3,Tubulin beta-3 chain,19195,164,0.83 [0.48-1.44],0.5154619468564818
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TWF2,Twinfilin-2,19801,169,0.88 [0.74-1.05],0.1649556098498816
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TXK,Tyrosine-protein kinase TXK,19422,163,1.14 [0.96-1.35],0.1445879786864564
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TXLNA,Alpha-taxilin,22595,190,0.94 [0.81-1.08],0.3669557506182468
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TXN,Thioredoxin,19466,167,0.93 [0.67-1.31],0.6876797546020654
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TXNDC15,Thioredoxin domain-containing protein 15,22813,190,1.15 [0.72-1.83],0.5636039074452146
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TXNDC5,Thioredoxin domain-containing protein 5,22944,191,0.89 [0.73-1.07],0.2196627530002772
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TXNDC9,Thioredoxin domain-containing protein 9,19765,168,0.94 [0.70-1.24],0.6461537843986296
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TXNL1,Thioredoxin-like protein 1,19159,164,1.02 [0.88-1.19],0.7824391276463284
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",22752,190,0.77 [0.58-1.03],0.0735392321380481
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TYMP,Thymidine phosphorylase,22592,184,0.81 [0.67-1.00],0.0450628414640401
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TYRO3,Tyrosine-protein kinase receptor TYRO3,22739,185,1.08 [0.68-1.71],0.7499102691622535
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",19252,163,0.77 [0.61-0.97],0.0288115916303603
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UBAC1,Ubiquitin-associated domain-containing protein 1,22638,187,1.12 [0.78-1.61],0.5267328752503457
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UBE2B,Ubiquitin-conjugating enzyme E2 B,19698,167,1.14 [0.70-1.86],0.5974067370630415
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,19806,170,0.85 [0.67-1.09],0.2070271690923278
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,19252,163,0.85 [0.64-1.13],0.2527444865442623
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UBQLN3,Ubiquilin-3,19204,165,1.11 [0.83-1.49],0.4845886161042261
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UBXN1,UBX domain-containing protein 1,19390,164,0.94 [0.75-1.17],0.5916185625769523
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,19705,168,0.95 [0.86-1.06],0.3568209056139265
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UGDH,UDP-glucose 6-dehydrogenase,19204,165,1.09 [0.95-1.25],0.2004309932396235
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UHRF2,E3 ubiquitin-protein ligase UHRF2,19204,165,0.70 [0.43-1.16],0.1651258178979422
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,22595,190,1.23 [0.88-1.72],0.2181317166847683
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UMOD,Uromodulin,22949,189,0.85 [0.68-1.07],0.164522248906976
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UNC5D,Netrin receptor UNC5D,19252,163,0.99 [0.56-1.75],0.9599282691379184
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UNC79,Protein unc-79 homolog,19107,162,0.94 [0.71-1.23],0.6262202362575964
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UNG,Uracil-DNA glycosylase,19698,167,0.86 [0.55-1.34],0.5027580789468753
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UPB1,Beta-ureidopropionase,19806,170,1.10 [0.95-1.28],0.197839210915684
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UPK3A,Uroplakin-3a,19195,164,0.88 [0.64-1.22],0.4488669047910527
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UPK3BL1,Uroplakin-3b-like protein 1,19394,163,1.02 [0.78-1.33],0.9045881792598558
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UROD,Uroporphyrinogen decarboxylase,19390,164,0.93 [0.75-1.15],0.481171249768521
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UROS,Uroporphyrinogen-III synthase,19251,160,1.01 [0.81-1.25],0.9527545989667364
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",USO1,General vesicular transport factor p115,22638,187,0.92 [0.80-1.06],0.2524592530561305
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",USP25,Ubiquitin carboxyl-terminal hydrolase 25,19698,167,0.94 [0.77-1.16],0.5708423035595158
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",USP28,Ubiquitin carboxyl-terminal hydrolase 28,19765,168,1.09 [0.75-1.58],0.6448038787675838
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",USP47,Ubiquitin carboxyl-terminal hydrolase 47,19204,165,1.03 [0.86-1.22],0.7728700921026944
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",USP8,Ubiquitin carboxyl-terminal hydrolase 8,22335,183,0.98 [0.85-1.12],0.7304164672481411
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UXS1,UDP-glucuronic acid decarboxylase 1,22228,185,1.07 [0.85-1.35],0.5776193002668362
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VAMP5,Vesicle-associated membrane protein 5,22335,183,1.03 [0.82-1.29],0.8186411169615362
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VAMP8,Vesicle-associated membrane protein 8,19252,163,0.88 [0.74-1.05],0.1660156667083264
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VASH1,Tubulinyl-Tyr carboxypeptidase 1,22702,187,0.84 [0.72-0.99],0.0344504735557127
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VASN,Vasorin,22358,189,1.04 [0.65-1.68],0.864516308148955
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VASP,Vasodilator-stimulated phosphoprotein,19809,169,0.87 [0.71-1.07],0.1824415097180401
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,22638,187,0.71 [0.37-1.37],0.3071637278054332
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VAV3,Guanine nucleotide exchange factor VAV3,19195,164,0.94 [0.81-1.09],0.4248576000912502
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,22771,192,1.46 [0.93-2.31],0.1036967121441777
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VCAN,Versican core protein,22944,191,0.99 [0.65-1.52],0.9748029676923397
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VCPKMT,Protein-lysine methyltransferase METTL21D,19107,162,1.10 [0.94-1.28],0.2317944188944044
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VEGFA,Vascular endothelial growth factor A,22923,190,1.10 [0.89-1.37],0.3749542427824003
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VEGFB,Vascular endothelial growth factor B,19252,163,1.24 [0.73-2.08],0.4274565525278548
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VEGFC,Vascular endothelial growth factor C,22813,190,1.00 [0.80-1.26],0.9770186054966296
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VEGFD,Vascular endothelial growth factor D,22952,190,1.07 [0.73-1.56],0.7265853108592231
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VGF,Neurosecretory protein VGF,19775,169,1.34 [0.83-2.17],0.2255920872658417
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VIM,Vimentin,22335,183,1.03 [0.92-1.16],0.5673691437919735
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VIPR1,Vasoactive intestinal polypeptide receptor 1,19304,165,1.14 [0.65-2.01],0.6380997261829997
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VIT,Vitrin,19806,170,1.20 [0.81-1.77],0.3729748597217859
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VMO1,Vitelline membrane outer layer protein 1 homolog,22638,187,1.24 [1.01-1.52],0.0402156426521393
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VNN1,Pantetheinase,19809,169,1.20 [0.97-1.47],0.0926057407740755
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VNN2,Vascular non-inflammatory molecule 2,22638,187,0.78 [0.60-1.03],0.0810585133204105
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VPS28,Vacuolar protein sorting-associated protein 28 homolog,19422,163,0.84 [0.67-1.07],0.161337448255789
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VPS37A,Vacuolar protein sorting-associated protein 37A,22638,187,1.03 [0.88-1.21],0.7296822948619559
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VPS4B,Vacuolar protein sorting-associated protein 4B,19698,167,0.85 [0.73-1.00],0.0503836701270808
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VPS53,Vacuolar protein sorting-associated protein 53 homolog,22638,187,0.92 [0.78-1.09],0.3428858584808338
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VSIG10,V-set and immunoglobulin domain-containing protein 10,19698,167,0.98 [0.64-1.49],0.916920826622907
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,19204,165,0.79 [0.49-1.27],0.3363566652374347
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VSIG2,V-set and immunoglobulin domain-containing protein 2,19698,167,0.98 [0.77-1.26],0.899405024957498
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VSIG4,V-set and immunoglobulin domain-containing protein 4,22719,190,1.07 [0.77-1.49],0.6781817196771427
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,22704,185,0.87 [0.70-1.08],0.2118468894588561
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VSNL1,Visinin-like protein 1,19765,168,1.21 [0.84-1.74],0.3073095574227512
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VSTM1,V-set and transmembrane domain-containing protein 1,22176,182,1.03 [0.79-1.35],0.8040154658582397
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VSTM2B,V-set and transmembrane domain-containing protein 2B,19422,163,1.10 [0.80-1.52],0.5561139036872503
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,22335,183,0.94 [0.75-1.19],0.630499433076601
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,22944,191,0.82 [0.69-0.98],0.0301440612253995
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VTCN1,V-set domain-containing T-cell activation inhibitor 1,22228,185,1.14 [0.76-1.72],0.513345984523824
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,19390,164,0.92 [0.71-1.20],0.5499277093094891
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VWA1,von Willebrand factor A domain-containing protein 1,22903,188,0.89 [0.65-1.21],0.4445191470419631
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VWA5A,von Willebrand factor A domain-containing protein 5A,19107,162,0.99 [0.82-1.19],0.898289461410196
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VWC2,Brorin,22511,189,1.41 [1.01-1.96],0.0455102976918823
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VWC2L,von Willebrand factor C domain-containing protein 2-like,19775,169,1.13 [0.87-1.47],0.3536578690215988
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VWF,von Willebrand factor,23014,190,1.03 [0.87-1.23],0.7238510992419966
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WARS,"Tryptophan--tRNA ligase, cytoplasmic",22752,190,0.82 [0.58-1.15],0.2420124079363535
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WAS,Wiskott-Aldrich syndrome protein,22309,181,0.87 [0.71-1.06],0.1748358719185587
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WASF1,Wiskott-Aldrich syndrome protein family member 1,22335,183,0.96 [0.83-1.11],0.5770820227479672
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WASF3,Wiskott-Aldrich syndrome protein family member 3,22176,182,1.06 [0.91-1.25],0.4573866090926571
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WASHC3,WASH complex subunit 3,19765,168,0.97 [0.79-1.18],0.7560474221274439
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WASL,Neural Wiskott-Aldrich syndrome protein,19252,163,0.91 [0.70-1.18],0.4878848377800731
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WDR46,WD repeat-containing protein 46,19698,167,0.96 [0.63-1.44],0.8310657493343193
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WFDC1,WAP four-disulfide core domain protein 1,19309,163,1.23 [1.00-1.51],0.0547755426033778
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WFDC12,WAP four-disulfide core domain protein 12,22915,189,1.20 [0.99-1.46],0.0572225891211759
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,21571,181,1.91 [1.41-2.58],2.6170999547057386e-05
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",22531,188,1.88 [1.40-2.53],2.8260166524622773e-05
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",22780,190,1.07 [0.74-1.55],0.7068395345525913
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WIF1,Wnt inhibitory factor 1,22943,189,1.43 [0.99-2.07],0.0586829709778926
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WNT9A,Protein Wnt-9a,22309,181,0.87 [0.54-1.39],0.5656851914692931
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,22595,190,0.99 [0.78-1.26],0.9291686769240908
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",XCL1,Lymphotactin,22943,189,1.17 [0.95-1.42],0.1344314055951507
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",XG,Glycoprotein Xg,22899,189,1.40 [0.93-2.10],0.1058186962554076
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",XIAP,E3 ubiquitin-protein ligase XIAP,19252,163,0.93 [0.71-1.21],0.5810025362538571
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",XPNPEP2,Xaa-Pro aminopeptidase 2,22813,190,0.95 [0.82-1.09],0.4528846176339428
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",XRCC4,DNA repair protein XRCC4,22176,182,0.72 [0.50-1.05],0.0921645626339832
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",YAP1,Transcriptional coactivator YAP1,19765,168,1.83 [1.11-3.01],0.0179343944758731
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",19705,168,0.95 [0.86-1.04],0.2705937043743077
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",YES1,Tyrosine-protein kinase Yes,22638,187,0.96 [0.85-1.07],0.426469160300668
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",YJU2,Splicing factor YJU2,19698,167,0.91 [0.57-1.45],0.6942855036651705
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",YOD1,Ubiquitin thioesterase OTU1,19204,165,1.10 [0.87-1.39],0.4143391181326536
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",YTHDF3,YTH domain-containing family protein 3,22309,181,0.97 [0.83-1.14],0.7239970436323296
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",YWHAQ,14-3-3 protein theta,19390,164,0.85 [0.69-1.05],0.1349491781091109
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",YY1,Transcriptional repressor protein YY1,19252,163,1.04 [0.60-1.78],0.895312750527319
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ZBP1,Z-DNA-binding protein 1,19252,163,0.71 [0.45-1.11],0.1316292759978826
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ZBTB16,Zinc finger and BTB domain-containing protein 16,22228,185,0.90 [0.74-1.09],0.2882112522186376
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ZBTB17,Zinc finger and BTB domain-containing protein 17,22335,183,0.95 [0.68-1.32],0.7596748039275913
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ZCCHC8,Zinc finger CCHC domain-containing protein 8,19204,165,0.92 [0.71-1.20],0.5314985304519221
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ZFYVE19,Abscission/NoCut checkpoint regulator,19705,168,0.85 [0.72-1.00],0.0522808622691837
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ZHX2,Zinc fingers and homeoboxes protein 2,19765,168,0.72 [0.42-1.24],0.2390481014478208
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ZNF174,Zinc finger protein 174,19252,163,0.87 [0.57-1.33],0.514395450856415
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ZNF75D,Zinc finger protein 75D,19422,163,1.12 [0.90-1.40],0.3180385065709118
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ZNF830,Zinc finger protein 830,19698,167,1.02 [0.85-1.22],0.8557918711362744
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ZNRD2,Protein ZNRD2,19705,168,1.00 [0.81-1.24],0.969663051329843
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,19698,167,1.00 [0.76-1.31],0.9906306899402716
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ZP3,Zona pellucida sperm-binding protein 3,19304,165,0.99 [0.93-1.04],0.6319966258052016
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ZP4,Zona pellucida sperm-binding protein 4,19107,162,0.78 [0.47-1.32],0.362836120962683
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ZPR1,Zinc finger protein ZPR1,19195,164,1.01 [0.87-1.17],0.9356076096685768
